BEGIN:VCALENDAR VERSION:2.0 PRODID:-//Alliance for SoCal Innovation - ECPv6.15.17//NONSGML v1.0//EN CALSCALE:GREGORIAN METHOD:PUBLISH X-WR-CALNAME:Alliance for SoCal Innovation X-ORIGINAL-URL:https://alliancesocal.org X-WR-CALDESC:Events for Alliance for SoCal Innovation REFRESH-INTERVAL;VALUE=DURATION:PT1H X-Robots-Tag:noindex X-PUBLISHED-TTL:PT1H BEGIN:VTIMEZONE TZID:America/Los_Angeles BEGIN:DAYLIGHT TZOFFSETFROM:-0800 TZOFFSETTO:-0700 TZNAME:PDT DTSTART:20220313T100000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0700 TZOFFSETTO:-0800 TZNAME:PST DTSTART:20221106T090000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:-0800 TZOFFSETTO:-0700 TZNAME:PDT DTSTART:20230312T100000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0700 TZOFFSETTO:-0800 TZNAME:PST DTSTART:20231105T090000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:-0800 TZOFFSETTO:-0700 TZNAME:PDT DTSTART:20240310T100000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0700 TZOFFSETTO:-0800 TZNAME:PST DTSTART:20241103T090000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:-0800 TZOFFSETTO:-0700 TZNAME:PDT DTSTART:20250309T100000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0700 TZOFFSETTO:-0800 TZNAME:PST DTSTART:20251102T090000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:-0800 TZOFFSETTO:-0700 TZNAME:PDT DTSTART:20260308T100000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0700 TZOFFSETTO:-0800 TZNAME:PST DTSTART:20261101T090000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:-0800 TZOFFSETTO:-0700 TZNAME:PDT DTSTART:20270314T100000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0700 TZOFFSETTO:-0800 TZNAME:PST DTSTART:20271107T090000 END:STANDARD END:VTIMEZONE BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20231025T183000 DTEND;TZID=America/Los_Angeles:20231025T203000 DTSTAMP:20260406T100728 CREATED:20231104T031832Z LAST-MODIFIED:20231104T031833Z UID:3796-1698258600-1698265800@alliancesocal.org SUMMARY:Whisky Tasting DESCRIPTION:The Alliance’s final Leadership Engagement and Discussion (LEAD) event of 2023. At a stunning modern home in LaCanada\, we will enjoy a tasting of a variety of Japanese whiskeys. The Alliance is dedicated to fostering collaboration and driving innovation in Southern California. This evening’s event will provide a relaxed environment to connect with your peers\, exchange ideas\, and forge valuable partnerships. . . and of course drink some good whisky! \n\n\n\nWhisky Expert: \n\n\n\nRenowned whisky expert Narbe Zohrabi\, led the tasting. Narbe has been a Whisky Enthusiast/Collector for 17 Years. During this time he’s been fortunate to try over 10\,000+ whiskies and share his experience doing reviews on his YouTube channel called Malt Reviews. He is also the Private Client Manager for Moet Hennessy. URL:https://alliancesocal.org/event/whisky-tasting/ CATEGORIES:Alliance Events ORGANIZER;CN="Alliance for SoCal Innovation":MAILTO:info@alliancesocal.org END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20240123T100000 DTEND;TZID=America/Los_Angeles:20240123T114500 DTSTAMP:20260406T100728 CREATED:20240109T221336Z LAST-MODIFIED:20240125T165827Z UID:4848-1706004000-1706010300@alliancesocal.org SUMMARY:Research Innovation Spotlight on Small Molecule Oncology 1.23.2024 DESCRIPTION:This is an exclusive invite-only opportunity for selected industry professionals (corporate representatives and venture investors) to attend our virtual Research Innovation Spotlight on Small Molecule Oncology featuring engaging presentations followed by moderated audience Q&A from four leading researchers based in Southern California. \n\n\n\n​You will learn about current research from principle investigators who are working on breakthroughs that would benefit from relationships with industry and/or additional investment in the research. This is a unique opportunity to see early advances before they are commercialized. \n\n\n\n​Presenting Researchers \n\n\n\nDr. Matthew Rettig\, M.D.; Medical Director\, Prostate Cancer Program of the Institute of Urologic Oncology at UCLA (profile). \n\n\n\n​Research presenting: analogs of JN103 that have similar in vitro performance as JN103 with improved PK\, which we have already partially demonstrated to be the case with one of our analogs (JN185). \n\n\n\n​—– \n\n\n\n​Dr. Wendong Huang\, Ph.D.; Professor\, Beckman Research Institute of City of Hope; Adjunct Professor of USC Keck Medical School; Professor\, Department of Diabetes Complications & Metabolism at City of Hope (profile). \n\n\n\n​Research presenting: a promising clinical strategy to treat lymphoma and other Myc-positive tumors with development of a potent berbamine derivative compound which selectively targets CamkII kinase. \n\n\n\n​—– \n\n\n\n​Dr. Mohan Kaadige\, Ph.D.; Research Associate Professor\, Applied Cancer Research and Drug Discovery Translational Genomics Research Institute\, part of City of Hope (profile). \n\n\n\n​Research presenting: findings from our preclinical investigation of TGN-1062\, a dual CDK7 and FLT3 inhibitor which shows potent anti-AML activity and synergizes with Venetoclax \n\n\n\n​—– \n\n\n\n​Dr. Jean Shih\, Ph.D.; Boyd & Elsie Welin Professor\, Pharmacology and Pharmaceutical Sciences at USC (profile). \n\n\n\n​Research presenting: NMI\, a near-infrared MAO-A inhibitor\, is a potent dual-action theranostic molecule enabling non-invasive diagnosis and treatment of brain\, prostate\, and colon cancers\, with added utility for tumor margin visualization during surgery. \n\n\n\n​—– \n\n\n\n​Event Moderator: Chris LeMasters\, CEO at XinThera\, a Gilead Company (profile) \n\n\n\n​XinThera\, Inc.\, a privately held biotechnology company focused on small molecule discovery and development of oncology and immunology therapeutics. \n\n\n\nProgram Format​• Virtual live presentations of 4 research projects \n\n\n\n​• Each project lead gets up to 10 minutes to present their research followed by moderated attendee Q&A for the remainder of their time (a total of 20 minutes per presenter). \n\n\n\n​Agenda \n\n\n\n​10:00 AM Welcome & Attendee Introductions10:15 AM Presentations and moderated Q&A11:45 AM Program Concludes \n\n\n\nFull video recording\n\n\n\n\n\n\n\n\n\nTimestamps: 00:00 Intros 00:21:25 Dr. Retting 00:41:40 Dr. Huang 00:59:25 Dr. Kaadige 01:21:24 Dr. Shih \n\n\n\n​Why You Should Attend​• Better understand compelling innovations emerging from SoCal’s finest research institutions \n\n\n\n​• See multiple solutions and technologies from a variety of geographies in one virtual session \n\n\n\n​• Interact directly with the primary investigators to discuss potential future applications and build valuable relationships \n\n\n\n​For our Life Sciences spotlight series\, the Alliance has partnered with BioscienceLA who bring an abundance of subject matter and industry experience. In addition\, we are grateful to Foresite Capital for underwriting the series and providing additional expertise and guidance. \n\n\n\n​Previous Spotlights and more program information can be found the Research Innovation Spotlight Series homepage. URL:https://alliancesocal.org/event/research-innovation-spotlight-on-small-molecule-oncology-1-23-2024/ LOCATION:Virtual via Zoom CATEGORIES:Alliance Events ATTACH;FMTTYPE=image/png:https://alliancesocal.org/wp-content/uploads/2024/01/RISS-Tile-with-sponsor.png ORGANIZER;CN="Alliance for SoCal Innovation":MAILTO:info@alliancesocal.org END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20240521T130000 DTEND;TZID=America/Los_Angeles:20240521T200000 DTSTAMP:20260406T100728 CREATED:20231206T232520Z LAST-MODIFIED:20240625T233937Z UID:4122-1716296400-1716321600@alliancesocal.org SUMMARY:First Look SoCal Innovation Showcase 2024 DESCRIPTION:Tuesday May 21 @ Skirball Cultural Center in Los Angeles (map) \n\n\n\nTHANK YOU FOR ATTENDING FIRST LOOK SOCAL 2024\n\n\n\nCheck out the Photo Gallery and Videos for Keynote and Startup Pitches \n\n\n\n\nPhoto & Video Gallery\n\n\n\n\n\n\n\n\nThe First Look SoCal Innovation Showcase is an annual celebration of the best early-stage teams commercializing deep tech and life science breakthroughs from the top research institutions in Southern California. This is the premiere gathering that celebrates research-based spinouts and connects them with top-tier investors and successful serial entrepreneurs with expertise to help them leap from the lab to market.  \n\n\n\n \n\n\n\nThe day’s program will feature a pair of keynote presentations followed by a full program of 24 quick-pitch presentations with investor-led Q&A. Stay for the networking reception to (re)connect with the community. \n\n\n\nLimited seats available for a special pre-event founder workshop on Protecting and Commercializing Intellectual Property. More details below.  \n\n\n\n \n\n\n\nLook Forward To…\n\n\n\nConnect with investors\, peers\, and mentors\n\n\n\nUnparalleled opportunities to connect with investors\, mentors and other support resources crucial for early stage startups. Past years attracted over 300 attendees including over 130 investors such as Lux Capital\, Alexandria Venture Investments\, Kairos\, Wavemaker 360\, NXT Biomedical\, NEA\, Elevation Ventures\, FullCycle\, Aligned Climate Capital\, Mitsubishi Ventures and many more.  \n\n\n\nKeynotes\n\n\n\nThe opening keynote from Keith Strier\, VP of Worldwide AI Initiatives at NVIDIA who will discuss the implications and opportunities of ubiquitous computing (AI) followed by a keynote from Mike Miller\, Director of Product at AWS (Amazon) who will show you how they built a generative AI app-building playground in ‘startup mode’ inside of a massive company like AWS. \n\n\n\nStartup quick-pitch presentations\n\n\n\nTwo concurrent tracks (Life Science and Technology) where each track features 12 startups doing 3-minute quick pitch presentations followed by 9 minutes of moderated Q&A led by a panel of investors\, corporates and subject matter experts. See full lineup below. \n\n\n\nThe largest showcase of university-based deep tech and life science startups\n\n\n\nThis is SoCal’s premiere gathering of the best startups emerging from the region’s top research institutions so it attracts the region’s community in a rare concentrated program that celebrates the entrepreneur’s journey from lab to market. \n\n\n\nWorkshop for startup founders (limited seats available)\n\n\n\nLearn from subject matter experts in IP law and licensing best practices for protecting and monetizing intellectual property as well as early stage startup commercialization of deep tech and life science innovations. \n\n\n\nNetworking Reception\n\n\n\nStay for drinks and small bites as we celebrate and connect with attendees and speakers. \n\n\n\nFree Parking\n\n\n\nParking is available in the Skirball’s North Parking garage\, located underground at the north end of the Skirball’s main driveway\, approximately 150 yards north of our Main Entrance. Parking is also available in the East Parking garage\, located across Sepulveda Blvd. \n\n\n\n\n\nLead Sponsor \n\n\n\n \n \n \n \n \n \n \n \n \n \n \n\n\nTrack Sponsors \n\n\n\n \n \n \n \n \n \n \n \n \n \n \n\n\n \n \n \n \n \n \n \n \n \n \n \n\n\nTransportation Sponsor \n\n\n\n \n \n \n \n \n \n \n \n \n \n \n\n\n\n\nAgenda\n\n\n\n1:00p: Pick up Name Badge + Networking \n\n\n\n1:30p: Opening remarks and Keynotes: Keith Strier\, Vice President of Worldwide AI Initiatives at NVIDIA and Mike Miller\, Director of Product at Amazon Web Services \n\n\n\n2:45p: Startup Pitch Presentations \n\n\n\n\n\nLIFE SCIENCE TRACKTECHNOLOGY TRACKSession 1 (2:45 – 3:50p)Medtech Session 1Computing & SoftwareBreak (3:50 – 4:10p)BREAKBREAKSession 2 (4:10 – 5:15p)Medtech Session 2Energy & MaterialsBreak (5:15 – 5:35p)BREAKBREAKSession 3 (5:35-6:40p)TherapeuticsHealth Tech\n\n\n\n\n\n6:40 – 8:00p: Networking Reception \n\n\n\nWhy You Should Attend:  \n\n\n\n\nGet a first look at emerging technology with high potential for market disruption and impact\n\n\n\nDiscover companies seeking early stage funding to commercialize big ideas with massive potential\n\n\n\nSee 24 emerging startups quick pitches w/Q&A led by specialized investors with deep domain expertise\n\n\n\nUnparalleled in-person networking opportunities\n\n\n\n\nRegistration \n\n\n\n\nAttendee Registration\n\n\n\n\n \n\n\n\nSpeakers and Startups\n\n\n\nKEYNOTE SPEAKERS\n\n\n\n\n \n \n \n \n \n Keith Strier\n Vice President\, Worldwide AI Initiatives\n NVIDIA\n View Bio \n \n \n \n \n \n \n \n \n \n \n Keith Strier\n Vice President\, Worldwide AI Initiatives\n NVIDIA\n \n \n \n \n \n \n \n Keith Strier is vice president of worldwide AI initiatives at NVIDIA\, with responsibility for NVIDIA’s strategic and commercial engagements with foreign governments. He also leads the company’s AI Nations Initiative\, facilitating public-private partnerships that help governments build sovereign AI capabilities to drive economic growth. Strier has 30 years of global leadership experience\, previously serving as the first global AI leader for EY and the first global chief digital officer for Deloitte. He has also been appointed to multiple AI policy advisory roles across the world\, serving on the U.S. National AI Advisory Committee (NAIAC) to help coordinate the AI strategy for the President; as Founding Chair\, AI Compute and Climate Expert Group\, OECD\, leading development of the first blueprint for building domestic compute capacity; and as the only non-Australian on Australia’s National AI Centre Think Tank. Strier holds a bachelor’s degree in labor and industrial relations from Cornell University and a J.D. from the New York University School of Law. He also served 10 years as a visiting lecturer at Harvard Medical School’s Center for BioInformatics. \n \n \n \n \n \n \n \n \n \n Mike Miller\n Director of Product\, AWS \n Amazon\n View Bio \n \n \n \n \n \n \n \n \n \n \n Mike Miller\n Director of Product\, AWS \n Amazon\n \n \n \n \n \n \n \n Mike Miller is a Director of Product Management at AWS\, leading multiple initiatives across AWS focusing on Generative AI. In November of 2023\, his team launched PartyRock\, an Amazon Bedrock Playground\, a fun\, intuitive\, and hands-on generative AI app-building playground – no coding skills required. Mike previously led the AWS AI & ML Thought Leadership team\, who brought AWS DeepLens\, AWS DeepRacer\, and AWS DeepComposer to developers worldwide\, helping aspiring machine learning developers get hands-on with the latest technologies. In 2020 Mike’s team launched AWS Panorama\, a service that allows organizations to bring computer vision (CV) to on-premises cameras to make predictions locally with high accuracy and low latency. Mike has been with Amazon for over eleven years\, previously leading product management for Fire TV at Lab126 before joining Amazon Web Services. Mike has over 30 years of technology experience from startups to large corporations\, including leadership roles at Google\, OnLive\, Motive\, and Trilogy\, spanning Silicon Valley and Austin\, TX. He holds bachelor’s and master’s degrees from MIT in Electrical Engineering and Computer Science. \n \n \n \n \n \n \n\n\n\n\n\n\n\nPRESENTING STARTUPS\n\n\n\nLife Science Track \n\n\n\n\n\n\n\n\n\n\n\nTechnology Track \n\n\n\n\n\n\n\n\n\n\n\nSelection Committee\n\n\n\nThank you to the following members of the ecosystem who lent their subject matter expertise to evaluate the Life Science applicants. Criteria used were 1) novelty/quality of the solution/invention 2) size of commercial opportunity and/or overall potential and 3) do they fit the First Look SoCal mission of showcasing breakthrough innovations emerging from SoCal institutions. The final 12 startups were ultimately chosen by Alliance for SoCal Innovation staff using the feedback provided by the Selection Committee. \n\n\n\nAllen Keel\, Senior Director\, Innovation at Edwards LifesciencesBeth Andrews\, Chief Digital Health Officer at Dell TechnologiesChris Bostick\, Partner at OCVChris Lew\, Principal at Rock Health AdvisoryDave Whelan\, Managing Director at Bespoke StrategyDavid H. Crean\, Managing Partner at Coast BioVentures LLCDebbie Lin\, Venture Partner at T.Rx CapJay Goss\, General Partner at Wavemaker Three-Sixty HealthKathryn Zavala\, Chief Operating Officer at MedTech Innovator \n\n\n\n\n\n\n\n\n \n \n \n \n Meet the "Judges"\n \n \n \n \n \n \n \n \n Representatives of industry (VCs\, corporate leaders) with domain expertise in frontier tech and life science innovation. \n \n\n \n \n \n \n \n \n\n \n \n\n \n Brian Wayne\n\n \n Managing Partner & Co-Founder\n CurvePoint Capital\n \n \n\n \n Bio \n \n \n \n \n \n\n \n \n\n \n Stephanie Gonzales\n\n \n Strategic Innovation and Care Solutions Director\n Kaiser Permanente\n \n \n\n \n Bio \n \n \n \n \n \n\n \n \n\n \n Tari Suprapto\n\n \n Director\, Search and Evaluation (West)\n Novo Nordisk\n \n \n\n \n Bio \n \n \n \n \n \n\n \n \n\n \n Kate Avaline Edwards\n\n \n Early Stage VC/Startup Business Development\n AWS\, Amazon\n \n \n\n \n Bio \n \n \n \n \n \n\n \n \n\n \n Duncan Huston-Paterson\n\n \n Director of Business Development\n Amgen\n \n \n\n \n Bio \n \n \n \n \n \n\n \n \n\n \n Beth Andrews\n\n \n Chief Digital Health Officer\, Life Sciences and Healthcare\n Dell Technologies\n \n \n\n \n Bio \n \n \n \n \n \n\n \n \n\n \n Aiden Aceves\n\n \n Vice President\, Investments\n Insight Partners\n \n \n\n \n Bio \n \n \n \n \n \n\n \n \n\n \n Tad Funahashi\, MD\n\n \n Chief Innovation and Transformation Officer\n Kaiser Permanente of Southern California\n \n \n\n \n Bio \n \n \n \n \n \n\n \n \n\n \n Allen Keel\n\n \n Senior Director of Strategic Innovation\, Advanced Technology \n Edwards Lifesciences\n \n \n\n \n Bio \n \n \n \n \n \n\n \n \n\n \n Tulsi Patel\n\n \n Head of LA Office\n FedTech\n \n \n\n \n Bio \n \n \n \n \n \n\n \n \n\n \n Zafer Sahinoglu\n\n \n VP Innovation\, GM – Mitsubishi Electric Innovation Center\n MELIC – Mitsubishi Electric Innovation Center \n \n \n\n \n Bio \n \n \n \n \n \n\n \n \n\n \n Kathyrn Zavala\n\n \n COO and Managing Director\, Biotools Innovator\n MedTech Innovator\n \n \n\n \n Bio \n \n \n \n \n \n\n \n \n\n \n Farahnaz Forozan\n\n \n President / CEO\n Forozan OncoGen Consulting\n \n \n\n \n Bio \n \n \n \n \n \n\n \n \n\n \n Eric Lee\n\n \n Senior Vice President\n Aligned Climate Capital\n \n \n\n \n Bio \n \n \n \n \n \n\n \n \n\n \n Katie Vasquez\n\n \n Investor\n Calibrate Ventures\n \n \n\n \n Bio \n \n \n \n \n \n\n \n \n\n \n Roberto Medrano\n\n \n CEO\n Beach View Capital\n \n \n\n \n Bio \n \n \n \n \n \n\n \n \n\n \n David Crean\n\n \n Managing Partner\n Cardiff Advisory\, LLC\n \n \n\n \n Bio \n \n \n \n \n \n\n \n \n\n \n Les Karpas\n\n \n Inception Partner Manager\, Robotics\, Automotive & Manufacturing\n NVIDIA\n \n \n\n \n Bio \n \n \n \n \n \n\n \n \n\n \n Ken Hayes\n\n \n Executive Director\n Cleantech Open\n \n \n\n \n Bio \n \n \n \n \n \n\n \n \n\n \n Howard Ko\n\n \n Partner\n Morpheus Ventures\n \n \n\n \n Bio \n \n \n \n \n \n\n \n \n\n \n Ahmed Mirza\n\n \n Investor\n Techstars\n \n \n\n \n Bio \n \n \n \n \n \n\n \n \n\n \n Erik Gonzalez-Leon\n\n \n Analyst\n Propel Bio Partners\n \n \n\n \n Bio \n \n \n \n \n \n\n \n \n\n \n Lucy Abgaryan\n\n \n Founder\n GrittGene Therapeutics\n \n \n\n \n Bio \n \n \n \n \n \n\n \n \n\n \n Steven Chin\n\n \n Regional Director of Neonatology\n Children’s Hospital Los Angeles\n \n \n\n \n Bio \n \n \n \n \n \n\n \n \n\n \n Leanna Levine\n\n \n President & CEO\n ALine\, Inc.\n \n \n\n \n Bio \n \n \n \n \n \n\n \n \n\n \n Iván Markman\n\n \n Startup Advisor\, Angel Investor\n Former CBO at Yahoo!\n \n \n\n \n Bio \n \n \n \n \n \n\n \n \n\n \n Dave Whelan\n\n \n Managing Director\n Bespoke Business Strategy Inc.\n \n \n\n \n Bio \n \n \n \n\n \n \n \n \n \n \n\n \n\n \n \n \n \n \n \n \n \n \n \n \n\n \n \n \n \n \n \n\n \n \n Brian Wayne\n\n \n Managing Partner & Co-Founder\n CurvePoint Capital\n \n \n\n \n \n \n \n \n \n\n \n \n \n Brian is the Managing Partner & Co-Founder of CurvePoint Capital\, a growth stage climate tech investment firm. CurvePoint focuses on investing in broadscale decarbonization themes through technology companies across areas of the built environment\, distributed energy resources and advanced materials. \n\nPrior to founding CurvePoint\, Brian was the co-founder of the Aegon Climate Capital strategy at Aegon Asset Management\, with a thesis of investing in companies solving the world’s most pressing issues related to the environment and society. Brian joined Aegon in 2017 to lead the design\, development\, and commercialization of numerous global investment businesses\, with a specific emphasis on sustainability and impact-related solutions and was the co-chair of Aegon’s US Social Responsibility Committee. \n\nPrior to Aegon\, Brian spent a decade at Congress Asset Management investing in private equity and venture capital and was head of product strategy\, deploying in excess of $1 billion across innovative ventures. \n\nBrian also is the co-founder of The Water Genome. A 501(c)3 non-profit impact studio that focuses on identifying and catalyzing water technologies to solve health and climate resilience issues.\n\nHe is a member of The Milken Institute’s Young Leaders Circle\, an expert advisor at AltaSea at the Port of Los Angeles\, and a startup mentor to the gener8tor sustainability program.\n \n \n \n \n\n \n \n \n \n \n \n\n \n \n Stephanie Gonzales\n\n \n Strategic Innovation and Care Solutions Director\n Kaiser Permanente\n \n \n\n \n \n \n \n \n \n\n \n \n \n Stephanie is the Strategic Innovation and Care Solutions Director for the Kaiser Permanente Care Transformation Office. Her team of physician leaders\, designers\, and consultants explore new possibilities and create care systems\, leveraging technologies\, clinical expertise\, and human-centered design. The team is tasked with transforming healthcare delivery through virtual care\, analytics\, and artificial intelligence advancements. Stephanie is responsible for collaborating with multiple leaders to set the strategic roadmap\, oversee operational execution\, bring innovation to scale\, and transform healthcare ideas into real-world solutions.\n\nPrior to this role\, Stephanie served as the founding Administrator for the Regional Virtual Medical Center Clinical Operations team and has over 15 years of operational experience in ambulatory and acute care settings. During her tenure with Kaiser Permanente\, she has successfully created high-performing teams and executed new and innovative ideas.\n\nStephanie earned her MPH from UCLA \n \n \n \n\n \n \n \n \n \n \n\n \n \n Tari Suprapto\n\n \n Director\, Search and Evaluation (West)\n Novo Nordisk\n \n \n\n \n \n \n \n \n \n\n \n \n About Tari Suprapto\n \n Tari Suprapto\, Ph.D.\, RTTP is a seasoned technology commercialization professional in the life sciences. She is currently the Director for Search & Evaluation for Western US and Canada for Novo Nordisk\, and previously was part of the External Innovation team at Elanco. Tari spent over 15 years commercializing innovations from world-class research institutions such as the Salk Institute\, The Rockefeller University\, and Memorial Sloan-Kettering Cancer Center.  Tari has extensive experience in licensing\, building and managing strategic alliances\, and a strong scientific background in a variety of therapeutic areas evidenced by her Ph.D. in cell biology from The Rockefeller University and an Honors B.A. from Swarthmore College.  Tari is also a member of BIOCOM’s Capital Development Committee and serves on the Board of the Association for University Technology Managers\, the San Diego Innovation Council\, and official advisor to Founders Corner Venture Capital in San Diego. \n \n \n \n\n \n \n \n \n \n \n\n \n \n Kate Avaline Edwards\n\n \n Early Stage VC/Startup Business Development\n AWS\, Amazon\n \n \n\n \n \n \n \n \n \n\n \n \n \n Kate was the first employee at Amp\, an internal live audio startup funded within Amazon Music. Kate helped grow the Amp team from 2 to 300 employees and managed 4 customer-facing teams as the Head of Creator Services. Amp\, which was greenlit by Jeff Bezos in 2020\, was a consumer app that enabled music-lovers to host their own live radio shows featuring licensed music and their own commentary. Think Twitch\, but for music aficionados rather than gamers.\n\nKate was previously the co-founder and COO of Heartbeat a B2B marketing software and B2C creator app that was the technology backbone behind tens of thousands of sponsored content posts on Instagram\, TikTok\, and beyond. Heartbeat went through the Techstars Los Angeles Accelerator program in Summer 2017\, raised $5M in venture funding\, and worked with over 400 DTC clients\, as well as Disney\, P&G\, Bose\, and Dunkin.\n\nAs COO of Heartbeat\, Kate led business operations\, OKR implementation\, product monetization\, and directly built and managed Sales\, Operations\, and Customer Success teams. She ran the full P&L including financial projections\, sales forecasting\, cash management\, and pricing\, and provided operational oversight across Product\, Marketing\, and Engineering teams. Kate is now part of AWS Startup Business Development\, a team of former startup founders\, investors\, and executives with one main goal: help startups succeed. She has been the Entrepreneur-in-Residence for Techstars LA and Techstars Iowa\, was rated a Techstars Top 1% mentor\, and runs a slack group focused on supporting women founders. She lives in LA with her son\, Wolf\, and her partner\, who she unsurprisingly also met at a startup. \n \n \n \n\n \n \n \n \n \n \n\n \n \n Duncan Huston-Paterson\n\n \n Director of Business Development\n Amgen\n \n \n\n \n \n \n \n \n \n\n \n \n About Duncan Huston-Paterson\n \n Duncan Huston-Paterson is a member of the Technology Business Development group. Duncan focuses on scouting and deal-making to access innovative technologies and platforms that enable the next generation of therapeutics at Amgen. Prior to joining Amgen in 2020\, Duncan spent 4 years at Integral Molecular where he led a team that developed\, launched\, and commercialized a novel target discovery platform\, resulting in multiple partnerships with large Pharma. Duncan grew up in South Africa and completed his early scientific training at University of Pretoria\, before going on to receive his DPhil at Oxford University in the UK\, where he studied the biochemical determinants of bird flu transmission to humans.\n \n \n \n \n\n \n \n \n \n \n \n\n \n \n Beth Andrews\n\n \n Chief Digital Health Officer\, Life Sciences and Healthcare\n Dell Technologies\n \n \n\n \n \n \n \n \n \n\n \n \n About Beth Andrews\n \n Allen currently serves as the Senior Director of Innovation for Edwards Lifesciences’ Advanced Technology Incubator. In his role\, he brings marketing\, engineering\, and clinical functions together to discover and build the next wave of groundbreaking products for the future of Edwards\, leading a team to build and implement the strategy for needs-driven innovation. The incubator is deeply dedicated to solving complex challenges in order to transform cardiovascular treatment and significantly improve patients’ lives around the world. Prior to Edwards\, Allen spent time in product management and R&D roles in various medtech industries ranging from digital health (Verily / Google Life Sciences) to cardiac rhythm management (St. Jude Medical)\, as well as a stint in management consulting with PwC’s medtech strategy & operations practice. In terms of educational background\, he holds an MBA from UC-Berkeley (Haas School of Business) and MS/BS in Biomedical Engineering from Johns Hopkins University. \n \n \n \n\n \n \n \n \n \n \n\n \n \n Aiden Aceves\n\n \n Vice President\, Investments\n Insight Partners\n \n \n\n \n \n \n \n \n \n\n \n \n \n Aiden Aceves is a Vice President on the investments team at Insight. He joined the firm in 2021 to focus on investments in therapeutics and enabling technologies. Aiden was previously an associate at Vida Ventures\, where he worked in the firm’s LA office making investments in innovative cell and gene therapy companies. Prior to becoming an investor\, Aiden worked on founding and operating biotechnology companies in San Diego California\, where he is based. \n\nAiden traces his academic lineage to Caltech\, where he earned his doctorate in the lab of Dr. Steven Mayo\, a leader in the space of computational protein engineering. Aiden received his B.S. in synthetic chemistry from the University of California\, Riverside. \n \n \n \n\n \n \n \n \n \n \n\n \n \n Tad Funahashi\, MD\n\n \n Chief Innovation and Transformation Officer\n Kaiser Permanente of Southern California\n \n \n\n \n \n \n \n \n \n\n \n \n \n Tad Funahashi\, MD is the Chief Innovation Officer for Kaiser Permanente Southern California. In this role\, he leads a team of physicians\, consultants\, designers\, data scientists\, and engineers​ who work together with teams and leaders across Kaiser Permanente ​to envision and build the healthcare delivery system of the future at the Kaiser Permanente Innovations Studio. Dr. Funahashi and the Innovation Studio take a people-first approach to healthcare to enhance the member experience by improving care across the continuum\, leveraging big data to provide personalized and improved quality of care\, and exploring merging opportunities that have transformative potential.\n\nDr. Funahashi maintains a busy clinical and teaching practice in orthopedic surgery and is a Clinical Professor of Orthopedic Surgery at University of California Irvine College of Medicine. Dr. Funahashi also founded and chairs the Kaiser Permanente National Implant Registries that currently tracks the safety and outcomes of over 3.2 million implants ranging from orthopedics and cardiology to vascular surgery. He has given hundreds of presentations across the country and internationally and has authored more than 60 papers in publications such as the Journal of Bone and Joint Surgery\, American Journal of Sports Medicine\, Journal of Pediatric Orthopedics\, and Journal of Bone and Mineral Research. Dr. Funahashi is a diplomat of the American Board of Orthopedic Surgery\, and an active fellow of the American Orthopedic Association\, American Academy of Orthopedic Surgeons\, American Orthopedic Society for Sports Medicine\, Arthroscopy Association of North America\, and a member of the Orange County Medical Association. He served as the Chief of the Department of Orthopedic Surgery in Kaiser Permanente Orange County from 1994 to 2012\, the Regional Chief of Orthopedic Surgery from 2004 to 2012\, Chaired the National Chiefs of Orthopedic Surgery from 2004 to 2012\, and an Assistant Area Medical Director from 1998 to 2012. He earned his medical degree and completed his orthopedic residency at UCLA School of Medicine. \n \n \n \n\n \n \n \n \n \n \n\n \n \n Allen Keel\n\n \n Senior Director of Strategic Innovation\, Advanced Technology \n Edwards Lifesciences\n \n \n\n \n \n \n \n \n \n\n \n \n \n Allen currently serves as the Senior Director of Innovation for Edwards Lifesciences’ Advanced Technology Incubator. In his role\, he brings marketing\, engineering\, and clinical functions together to discover and build the next wave of groundbreaking products for the future of Edwards\, leading a team to build and implement the strategy for needs-driven innovation. The incubator is deeply dedicated to solving complex challenges in order to transform cardiovascular treatment and significantly improve patients’ lives around the world. Prior to Edwards\, Allen spent time in product management and R&D roles in various medtech industries ranging from digital health (Verily / Google Life Sciences) to cardiac rhythm management (St. Jude Medical)\, as well as a stint in management consulting with PwC’s medtech strategy & operations practice. In terms of educational background\, he holds an MBA from UC-Berkeley (Haas School of Business) and MS/BS in Biomedical Engineering from Johns Hopkins University. \n \n \n \n\n \n \n \n \n \n \n\n \n \n Tulsi Patel\n\n \n Head of LA Office\n FedTech\n \n \n\n \n \n\n \n \n \n \n\nTulsi heads the Los Angeles Office of FedTech\, one of the world’s most successful innovation catalysts and entrepreneurial ecosystem builders. There she oversees multi-million dollar programming for the US Navy\, Northrop Grumman\, and other stakeholders.\n\nPreviously\, she served as the Director of Innovation and Partnerships for VentureFuel. There she ran accelerator programs for Fortune 500 companies and led executive briefings focused on blue ocean opportunities and startup partnerships. Prior to VentureFuel\, she was a Senior Associate at Plug and Play Ventures where she led investments and built multiple greatly successful innovation and accelerator programs. During her tenue\, Tulsi worked with 100+ significant global brands\, including PepsiCo\, Arcelor Mittal\, Swiss Post\, Tetra Pak\, BASF\, Ajinomoto\, Georgia Pacific\, Coca-Cola\, Sherwin Williams\, and Dominion Energy. As a result\, Tulsi has cultivated a nuanced skillset and extensive network of technology and innovation subject matter experts\, including top tier investors\, Fortune 500 companies\, and emerging startups. \n \n \n \n\n \n \n \n \n \n \n\n \n \n Zafer Sahinoglu\n\n \n VP Innovation\, GM – Mitsubishi Electric Innovation Center\n MELIC – Mitsubishi Electric Innovation Center \n \n \n\n \n \n \n \n \n \n\n \n \n \n Dr. Zafer Sahinoglu is currently the General Manager of Mitsubishi Electric Innovation Center (MELIC Ventures)\, which was launched in April 2020 as the innovation and investment arm of Mitsubishi Electric in North America. He is also serving as VP Innovation at Mitsubishi Electric US (MEUS). In MEUS\, he has developed and launched SaaS businesses and new products in the fields of energy management\, infrastructure monitoring\, touchless interfaces\, connected vehicles. He has led and managed product design and agile product development\, built new business models\, developed technology strategies\, and bundled these steps into customized processes with continuous innovation.\n\nZafer was a senior principal research scientist in MERL between 2001 and 2016. In his MERL years\, he was an inventor on more than 80 patents\, co-authored more than 100 international journal and conference papers\, made more than 50 key contributions to international standards including ZigBee\, IEEE 802.15.4a UWB PHY and MAC\, IEEE 802.15.4e MAC\, and MPEG 21. His technical expertise includes deep learning\, stochastic signal processing\, space-time adaptive processing\, ultra-wideband and OFDMA wireless communications\, and indoor localization and tracking\, biomedical signal processing\, and Li-ion battery modeling. He has written two books on wireless communication and localization systems published by Cambridge University Press. \n \n \n \n\n \n \n \n \n \n \n\n \n \n Kathyrn Zavala\n\n \n COO and Managing Director\, Biotools Innovator\n MedTech Innovator\n \n \n\n \n \n \n \n \n \n\n \n \n \n Kathryn Zavala\, PhD\, is Chief Operating Officer of MedTech Innovator\, the largest accelerator of medical devices in the world. In 2016\, she helped spin the nonprofit entity out of the venture capital firm where it was founded and has been instrumental in expanding the organization. To date\, MedTech Innovator has supported 612 alumni that have gone on to raise over $7.8 billion in follow-on equity funding and achieved 45 exits. In 2021\, Kathryn launched and now serves as Managing Director of BioTools Innovator\, a new program powered by MedTech Innovator to support life science tools.\nKathryn previously held positions at the UCLA Technology Development Group\, where she assisted with the commercialization of university technologies\, and at Campbell Alliance (now Syneos Health)\, where she developed launch strategies for biopharma clients. Kathryn received a Bachelor’s degree in Molecular and Cell Biology and Rhetoric from UC Berkeley and a PhD in Molecular\, Cell\, and Developmental Biology from UCLA. \n \n \n \n\n \n \n \n \n \n \n\n \n \n Farahnaz Forozan\n\n \n President / CEO\n Forozan OncoGen Consulting\n \n \n\n \n \n \n \n \n \n\n \n \n \n Farahnaz Forozan is a Clinical Ph.D.\, with 20+ years of global experience in the life sciences industry & proven track record having contributed to the development\, approval\, & post-marketing launch of more than 15 marketed products & more than 30 global programs in various stages of clinical development. She is the Founder & President of Vash ImmOnc\, LLC; a global\, virtual consulting firm that provides strategic\, regulatory\, & technical support to clients across the healthcare sector\, inducing biotech\, pharma\, VCs\, investment firms\, family offices\, global consulting companies\, platform companies\, diagnostic ompanies\, KOLs\, accelerator programs\, incubators\, early-stage startups\, research academic centers\, hospitals\, & laboratories\, encompassing the therapeutics\, diagnostics\, & med device sectors\, globally including Australia and Asia).\n\nShe offers a spectrum of expertise & experiences pertaining to pharma\, biotech\, diagnostics\, med device\, clinical development\, clinical trials & CRO/Central lab industries with specialized expertise in drug discovery/drug development\, evaluation and development of complex R&D/preclinical as well as clinical programs\, laboratory build outs\, implementing precision medicine\, developing global regulatory expertise in oncology\, & immuno-Oncology\, neurology\, autoimmune disorders\, and microbiome.\n\nThrough extended industry network & collaborations\, she provide expertise & develop partnerships & form consortiums\, with pharma\, biotech\, KOLs\, research academic centers\, device & diagnostic companies\, CROs\, tech transfer offices\, to not only develop innovative scientific programs but also co-develop & launch diagnostics\, device\, & therapeutic drugs by translating fundamental biology into impactful therapies\, de-risking new ideas by bringing them into a developmental pipeline\, fast tracking the evaluation with efficiency\, ensure the most promising drug targets are rapidly identified & validated\,\nand advance first-in-class therapies towards therapeutic & commercial success\, AND ultimately bring more groundbreaking therapies to patients.\n\nFarahnaz earned her Ph.D. through a joint program between the George Washington University & National Institutes of Health\, National Human Genome Research Institute and obtained her clinical licensure in Los Angles after completing her postdoc at UCLA\, while serving as Faculty at Cedars-Sinai Medical Center. \n \n \n \n\n \n \n \n \n \n \n\n \n \n Eric Lee\n\n \n Senior Vice President\n Aligned Climate Capital\n \n \n\n \n \n \n \n \n \n\n \n \n \n Eric Lee is a Senior Vice President with Aligned Climate Capital\, an asset manager that invests exclusively in the companies and real assets that are decarbonizing the global economy and its infrastructure. In this role\, Eric leads Aligned’s Environmental\, Social\, and Governance (ESG) analysis of climate infrastructure and venture capital investment opportunities. Previously\, Eric was an investment professional at TriLinc Global\, a global impact investing fund manager based in Los Angeles\, CA. At TriLinc\, Eric led the firm’s ESG & Impact efforts across all portfolios and served as a member of TriLinc’s Credit Committee and Sustainability & Impact Committee. Prior to TriLinc\, Mr. Lee worked at Sustainable Insight Capital Management\, an ESG public equities fund based in New York\, NY. Mr. Lee holds a B.S. from Cornell University and a M.S. in Sustainability Management with a concentration in Sustainable Finance from Columbia University. \n \n \n \n\n \n \n \n \n \n \n\n \n \n Katie Vasquez\n\n \n Investor\n Calibrate Ventures\n \n \n\n \n \n \n \n \n \n\n \n \n \n Before joining Calibrate\, Katie was an investor at MTech Capital\, investing in early- to growth-stage companies in the fintech and insurtech industries in the US and Europe. She has also worked as a strategy consultant at EY-Parthenon advising leading private equity firms and corporate executives in the software and technology sectors. Fascinated by the universe’s biggest questions\, Katie was an astrophysics major in college and conducted research on superfluid dark matter in dwarf galaxies.\n\nOutside of work\, Katie can often be found on the ski slopes or at a yoga class. She is also on the board of the LA Chapter of Synergist Network\, a network of women in investing. Katie received a BS in astrophysics with honors from Brown University.\n\nBest\, \n \n \n \n\n \n \n \n \n \n \n\n \n \n Roberto Medrano\n\n \n CEO\n Beach View Capital\n \n \n\n \n \n \n \n \n \n\n \n \n \n CEO Beach View\, previous GM of HP Software\, CEO Polivec\, President Finjan\, EVP Akana\, Executive Sun Microsystems\, ICO Advisor\, Board Member. Executive with 5 public companies\, 3 of them were private when he joined; 14 companies have been acquired when he was in a board position. Executive in the information technology field of cybersecurity\, Artificial Intelligence\, Blockchain\, IoT\, governance\, compliance\, software\, cloud\, SOA/API management and enterprise architecture. ICO and board advisor for several Blockchain\, AI and cloud companies. \n\nHe is has been an ICO advisor to more than 10 ICOs. Latest projects: www.Etheal.com \, VaultBank.io\, CapLinked.com\, www.transitnet.io\, www.BlockSafe.network\, www.bonafi.io\, www.ipwe.com\, www.blockchainbtm.com\, and others. He is also in the board of advisors to the following cloud AI companies: www.ContractSafe.com \, www.DeepCurrent.com\, www.durolabs.co. In addition\, he is an advisor to http://www.actoneventures.com/ VC firm\, https://www.manhattanstreetcapital.com/about-us\, and http://nex3.com/. He has been on the board of directors or board of advisors for more than 20 companies and organizations among others: Arcot (Acquired by CA)\, Aventail (aquired by SonicWall\, acquired by Dell)\, Encentuate (Acquired by IBM)\, Netscaler (Acquired by Citrix)\, Bigfix (Acquired by IBM)\, AirZip (Acquired by Willow Tech)\, Confluent Software (acquired by Oblix/Oracle)\, PivX (IPO 2004)\, Polivec\, Clearpath Networks\, Sand Hill IT Security (reverse IPO with EdgeWave)\, JackBe (acquired by SoftwareAG)\, NAFINSA\, Bancomext\, Technet. He has an MBA from UCLA\, MSEE from MIT and BSEE from USC. \n \n \n \n\n \n \n \n \n \n \n\n \n \n David Crean\n\n \n Managing Partner\n Cardiff Advisory\, LLC\n \n \n\n \n \n \n \n \n \n\n \n \n \n David H. Crean was a managing partner with Cardiff Advisory\, LLC where he led the firm’s strategic and financial advisory service practice focusing on mergers and acquisitions (M&A) and partnering transactions with life science and healthcare companies. For the past five years\, he was Managing Director for Objective Capital Partners\, LLC driving Objective’s practice in the same domains\, and currently serves in a Senior Advisory capacity with his former firm. Dr. Crean has in excess of 25 years of life sciences R&D\, corporate development and executive leadership experience in the healthcare and biopharmaceutical industries. Dr. Crean holds FINRA Series 79 and Series 63 licenses and is a Registered Investment Banking Representative of BA Securities LLC\, Member FINRA SIPC.\n\nIn parallel to his investment banking leadership\, Dr. Crean currently serves in leading roles on the Boards of Directors for Histogen\, Inc. (Nasdaq: HSTO) as Board Chairman and Chair of Audit\, and the California Life Sciences Association (CLSA) as Chairman of Development and a member of the Executive Committee. He serves as a strategic business advisor for several life science companies in the U.S.\, is a limited partner with a leading life sciences venture fund\, Mesa Verde Venture Partners\, and a member of Corporate Directors Forum. Dr. Crean is also a contributing author for PharmaBoardroom.com and Forbes.com through his work with Forbes Los Angeles Business Council. \n \n \n \n\n \n \n \n \n \n \n\n \n \n Les Karpas\n\n \n Inception Partner Manager\, Robotics\, Automotive & Manufacturing\n NVIDIA\n \n \n\n \n \n \n \n \n \n\n \n \n \n Leslie Oliver Karpas has a deep product centric background in computer vision\, SaaS\, digital manufacturing\, and robotics. A strategist\, evangelist\, and technologist with expertise in driving innovative solutions from inception to market; he’s collaborated with such entities as Stanley Black & Decker (DeWalt / Craftsman)\, Intellectual Ventures\, Singularity University\, Herman Miller\, iRobot\, Cirque du Soleil\, and the artist Anish Kapoor. He is passionate about innovative user-oriented design through the interplay between digital and physical environments be it computer vision AI at the edge\, mixed reality\, spatial computing\, advanced manufacturing\, or scan-to-fit 3D printing; and has been lead inventor on 5 issued patents around said technologies. \n \n \n \n\n \n \n \n \n \n \n\n \n \n Ken Hayes\n\n \n Executive Director\n Cleantech Open\n \n \n\n \n \n \n \n \n \n\n \n \n \n Ken Hayes helps start-ups grow\, get funded and build value. He joined Cleantech Open in 2017 as Executive Director with US National and Global responsibilities for this established environmental-tech startup accelerator\, working with 100 companies per year assisting them gain funding and establish corporate partnerships. Concurrently\, he is Co-founder and Venture Partner of Canyon Creek Capital’s Fund II\, a VC fund focused on SoCal tech companies from Seed to Series A\, with 40+ investments since 2014\, including early investments in companies such as Miso Robotics\, Relativity Space\, FIGS and Jukin Media. He is also a Director Emeritus of the Pasadena Angels\, one of the Top 10 angel groups in the US\, where he continues to focus on deal sourcing\, mentoring entrepreneurs\, and performing due diligence. Finally\, Ken is a “recovering entrepreneur” who has built and sold several companies in Europe and the USA\, in the ed-tech and ad-tech sectors. He earned an MBA at INSEAD\, France\, and a BA Economics at Pomona College. \n \n \n \n\n \n \n \n \n \n \n\n \n \n Howard Ko\n\n \n Partner\n Morpheus Ventures\n \n \n\n \n \n \n \n \n \n \n \n\n \n \n \n Howard is a Partner with Morpheus Ventures\, a venture capital firm based in Los Angeles that focuses on early stage technology investments. He currently serves as a Board Director of Ingenious.Build\, RIZE\, and Tagnos as well as a Board Observer at Morpheus Space\, Rugged Robotics\, RIOS and RapidDeploy. Howard was previously with Mission Ventures\, a leading Southern California early stage venture capital firm. While at Mission he focused on investments in software\, wireless technologies and semiconductors. Prior to Mission\, he was with Salomon Smith Barney in their Technology Investment Banking Group where he was involved in over $3 billion of public and private financings and M&A. Howard has served as co-chair of the San Diego Telecom Council Wireless Infrastructure Group. He was a member of the Board of Reviewers for the San Diego based Center for Commercialization of Advanced Technology\, an organization funded by the Department of Defense. Howard holds a BS in Electrical Engineering from UCLA and an MBA from the UCLA Anderson School of Management.\n \n \n \n \n\n \n \n \n \n \n \n\n \n \n Ahmed Mirza\n\n \n Investor\n Techstars\n \n \n\n \n \n \n \n \n \n\n \n \n \n Ahmed is an early stage Investor at Techstars\, where he helps run the Los Angeles\, Healthcare\, and Space programs. At Techstars\, Ahmed invests in 48 companies a year across six sectors: B2B SaaS\, Retail / E-Commerce\, Health & Wellness\, Deep-Tech\, Prop-Tech\, and Climate / Sustainability. Most recently\, Ahmed was selected to Business Insider’s Rising Stars list of Venture Capital. Ahmed also serves as a Faculty Lecturer at the Anderson School of Management at UCLA.\n\nPreviously\, Ahmed incubated ideas at Wavemaker Labs\, Share Ventures\, and Pilot44 by helping the teams bring various concepts to market. There\, he partnered with internal corporate venture groups at Fortune 100 companies to launch new products and build businesses. \n\nHe’s also spent part of his career as an entrepreneur launching multiple ventures — from retail businesses to digital software products. His expertise in early-stage company building has helped him go 0-to-1 seven times in a span of 3 years. Prior to his entrepreneurial endeavors\, Ahmed was an investment banker transacting technology mergers and acquisitions\, joint ventures\, and partnerships.\n\nIn his spare time\, you can find him cycling the sunny streets of Los Angeles\, playing basketball (go Knicks!)\, and building elaborate Lego sets.\n \n \n \n \n\n \n \n \n \n \n \n\n \n \n Erik Gonzalez-Leon\n\n \n Analyst\n Propel Bio Partners\n \n \n\n \n \n \n \n \n \n\n \n \n \n Dr. Gonzalez-Leon earned his PhD in biomedical engineering from the University of California\, Irvine. There\, his research focused on increasing the functional properties of self-assembled articular cartilage and knee meniscus tissue toward their implantation in a large-animal model. Dr. Gonzalez-Leon was also a Research Transfer Group Fellow at Beall Applied Innovation where he evaluated engineering & scientific inventions from UC Irvine through technical assessment\, patentability assessment\, market research\, and prior art searches \n \n \n \n\n \n \n \n \n \n \n\n \n \n Lucy Abgaryan\n\n \n Founder\n GrittGene Therapeutics\n \n \n\n \n \n \n \n \n \n\n \n \n \n Dr. Lucy Abgaryan is a scientist\, and entrepreneur with over 15 years of experience in drug development. She obtained her doctoral degree in Biophysics and conducted postdoctoral research in the field of Experimental Medicine at The Scripps Research institute. Her team’s research resulted in an FDA-approved drug\, Ozanimod at a Scripps spin-off\, Receptos. Subsequently\, two more compounds laid the basis for Blackthorn biotherapeutics (now part of Neumora Therapeutics\, Inc)\, drug candidates for Phase 1 and 2 clinical trials. This prompted her to continue her education at UCSD in pursuit of an MBA in Innovation and entrepreneurship. For the last 5 years\, she has been involved in the formation of several startup companies (Biotech\, digital-tech\, Bioprinting\, etc.) in the US\, Armenia\, and Israel where she performs business strategy developments\, operations\, market entries\, as well as regulations advisory. She founded/co-founded 4 science-based organizations including Proone Labs and GrittGene Therapeutics where she is also the CEO. Dr. Abgaryan is an adviser and/or board member for several tech/biotech companies\, investment institutions & educational organizations. \n \n \n \n\n \n \n \n \n \n \n\n \n \n Steven Chin\n\n \n Regional Director of Neonatology\n Children’s Hospital Los Angeles\n \n \n\n \n \n \n \n \n \n\n \n \n About Steven Chin\n \n Steven W. Chin\, MD\, MMSc is the Regional Director of Neonatology for the Children’s Hospital Los Angeles and the Section Head of Quality and Performance Improvement for the Division of Neonatology. He is an Associate Clinical Professor of Pediatrics at the Keck School of Medicine of the University of Southern California. Dr Chin completed his residency training in pediatrics at Rush University Medical Center and his Neonatal-Perinatal Medicine fellowship training at the Harvard Neonatal-Perinatal Medicine Fellowship Program. He completed a research fellowship in Clinical and Translation Science and advanced training in Quality Improvement and Clinical Informatics at Harvard Medical School.\n\nDr. Chin holds numerous leadership roles at the regional and national level including serving on the Board of the Providence St. Joseph Health (PSJH) Women and Children’s Executive Leadership Council and the California Perinatal Advisory Committee – Leadership Advocacy and Consultation (PAC-LAC). Dr Chin also serves as the Director of Virtual Pediatric Systems – NICU \n \n \n \n\n \n \n \n \n \n \n\n \n \n Leanna Levine\n\n \n President & CEO\n ALine\, Inc.\n \n \n\n \n \n \n \n \n \n \n \n\n \n \n \n Dr. Levine\, founder of ALine\, Inc.\, is an entrepreneur\, technologist\, and inventor. She has a unique blend of technical expertise in bioanalytical science and manufacturing process development. Dr. Levine’s success in new technology development has been at the intersection of physics and biology. She conceived and developed ALine’s proprietary fluid circuit technology. \n\nWhile at Monsanto\, her lab led the industry in the development of a fluorescence polarization instrument and a patented assay to screen novel therapeutics for HSV. In collaboration with Pui Kwok at the Washington University medical school\, a novel fluorescence polarization SNP assay was developed\, patented and sold commercially. 1998 she joined Spectrum Laboratories as Director of Hollow Fiber Manufacture and Product Development. In 2000 she was the chair of the Gordon Conference on Bioanalytical Sensors. Dr. Levine has served as conference chair for the Selectbio conferences in Microfluidics and Organ-on-Chip for the last several years. Dr. Levine is a reviewer for the NIH SBIR program.\n \n \n \n \n\n \n \n \n \n \n \n\n \n \n Iván Markman\n\n \n Startup Advisor\, Angel Investor\n Former CBO at Yahoo!\n \n \n\n \n \n \n \n \n \n\n \n \n \n Iván is currently an investor\, advisor and board member with a focus on Business to Business\, Data and AI-driven SaaS businesses in Climate\, Marketing\, and Education technology spaces.\n\nHe was previously a Strategic Advisor at Yahoo\, following four years as Chief Business Officer where he led the businesses representing most of its global revenue and importantly\, turned it around and successfully exited it to Apollo Global for $5 billion.\n\nImmediately before Yahoo\, Iván was a special advisor to the CEO & Board of Directors of comscore\, where he led a significant turnaround rekindling innovation\, operational scale and growth. Previously\, Iván was GM of Neustar’s Marketing Services business\, after its $450M acquisition of MarketShare where he was COO and early management team member. At MarketShare he grew the business and built the technology globally\, increasing its valuation 15x leading to two exits. Prior to that\, Iván held various senior strategic and operational roles in his first run at Yahoo after joining it via its acquisition of Overture. He started his career in Argentina working in various talent\, sales & marketing roles at Procter & Gamble.\n\nHe serves on the Board of Directors of the Alliance for SoCal Innovation\, a non-profit organization that supports the growth and development of Southern California’s innovation ecosystem\, as well as the Board of the Center for Impact at the UCLA Anderson School of Management.\n\n \n \n \n \n\n \n \n \n \n \n \n\n \n \n Dave Whelan\n\n \n Managing Director\n Bespoke Business Strategy Inc.\n \n \n\n \n \n \n \n \n \n \n \n\n \n \n \n David Whelan is the Managing Director of Bespoke Business Strategy Inc. and offers strategy and operations consulting\, including interim executive leadership roles\, for a variety of organizations\, many at the intersection of technology\, health\, and wellness. Most engagements include significant project management (of internal and external resources)\, budgeting\, oversight of detailed financial modeling\, and development of business and marketing strategies.\n\nHe is the former CEO at BioscienceLA\, a regional accelerator with all stakeholders as constituents\, participants\, and beneficiaries. We support a diverse economy\, including biotech and biopharma\, medical devices\, digital health\, bioinformatics\, healthcare IT\, MedTech\, synthetic biology\, and adjacent industries. \n \n \n \n\n \n\n\nParticipating Academic and Research Institutions URL:https://alliancesocal.org/event/first-look-socal-innovation-showcase-2024/ LOCATION:Skirball Cultural Center\, 2701 N. Sepulveda Blvd.\, Los Angeles\, CA\, 90049\, United States CATEGORIES:Alliance Events ATTACH;FMTTYPE=image/jpeg:https://alliancesocal.org/wp-content/uploads/2023/03/FLSIS_EventPage_Banner-1.jpg END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20240918T133000 DTEND;TZID=America/Los_Angeles:20240918T183000 DTSTAMP:20260406T100728 CREATED:20240827T231031Z LAST-MODIFIED:20250527T210832Z UID:6017-1726666200-1726684200@alliancesocal.org SUMMARY:Deep Tech Symposium DESCRIPTION:Join us at the Deep Tech Symposium\, a meticulously curated one-day event during SoCal Deep Tech Week in Los Angeles. Hosted by The Alliance for SoCal Innovation and proudly sponsored by Edison International. \n\n\n\nEvent Sponsored by \n\n\n\n\n\n\n\n📅 When: September 18\, 2024\, 1:30 PM – 6:30 PM📍 Where: El Segundo\, CA👥 Who: 125 Deep Tech industry leaders\, innovators\, and subject matter experts \n\n\n\n🔑 What to know: A one-day\, highly curated event during SoCal Deep Tech Week\, featuring keynotes and panels on cutting-edge innovations in Aerospace & Defense\, Cleantech & Sustainability\, and AI/Robotics & Advanced Manufacturing. \n\n\n\n🎤 Opening remarks: Mayor Drew Boyles\, City of El Segundo \n\n\n\n🎤 Keynote: Stephen Cheung\, President & CEO of LAEDC and WTCLA \n\n\n\n🛠️ Panels: \n\n\n\n\nNavigating the Future of Aerospace and DefenseLatest advancements in aerospace and defense\, including new materials and satellite technologies.\n\nModerator: Conn Doherty (RTX)\n\n\n\nPanelists: Jordan Noone (Embedded Ventures\, Zoo\, Relativity Space)\, Erin Hammons (Northrop Grumman)\, Elizabeth Reynolds (Starburst Aerospace)\, Zane Mountcastle (PicoGrid)\n\n\n\n\n\nHarnessing Hard Tech for a Sustainable FutureThe intersection of technology and sustainability\, focusing on cleantech and renewable energy.\n\nModerator: Sergej Mahnovski (Edison International)\n\n\n\nPanelists: Eric Lee (Aligned Climate Capital)\, Adrienne Lindgren (LACI)\, Jess Adkins (Caltech)\n\n\n\n\n\nPioneering Innovations in AI\, Robotics\, and Advanced ManufacturingHow AI and robotics are reshaping industries like healthcare\, transportation\, and manufacturing.\n\nModerator: Krisztina “Z” Holly (Good Growth Capital)\n\n\n\nPanelists: Alice Liu (ID8 Innovation)\, Scott Graybeal (Caelux)\, Peter Lee (Embark Ventures)\n\n\n\n\n\n\n💬 Why it matters: Connect with top minds and explore the technologies driving the future of deep tech. \n\n\n\nSpeakers\n\n\n\n\n \n \n \n \n \n Andy Wilson\n Emcee\n CEO\, Alliance for SoCal Innovation\n View Bio \n \n \n \n \n \n \n \n \n \n \n Andy Wilson\n Emcee\n CEO\, Alliance for SoCal Innovation\n \n \n \n \n \n \n \n Andy is a leader in the Southern Californian innovation ecosystem and has started\, led or invested in more than two dozen tech start-ups. In addition to leading the Alliance as its Executive Director\, he served on the City Council for the City of Pasadena for almost 8 years (2 years as vice mayor) and he is a founder of Innovate Pasadena (www.innovatepasadena.org)\, which is dedicated to advancing the Eastside of Los Angeles as a vibrant innovation center for deep tech. \nPreviously\, as founder of Momentum Ventures\, an early stage tech accelerator and venture fund\, he personally led more than a half dozen SoCal tech start-ups and invested in almost a dozen others. He previously held senior executive roles (President\, SVP Product\, CIO\, COO) at Overture Services/Yahoo!\, RiverOne\, Bowne & Co and RR Donnelley & Sons. He has extensive board experience in not-for-profit and community organizations such as Pacific Oaks College\, Pasadena Heritage\, STEAMCODERS\, and currently serves on the Hollywood-Burbank Airport Authority. He has a deep track record of community service including the Pasadena Design Commission\, the Pasadena Planning Commission\, Pasadena Operating Company and the Burbank Airport. \nHe is a regular speaker at entrepreneurs’ events and business schools and was named one of the 50 Most Innovative Men in the San Gabriel Valley. Andy holds an engineering degree with honors from Dartmouth College and received his MBA with a concentration in operations and technology management from Harvard Business School. \n \n \n \n \n \n \n \n \n \n Drew Busbee\n Speaker\n Chief Operations Officer\, DTI\n View Bio \n \n \n \n \n \n \n \n \n \n \n Drew Busbee\n Speaker\n Chief Operations Officer\, DTI\n \n \n \n \n \n \n \n Drew Busbee is the Chief Operations Officer of DTI. He has spent the better part of the last decade supporting early-stage dual-use startups to navigate the federal funding landscape and has helped portfolio companies secure 500+ million in government contracts and non-dilutive financing. He is a founding member of several government innovation organizations\, secured multiple cooperative research and development agreements between venture firms and the DOD\, and has spent time as a Defense Ventures Fellow. He holds an MBA from the University of North Carolina Chapel Hill and a master’s in international real estate from Florida International University. \n \n \n \n \n \n \n \n \n \n Mayor Drew Boyles\n Speaker\n The City of El Segundo\n View Bio \n \n \n \n \n \n \n \n \n \n \n Mayor Drew Boyles\n Speaker\n The City of El Segundo\n \n \n \n \n \n \n \n In addition to serving as El Segundo’s Mayor since 2018\, Drew Boyles is an entrepreneur and CEO of businesses in multiple states with several hundred employees. Drew achieved his Bachelor’s Degree by the age of 21\, while fully enlisted in the US Navy. After the military\, Drew quickly progressed through the leadership ranks at Brunswick Corporation and Starbucks Coffee\, while solely raising his two sons. Drew went on to get his MBA in Finance from USC and became a Big 5 Management Consultant. \nOn the entrepreneurial front\, Drew has owned and operated as many as three dozen 1-800-GOT-JUNK? franchises.  Drew founded HazAwayToday.com\, which provides the first of its kind residential and commercial hazardous waste removal services. Drew’s latest ventures involve a patented consumer product for the action sports industry and wave pool\, surfing centric large real estate developments. Drew believes building great relationships is even more valuable than building businesses\, taking great pride in the dozens of leadership and company ownership opportunities he has created for his employees. \nBeyond the world of his businesses\, Drew has served in various leadership capacities with Entrepreneurs’ Organization\, including President of the LA Chapter and the U.S. West Regional Director. He is a Board Member of The World Is Just a Book Away\, which builds libraries for impoverished children in Mexico and Indonesia. Drew served as Co-Chairperson of the Surfrider Foundation Malibu/Santa Monica chapter. \nIn government capacities\, Drew served as Chairman of the El Segundo Economic Development Advisory Council from 2014 through 2016. He was then elected to the El Segundo City Council in 2016\, immediately voted in as Mayor Pro Tem and then voted in as Mayor in 2018\, where he has served since. During his time on the Council\, Drew has emphasized bringing performance-based and private industry techniques to government\, driving economic development and fostering nimble\, effective communication and leading responsible fiscal strategy\, while ensuring our residents and businesses love where they live and work. \nDrew’s personal passions are spending time with his wife\, Lee and his five children\, working to leave the world a better place\, and surfing\, skiing and snowboarding as hard and as often as possible. Drew has a goal of surfing every country in the world; somehow\, even the land locked ones! As of 2024\, he has surfed 25 countries. \n \n \n \n \n \n \n\n\n\n\n \n \n \n \n \n Stephen Cheung\n Keynote Speaker\n President & CEO\, LAEDC\n View Bio \n \n \n \n \n \n \n \n \n \n \n Stephen Cheung\n Keynote Speaker\n President & CEO\, LAEDC\n \n \n \n \n \n \n \n Stephen Cheung is the President and Chief Executive Officer of the Los Angeles County Economic Development Corporation (LAEDC) and its subsidiary\, the World Trade Center Los Angeles (WTCLA).  As CEO of the LAEDC\, Mr. Cheung leads LAEDC’s efforts to drive equitable economic growth in the Los Angeles Region. \nPrior to joining LAEDC and WTCLA\, Cheung was the Secretary General and Managing Director of International Trade and Foreign Affairs for Los Angeles Mayors Eric Garcetti and Antonio Villaraigosa and was responsible for managing policies and programs related to the Port of Los Angeles\, Los Angeles World Airports\, International Affairs\, Global Trade and Clean Technology. \nCheung currently sits on the Board of Advisors of UCLA’s Luskin School of Public Affairs\, UCLA Extension\, Coro Southern California and Sister Cities of Los Angeles\, while also serving on the Los Angeles County Workforce Development Board. \n \n \n \n \n \n \n\n\n\nPanel: Navigating the Future of Aerospace and Defense\n\n\n\n\n \n \n \n \n \n Elizabeth Reynolds\n Panelist\n Managing Director\, USA at Starburst\n View Bio \n \n \n \n \n \n \n \n \n \n \n Elizabeth Reynolds\n Panelist\n Managing Director\, USA at Starburst\n \n \n \n \n \n \n \n As the Managing Director of Starburst’s US business\, Elizabeth Reynolds is championing today’s aerospace renaissance\, aligning early-stage technology innovators with government and commercial stakeholders and investors to modernize infrastructure in space\, transportation\, communications\, and intelligence. Her team works alongside hundreds of technology startups developing new aircraft\, spacecraft\, satellites\, drones\, sensors\, autonomy\, robotics\, and much more. \nElizabeth brings 15 years of experience in deep tech entrepreneurship\, growth\, business operations\, and strategy to the team. Prior to joining Starburst\, she served as an executive for biotech\, medtech\, mobility\, and interactive media companies\, from founding through IPO. She is also an advisor to a number of startups and nonprofits supporting STEM education. \n \n \n \n \n \n \n \n \n \n Erin Hammons\n Panelist\n Director\, Program Manager\, Military Space Systems\, Northrop Grumman Space Systems\n View Bio \n \n \n \n \n \n \n \n \n \n \n Erin Hammons\n Panelist\n Director\, Program Manager\, Military Space Systems\, Northrop Grumman Space Systems\n \n \n \n \n \n \n \n Erin Hammons is the Director and Program Manager for the Evolved Strategic Satellite Communications System (ESS) program within the Military Space Systems (MSS) Business Unit of Northrop Grumman Space Systems. In this role\, Erin is responsible for the day-to-day management and oversight of the ESS Rapid Protype (RP) effort as well as the ESS Production contract slated for award later this year. \nPrior to her current position\, Erin was the Business Development Director for the National Security Space (NSS) Business Unit\, formulating and executing growth strategies in support of NSS core programs and new business\, including the management of all NSS strategic investments and partnerships. She was also responsible for leading NSS engagement with senior USG and international customers as well as industry partners. \nErin previously worked a number of years within various Restricted portfolios at Space Park\, holding leadership roles in program management\, integrated planning\, risk management\, and new business. Most recently\, she was the Director of Operations for a large-scale Class A program\, leading the team through multiple critical milestones in both design and production phases. \nPrior to joining Northrop Grumman\, Erin was with Boeing Space and Launch\, occupying roles of increasing responsibility within Systems Engineering\, Mechanical Design\, and Business Development organizations. \nErin holds a bachelor’s degree in mechanical engineering from the University of Nebraska and a master’s degree in management from the International Space University in Strasbourg\, France. \nNorthrop Grumman solves the toughest problems in space\, aeronautics\, defense and cyberspace to meet the ever-evolving needs of our customers worldwide. Our 90\,000 employees define possible every day using science\, technology and engineering to create and deliver advanced systems\, products and services. \n \n \n \n \n \n \n \n \n \n Zane Mountcastle\n Panelist\n Co-Founder and CEO\, PicoGrid\n View Bio \n \n \n \n \n \n \n \n \n \n \n Zane Mountcastle\n Panelist\n Co-Founder and CEO\, PicoGrid\n \n \n \n \n \n \n \n Zane is Co-Founder and CEO at Picogrid\, a defense technology company building a command and control technology for unmanned systems. Prior to Picogrid\, Zane started his career developing autonomous vehicles and field sensors for the US Army and US Navy. \n \n \n \n \n \n \n \n \n \n Jordan Noone\n Panelist\n Co-Founder and General Partner\, Embedded Ventures // Co-Founder and Executive Chairman\, Zoo // Co-Founder\, Relativity Space\n View Bio \n \n \n \n \n \n \n \n \n \n \n Jordan Noone\n Panelist\n Co-Founder and General Partner\, Embedded Ventures // Co-Founder and Executive Chairman\, Zoo // Co-Founder\, Relativity Space\n \n \n \n \n \n \n \n Jordan Noone is the Co-Founder and General Partner at Embedded Ventures\, along with Co-Founder Jenna Bryant. Launched in 2020\, Embedded Ventures is a next generation venture capital firm investing in early-stage deep tech startups. With a thesis that takes a commercial-first approach to investing in early-stage startups with applications that can serve the Department of Defense\, Embedded has a first-of-its-kind partnership with the United States Space Force. In addition to his role at Embedded\, Jordan is Co-Founder and Executive Chairman of portfolio company Zoo\, the world’s only company to develop advanced tools for hardware design. \nJordan and Jenna both have nontraditional industry experiences and strong passions for the communities they represent. The firm invests in the pre-seed\, seed and Series A rounds for startups focused on space operations\, digital engineering\, and advanced manufacturing. To date\, Embedded Ventures has announced investments in Akash Systems\, Anduril\, Chromatic 3D Materials\, Inversion\, OurSky\, Slingshot Aerospace\, Skyryse and Zoo. \nIn 2015\, at 22 years old\, Jordan started Relativity Space\, which was most recently valued at $4.2B. As Relativity’s CTO for five years\, Jordan focused on technical direction and engineering design\, including: developing printing technology\, launch vehicle design\, propulsion design\, software development\, infrastructure development\, and government affairs. Jordan also led many Relativity initiatives including: expansion of Relativity’s Stargate Factory into the rest of aerospace manufacturing\, Relativity’s strategy for expanding printing technology off-planet; and the ability of Relativity’s factory to flexibly scale to a wide range of rocket sizes. \nJordan has had a lifelong interest in aerospace and began designing and building spaceflight hardware at the University of Southern California. Jordan led USC’s Rocket Propulsion Lab and became the first student and youngest individual in the world to receive Federal Aviation Administration clearance to fly a rocket into space. \nJordan has been chosen for “30 Under 30” lists by Forbes\, Business Insider\, and Inc. Magazine. He received a BS in Aerospace Engineering\, and dropped out of a BS in Biophysics\, both from University of Southern California. Jordan lives in the greater Los Angeles area and is still involved with USC’s Rocket Propulsion Lab advising student members. \n \n \n \n \n \n \n \n \n \n Conn Doherty\n Panel Moderator\n VP & GM\, Strategic Solutions at RTX\n View Bio \n \n \n \n \n \n \n \n \n \n \n Conn Doherty\n Panel Moderator\n VP & GM\, Strategic Solutions at RTX\n \n \n \n \n \n \n \n Conn Doherty is a seasoned executive with extensive experience in the defense and aerospace industries. Currently serving as Vice President and General Manager of Strategic Solutions at RTX\, Conn has held key leadership roles at Collins Aerospace\, including Vice President and General Manager of BMC2 and Autonomy Solutions. Prior experience at Raytheon Intelligence & Space includes positions as Vice President of Strategic Campaigns\, Vice President of Future Assured Systems & Technology\, and Deputy Vice President of Advanced Concepts & Technology. Conn’s educational background includes an MBA in International Business from UCLA Anderson School of Management and a Master’s degree in Computer Science from Worcester Polytechnic Institute. \n \n \n \n \n \n \n\n\n\nPanel: Harnessing Hard Tech for a Sustainable Future\n\n\n\n\n \n \n \n \n \n Adrienne Lindgren\n Panelist\n Senior Vice President\, LACI\n View Bio \n \n \n \n \n \n \n \n \n \n \n Adrienne Lindgren\n Panelist\n Senior Vice President\, LACI\n \n \n \n \n \n \n \n Adrienne Lindgren joined LACI in January 2024 as the Senior Vice President of Unlocking Innovation. In this role\, she is responsible for incubation and investment services\, overseeing the development\, delivery\, and execution of LACI’s founder-facing programs\, in addition to the administration of LACI’s in-house debt and equity financing vehicles. A dynamic professional with a mix of skills and expertise spanning policy analysis\, project finance\, partnerships\, and go-to-market strategies\, she brings demonstrable success in industries including zero-emissions transportation\, sustainable aviation tech\, consulting\, banking\, and municipal government. Prior to joining the team at LACI\, she held key positions at Hyundai Motor Group\, WSP USA\, the City of Los Angeles\, and Goldman Sachs. She is a graduate of London Business School (Ex. Ed. – Project Finance)\, the University of Southern California (M.A. – Urban Planning)\, and Scripps College (B.A. – Political Economy). \n \n \n \n \n \n \n \n \n \n Scott Graybeal\n Panelist\n CEO\, Caelux\n View Bio \n \n \n \n \n \n \n \n \n \n \n Scott Graybeal\n Panelist\n CEO\, Caelux\n \n \n \n \n \n \n \n   \n\n\n\n\n\n\n\n\n\n\n\n\n\nScott Graybeal is a veteran executive who led the Energy Solutions Segment at Flex Ltd (NASDAQ: FLEX)\, a $2B division within the company serving the solar\, energy storage\, and LED lighting markets. Under his leadership\, Flex Energy became the third largest producer of PV modules outside of mainland China\, and patented several key solar manufacturing innovations. Scott’s career spans several industries from construction tech to solar to semiconductors. Before joining Caelux\, Scott was COO of Veev Group & CEO of Veev Build and has held key leadership roles at Intevac\, Amonix\, Oerlikon Solar\, Veeco Instruments\, Applied Materials\, and General Electric.Scott has guest lectured on renewables and entrepreneurship at Carnegie Mellon and Georgetown. He served with distinction as a nuclear submarine officer and is a certified nuclear engineering officer by the Departments of the Navy and Energy. Scott earned his MBA from Thunderbird School of Global Management and his BS in Chemistry from UC San Diego. \n\n\n\n\n\n\n\n\n\n\n\n\n\n  \n \n \n \n \n \n \n \n \n \n Eric Lee\n Panelist\n Sr. Vice President\, Aligned Climate Capital\n View Bio \n \n \n \n \n \n \n \n \n \n \n Eric Lee\n Panelist\n Sr. Vice President\, Aligned Climate Capital\n \n \n \n \n \n \n \n Eric Lee is a Senior Vice President with Aligned Climate Capital\, an asset manager that invests exclusively in the companies and real assets that are decarbonizing the global economy and its infrastructure. In this role\, Eric leads Aligned’s Environmental\, Social\, and Governance (ESG) analysis of climate infrastructure and venture capital investment opportunities. \n \nPreviously\, Eric was an investment professional at TriLinc Global\, a global impact investing fund manager based in Los Angeles\, CA. At TriLinc\, Eric led the firm’s ESG & Impact efforts across all portfolios and served as a member of TriLinc’s Credit Committee and Sustainability & Impact Committee. Prior to TriLinc\, Mr. Lee worked at Sustainable Insight Capital Management\, an ESG public equities fund based in New York\, NY. \n \nMr. Lee holds a B.S. from Cornell University and a M.S. in Sustainability Management with a concentration in Sustainable Finance from Columbia University.\n \n \n \n \n \n \n \n \n \n Jess Adkins\n Panelist\n Founder at Calcarea and Professor at Caltech\n View Bio \n \n \n \n \n \n \n \n \n \n \n Jess Adkins\n Panelist\n Founder at Calcarea and Professor at Caltech\n \n \n \n \n \n \n \n Jess Adkins is the Smits Family Professor of Geochemistry and Global Environmental Science in the Department of Geological and Planetary Sciences at Caltech.  He is a member of the Linde Center for Global Environmental Sciences and on the faculty of the Department of Engineering and Applied Science.  Jess started at Caltech in 2000 after receiving a BS in Chemistry from Haverford College in 1990 and a PhD in Chemical Oceanography from the MIT/WHOI Joint Program in 1998.  The Adkins lab studies the history of earth’s climate on a variety of timescales and biogeochemical cycles in the modern ocean.  They use stable isotopes and trace metals in deep-sea corals to understand the mechanisms of rapid climate change during the last glacial cycle.  Uranium series and radiocarbon dating provide constraints on the rate of the ocean’s overturning circulation in the past.  Pore water measurements from sediments retrieved by the IODP constrain the temperature and salinity of the glacial deep ocean and lead to theories and models of the density structure of the past deep ocean.  The group has also worked on stalagmite records of tropical climate change\, biomineralization mechanisms in corals\, and iron isotopes in the modern ocean.  A recent innovation has lowered the detection limit for sulfur isotopes by 1\,000x and has led to work on the sulfur cycle more generally\, investigating the modern budget of river sulfur isotopes\, ice core records of volcanic eruptions\, and measuring the history of marine sulfate isotopic change from the Archean to the Cenozoic.  With Will Berelson at USC\, the Adkins lab has measured the dissolution rate of calcite in seawater with a new technique that is very precise even close to equilibrium.  They have unpacked the dual effects of solution chemistry and surface energy on carbonate dissolution in the lab and in the ocean water column\, leading to the first physical chemistry-based understanding of carbonate dissolution mechanisms in seawater.  This work pushed Jess to start a company\, Calcarea\, that is focused on using the accelerated weathering of limestone to decarbonize the ocean shipping industry and participate in the larger decarbonization economy. \nJess was awarded the Houtermans medal from the European Association of Geochemistry in 2003.  He received the Ruth and Paul Fye MIT/WHOI and the Geochemical Society Best Paper Awards in 2005 and 2009 respectively.  He was the Chow Lecturer at The Scripps Institute of Oceanography in 2017.  Adkins won the Shackleton Medal of the EAG and was named a fellow of the AGU and Geochemical Societies in 2018. \n \n \n \n \n \n \n \n \n \n Sergej Mahnovski\n Panel Moderator\n Managing Director\, Strategy\, Technology\, and Innovation at Edison International\n View Bio \n \n \n \n \n \n \n \n \n \n \n Sergej Mahnovski\n Panel Moderator\n Managing Director\, Strategy\, Technology\, and Innovation at Edison International\n \n \n \n \n \n \n \n Sergej Mahnovski is a member of Evergreen Climate Innovations’ Investment Committee. Sergej is Director of Growth and Innovation at Edison International\,  where he leads a team focused on identifying\, incubating\, and commercializing growth opportunities in four key focus areas of clean energy\, transportation electrification\, grid edge\, and customer choice. \nPrior to Edison\, Sergej served as the Director of the Utility of the Future team at Consolidated Edison and as the Director of the Office of Long Term Planning and Sustainability for Mayor Michael R. Bloomberg. \nUnder Mayor Bloomberg\, Sergej and his team managed citywide energy and sustainability policy\, developing a strategy for reducing carbon emissions in NYC by 80 percent by 2050\, and a comprehensive evaluation and approach to resilience of regional energy infrastructure after Superstorm Sandy. The team was awarded the Citizens Budget Commission Prize for Public Service Innovation for developing new approaches to reducing air pollution in NYC through the Clean Heat program. \nSergej previously served as a Chair of the NYC Energy Efficiency Corporation. Sergej has served as Adjunct Associate Professor at Columbia University’s School of International and Public Affairs. He was previously Director for the Global Power Group at IHS CERA and Doctoral Fellow at RAND Corporation. \nSergej holds a B.S. in Chemical Engineering and B.A. in History from Stanford University\, an M.S. in Chemical Engineering from University of California\, Berkeley\, and a Ph.D. in Policy Analysis from the RAND Graduate School. \n \n \n \n \n \n \n\n\n\nPanel: Pioneering Innovations in AI\, Robotics\, and Advanced Manufacturing\n\n\n\n\n \n \n \n \n \n Alice Liu\n Panelist\n Partner\, ID8 Innovation\n View Bio \n \n \n \n \n \n \n \n \n \n \n Alice Liu\n Panelist\n Partner\, ID8 Innovation\n \n \n \n \n \n \n \n Dr. Alice Liu is a partner at ID8 Innovation\, an innovation strategy consultancy. She has a diverse background spanning technology\, innovation\, and entrepreneurship across academia\, corporations\, and start-ups. At Stanley Black and Decker\, she led the venture studio where tangible innovation was created through the launch of new ventures. At University of Southern California (USC)\, she helped lead Technology Innovation and Entrepreneurship at USC’s Viterbi School of Engineering. Under her leadership the school launched its first deep technology incubator\, the Viterbi Startup Garage\, where she created an ecosystem for venture acceleration and training to rapidly launch technology companies. She was named an Amazon Alexa Innovation Fellow in 2018. Prior to this\, Alice was Director of Business Development and Strategy at Applied Minds\, a multidisciplinary innovation company that designs\, builds\, and creates new technologies and companies in partnership with leading corporations and entrepreneurs. Alice started her career in management strategy consulting at Bain and Company and Boston Consulting Group. \nAlice holds a B.S. in Biology and Ph.D. in Computational Neural Systems from Caltech\, where she also taught data science and machine learning and served on the Board of Directors of the Caltech Y and the Caltech Alumni Association. \n  \n \n \n \n \n \n \n \n \n \n Ed Mehr\n Panelist\n Co-Founder and CEO\, Machina Labs\n View Bio \n \n \n \n \n \n \n \n \n \n \n Ed Mehr\n Panelist\n Co-Founder and CEO\, Machina Labs\n \n \n \n \n \n \n \n Edward Mehr is an entrepreneur and engineer with the background in smart manufacturing and artificial intelligence. He is the cofounder and CEO of Machina Labs\, a company that is developing next generation of manufacturing plants through use of robotics and artificial intelligence. Previously at Relativity Space\, He led a team\, in charge of developing the world’s largest metal 3D printer. Relativity Space is working to become the first company to print a rocket on Mars. Before Relativity Space\, he was CTO and founding member of Averon. Averon develops fully automated internet authentication solutions that don’t require any human intervention. His work has been featured\, on the main stage of TED\, TechCrunch Disrupt\, and Cable Lab’s invocation showcase. Early in his career\, he worked as an engineer in companies such as SpaceX\, Google\, and Microsoft. \n \n \n \n \n \n \n \n \n \n Peter Lee\n Panelist\n General Partner\, Embark Ventures\n View Bio \n \n \n \n \n \n \n \n \n \n \n Peter Lee\n Panelist\n General Partner\, Embark Ventures\n \n \n \n \n \n \n \n Peter Lee is the Founding Managing Partner at Embark Ventures\, a seed stage deep-tech venture capital fund based in Los Angeles. At Embark\, Peter primarily focuses on robotics and autonomy sectors having made over a dozen robotics investments in the space. Prior to entering venture capital\, he was the VP of Product at a venture backed startup. Peter was a manager with McKinsey and also worked as a product manager at Microsoft. Peter earned his BS and MS at MIT in Mechanical Engineering with a focus on robotics and product development and has an MBA from Harvard Business School. \n \n \n \n \n \n \n \n \n \n Krisztina "Z" Holly\n Panel Moderator\n Operating Partner\, Good Growth Capital\n View Bio \n \n \n \n \n \n \n \n \n \n \n Krisztina "Z" Holly\n Panel Moderator\n Operating Partner\, Good Growth Capital\n \n \n \n \n \n \n \n For the last two decades\, Krisztina Holly—aka “Z”—has been scouting\, cultivating\, and investing in innovators at the frontier. She is currently a venture partner at Good Growth Capital\, investing in early-stage complex science and technology ventures. An MIT-trained engineer and serial tech entrepreneur\, Z is probably best known as the curator of the first-ever TEDx event and the former vice provost for innovation at the University of Southern California. She built pioneering innovation centers at MIT and USC and started her career as a founder and key team member at tech companies in Boston and Silicon Valley. Since then\, she has advised hundreds of leaders across the private sector\, academia\, and government\, including entrepreneurs who have raised over $1B in capital. An instrument-rated private pilot and avid backcountry skier\, Z has B.S. and M.S. degrees in mechanical engineering and is based in Los Angeles. URL:https://alliancesocal.org/event/deep-tech-symposium/ LOCATION:The BR-DGE in El Segundo\, 2100 E Grand Ave #100\, El Segundo\, California\, 90245\, United States CATEGORIES:Alliance Events ATTACH;FMTTYPE=image/png:https://alliancesocal.org/wp-content/uploads/2024/08/Deep-Tech-Symp-Luma-banner-5.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20241030T110000 DTEND;TZID=America/Los_Angeles:20241030T140000 DTSTAMP:20260406T100728 CREATED:20241025T181618Z LAST-MODIFIED:20241030T185859Z UID:6163-1730286000-1730296800@alliancesocal.org SUMMARY:Health Systems Innovation Council Inaugural Meeting DESCRIPTION:Reshaping Health Care with A.I.: How we can be a leader (and not a laggard) in this next technology wave\n\n\n\n\n\nEvent Sponsors\n\n\n\n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n\n\n\n\n\nStartup Showcase Sponsors\n\n\n\n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n\n\n\n\n\nEvent Hosts\n\n\n\n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n\n\n\n\n\n \n\n\n\nAGENDA \n\n\n\n11:00 AM Welcome \n\n\n\nHASC\, Cedars-Sinai\, Keck Medicine of USC\, and Alliance for SoCal Innovation \n\n\n\n11:20 AM Rapid Fire Introductions \n\n\n\n11:30 AM Keynote \n\n\n\nDr. Eran Halperin\, SVP of AI and Machine Learning in Optum AI (UnitedHealth  \n\n\n\nGroup) and Adjunct Professor\, Computer Science\, UCLA \n\n\n\n12:00 PM Lunch \n\n\n\n12:15 PM Startup Showcase Introduction \n\n\n\nJay Goss\, Wavemaker Three-Sixty Health \n\n\n\nHelen McBride\, Bold Capital Partners \n\n\n\n12:20 PM Startup Presentations \n\n\n\nAkara Robotics \n\n\n\nEsperto Medical \n\n\n\nRegard \n\n\n\n12:50 PM Group Discussion \n\n\n\nModerated by Austin Gispanski\, Managing Director and Partner at BCGX \n\n\n\n1:35 PM Wrap up and Conclusions \n\n\n\nSpeakers\n\n\n\n\n \n \n \n \n \n Dr. Eran Halperin\n SVP of AI and Machine Learning in Optum AI (UnitedHealth  Group) and Adjunct Professor\, Computer Science\, UCLA\n Keynote Speaker\n View Bio \n \n \n \n \n \n \n \n \n \n \n Dr. Eran Halperin\n SVP of AI and Machine Learning in Optum AI (UnitedHealth  Group) and Adjunct Professor\, Computer Science\, UCLA\n Keynote Speaker\n \n \n \n \n \n \n \n Dr. Halperin’s research focuses on the development of computational tools for the analysis of genetic data; particularly in the development of tools that enable and facilitate genetic and epigenetic studies of common complex diseases\, such as cancer\, rheumatoid arthritis\, or cardiovascular diseases. These studies shed important light on the biological mechanisms of these diseases\, and they will pave the way to improved diagnosis and a personalize treatment based on an individual’s genetics. \n \n \n \n \n \n \n \n \n \n Austin Gispanski\n Managing Director & Partner\, BCGX\n Group Discussion Moderator\n View Bio \n \n \n \n \n \n \n \n \n \n \n Austin Gispanski\n Managing Director & Partner\, BCGX\n Group Discussion Moderator\n \n \n \n \n \n \n \n ​Profile summary \n\nAustin is a Managing Director and Partner within BCG X\, BCG’s tech build and design unit focused in healthcare\nAustin partners with healthcare companies to launch innovative new products and businesses ranging from digital front door solutions to digital care delivery products\nAustin lead the GenAI efforts for the Healthcare Payer and Provider unit at BCG\nPrior to BCG\, Austin has held roles across strategy\, engineering\, product\, design\, and operations in consulting\, technology companies\, and start-ups\n\nRelevant BCG experience \n\nLed shift for hospital from digital to product organization launching multiple products across maternity postpartum\, migraine treatment\, next-gen urgent care\nLaunched digital 2nd opinion platform for top specialty health system\nDeveloped digital home health business and product strategy for regional health system\nBuilt digital engagement platform aimed at preventing the progression of cardiac disease through sustained behavior change\nBuilt AI-patient engagement app to improve adherence and experience\nLaunched healthcare business and hardware / software AI medical device for consumer goods company focused on driving health at home and preventative care\nConducted enterprise assessment and redesign for prior-authorization technology portfolio at a large national payer\n\nEducation \n\nStanford University\, M.S. in Mechanical Engineering & Product Design\nUniversity of Florida\, B.S. in Mechanical Engineering & Business Administration\n\n \n \n \n \n \n \n\n\n\nStartup Showcase\n\n\n\n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n\n\n\n\n\n\n \n \n \n \n \n FOUNDING HEALTH SYSTEMS INNOVATION COUNCIL MEMBERS\nAndrew Goldfrach \nCEO \nArrowhead Regional Medical Center  \nGeoffrey Hall \nCEO \nCalifornia Rehabilitation Institute  \nKelly Linden \nPresident and CEO \nCasa Colina Hospital and Centers for Healthcare \nBryan Croft \nExecutive Vice President & Chief Operating Officer \nCedars-Sinai \nNaser Mohammad \nCEO \nCentinela Hospital Medical Center \nHarlan Levine \nPresident\, Health Innovation and Policy \nCity of Hope \nMick Zdeblick \nCEO \nCommunity Memorial Healthcare \nAnthony Russell \nCAO\, Ambulatory Medicine \nCommunity Memorial Healthcare \nJeremy Zoch \nPresident and CEO \nDignity Health\, Northridge Hospital Medical Center \nCarolyn Caldwell \nHospital President and CEO \nDignity Health\, St. Mary Medical Center \nLori Morgan \nCEO \nHuntington Hospital \nTad Funahashi \nChief Innovation Officer \nKaiser Permanente \nCamille Applin-Jones \nSVP & Area Manager \nKaiser Foundation Hospitals\, Panorama City Medical Center and Antelope Valley \nAlen Oganesyan \nAssoc. Chief Information Officer \nKeck Medicine of USC \nManeesh Goyal \nCOO \nMayo Clinic Platform \nMichael Torgan \nChief Transformation Officer \nMission Community Hospital  \nKent Hoyos \nVP & Chief Information Officer \nPomona Valley Hospital Medical Center \nBernie Klein \nCEO \nProvidence Holy Cross \nJohn Chapman \nPresident and CEO \nSan Antonio Regional Hospital \nNana Deeb \nCEO \nSouthwest Healthcare\, Palmdale Regional Medical Center \nKhurram Mir \nDirector of Innovation \nUCI Health \nJennifer McCaney \nChief of Innovation \nUCLA Health \nArmand Dorian \nCEO \nUSC Verdugo Hills Hospital \nSteven Shapiro \nSenior Vice President for Health Affairs \nUSC Health \nGus Valdespino \nPresident and CEO \nValley Presbyterian Hospital URL:https://alliancesocal.org/event/health-systems-innovation-council-inaugural-meeting/ CATEGORIES:Alliance Events END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20241115T093000 DTEND;TZID=America/Los_Angeles:20241115T150000 DTSTAMP:20260406T100728 CREATED:20241108T211541Z LAST-MODIFIED:20241114T022610Z UID:6211-1731663000-1731682800@alliancesocal.org SUMMARY:Sixth Annual SoCal Ecosystem Leadership Forum DESCRIPTION:Brought to you by Alliance for SoCal Innovation\n\n\n\nDriving economic development in our diverse SoCal communities through industry/sector selection and alignment\, targeted program development\, business incentives\, and brand building. \n\n\n\n\n\nLong Beach\, CA \n\n\n\nEvent Sponsors\n\n\n\n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n\n\n\n\n\nEvent Overview \n\n\n\n​This annual strategic planning workshop is focused on uniting and catalyzing the leadership of Southern California’s diverse and compelling innovation nodes which define the SoCal innovation network. To accomplish this\, we convene a diverse cross section of leaders from across the region for a facilitated workshop to generate a shared understanding of innovation-focused economic development opportunities\, challenges\, and best practices in the region. \n\n\n\n​This year’s focus \n\n\n\n​This year we will explore strategies and best practices for driving innovation-based economic development in our diverse SoCal communities through presentations\, city-specific case studies and group discussions where we’ll identify and discuss best practices around industry/sector selection and alignment\, targeted program development\, business incentives\, and brand building. \n\n\n\n​The primary audience will be representatives from SoCal ecosystem-focused organizations such as economic development agencies\, accelerators\, regional and industry-specific startup support organizations\, and local and state government agencies. \n\n\n\n​Why are we doing this? \n\n\n\n​There are common challenges and opportunities that unite the often fragmented\, geographically dispersed hubs of innovation throughout Southern California. Our analysis of the region\, in partnership with the Boston Consulting Group\, has revealed that there is little coordination among these compelling pockets of innovation to address common issues. However\, the Alliance believes aligning best practices\, external messaging\, and delivery of services and resources are necessary to harness the collective potential of the region’s innovation assets to make Southern California the next great innovation ecosystem. \n\n\n\n​Forum Goals\n\n\n\n\n​Connect the key people and organizations working to drive economic development and prosperity within SoCal’s innovation ecosystem\n\n\n\n​Identify trends and best practices that drive innovation-based economic development initiatives\n\n\n\n​Instigate and support deeper relationships between SoCal’s innovation ecosystem leaders to ensure improved coordination of effort and collaboration within the region\n\n\n\n\n\n \n \n \n \n Forum Agenda\n \n \n \n 9:30 AM: Informal networking \n​Come early for coffee and refreshments while you (re)connect with colleagues. \n​​10:00a: Welcome + State of the Region report \n​10:20a: Rapid Introductions. Let’s see who’s in the room. \n​10:50a: Conversation Round 1. Where We’re At – Current Landscape and Opportunities for the Region. \n​Let’s set the table for the rest of the day’s discussions by getting up to speed on regional economic development priorities and initiatives through presentations and discussion. \n​Speakers: \nModerator: Stacy Cumberbatch\, Managing Director at Blended Impact \n​Chris Earl\, Acting Deputy Director & So Cal Regional Advisor at Go-Biz CalOSBA \n​Matt Horton\, VP of Policy and Research at LAEDC \n​Jennifer McLain Hiramoto\, Chair at CALED and Director of Economic Development at City of Ontario \n​12:00p: Lunch Break \n​12:30p: Conversation Round 2. Going Vertical: Selecting and Developing Industry Specialization. \n​Presentations and interactive group discussion on best practices for industry/sector selection and alignment\, effective stakeholder collaboration\, targeted program development\, business incentives\, messaging and brand building. \n​Industry Deep Dives: \nModerated by John Keisler\, CEO & Managing Partner at Sunstone Management \n​Cleantech/Bluetech: Jenny Krusoe\, Chief Operations Officer and EVP at AltaSea + Michael Galvin\, Director of Waterfront & Commercial Real Estate at Port of LA) \n​Life Science: Dan Gober\, Executive Director\, Los Angeles at Biocom + Howard Kozloff\, Founder & CEO at Noblespace + Gunjan Siroya\, Chief Solutions Officer at Larta Institute \n​Aerospace & Defense: Chris Pimentel\, Mayor Pro Tem at City of El Segundo + Lucius Martin\, Deputy Mayor at City of Long Beach + Drew “Murph” Busbee\, COO at DTI \n​1:45p: Conversation Round 3. Getting it Done: How Cities Invest in Innovation \n​Moderated chats with city representatives who are driving innovation-based economic development initiatives that reflect a range of complex strategic decision making\, collaboration and overcoming pragmatic challenges. \n​Glendale expands beyond Hollywood to support startup innovation: David Crawley Delgado\, Senior Economic Development Coordinator at City of Glendale + Neal Bloom\, Managing Partner at Rising Tide Partners and Interlock Capital \n​Pasadena’s path to build leading Biotech + Deep Tech hubs: Felicia Williams\, Councilperson at City of Pasadena + Mike Schaffer\, CEO at Echo Factory + Patrick Church\, Managing Director at JLL Los Angeles + Andy Wilson\, CEO at Alliance for SoCal Innovation and former Councilperson at City of Pasadena \n​2:30p: Wrap Up \n​3:00p: Networking and Refreshments URL:https://alliancesocal.org/event/socal-ecosystem-leadership-forum-2024/ CATEGORIES:Alliance Events END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20250320T103000 DTEND;TZID=America/Los_Angeles:20250320T143000 DTSTAMP:20260406T100728 CREATED:20250317T194305Z LAST-MODIFIED:20260310T200104Z UID:6446-1742466600-1742481000@alliancesocal.org SUMMARY:Health System Innovation Council Meeting - Q1 2025 DESCRIPTION:Topic: Selecting and piloting new technologies in a heavily regulated environment\n\n\n\n\n\nHosted by USC Keck \n\n\n\nEvent Sponsors\n\n\n\n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n\n\n\n\n\nStartup Showcase Sponsors\n\n\n\n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n\n\n\n\n\nEvent Hosts\n\n\n\n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n\n\n\n\n\n \n\n\n\nAGENDA \n\n\n\n10:30 AM Welcome \n\n\n\nKeck Medicine of USC\, HASC\, and Alliance for SoCal Innovation \n\n\n\n10:40 AM Rapid Fire Introductions \n\n\n\n11:00 AM Keynote \n\n\n\nCarey Ransom\, Managing Director of BankTech Ventures: “Building a shared new ventures capability for industry players” \n\n\n\n11:45 PM Lunch Break \n\n\n\n12:00 PM Panel Discussion \n\n\n\nAustin Gispanski\, BCGX (moderator) and panelists TJ Malseed\, CIO\, Keck Medicine of USC; Debbie Lin\, VP\, Caris Life Sciences; and Phil Martie\, CEO\, Nicolette \n\n\n\n12:45 PM Group Discussion \n\n\n\nModerated by Austin Gispanski\, Managing Director and Partner at BCGX \n\n\n\n1:15 PM Wrap up and Conclusions \n\n\n\n1:30 PM Tour of USC’s Mark and Mary Stevens Neuroimaging and Informatics Institute \n\n\n\nSpeakers\n\n\n\n\n \n \n \n \n \n Carey Ransom\n Managing Director\n BankTech Ventures\n View Bio \n \n \n \n \n \n \n \n \n \n \n Carey Ransom\n Managing Director\n BankTech Ventures\n \n \n \n \n \n \n \n Carey Ransom is an SaaS entrepreneur\, executive\, investor and advisor\, and has started\, grown and/or led 8 B2B and consumer SaaS companies during startup and growth phases. He is currently President of Operate and the Managing Director of BankTech Ventures\, a newly-launched strategic investment fund focused on compelling technologies for community banks\, and founded and funded by leaders in the community bank ecosystem. With full support and endorsement by the ICBA (Independent Community Bankers of America) and The Venture Center\, Finovate’s 2020 Accelerator of the Year\, the fund serves the community banking ecosystem through strategic investments\, education and collaboration with its limited partners. Prior to Operate he was COO at Aspiration\, the leading “consumer financial firm with a conscience\,” where he led the firm’s growth from 20 to 200 people and the build out of infrastructure and approval as a FINRA-regulated broker-dealer. He was also CEO of RealPractice\, a venture-backed SaaS company\, which he sold to ReachLocal (RLOC); Chief Product & Innovation Officer of Experian Consumer Services; and founding CMO of Happy Money\, a venture-backed consumer fintech company (and unicorn) that innovated in lending and financial health. Carey’s 25-year career spans executive roles in product\, marketing\, business development\, strategy and corporate development. He was VP Business Development at Brand Affinity Technologies (BAT)\, an Internet advertising and celebrity endorsement business; VP Marketing and Corporate Development at WebVisible\, where he forged new partnerships with AT&T\, American Express and Microsoft and led them to nearly 10X revenue growth; VP Sales and Marketing at MessageRite\, security compliance SaaS business acquired by Frontbridge Technologies\, and then Microsoft. Carey is active in the SoCal startup and investment community – OCTANe\, CEO Leadership Alliance of Orange County (CLA-OC)\, and has been an instructor or guest lecturer at numerous schools including UCLA\, USC\, UC Irvine\, Chapman\, Cal State Fullerton\, Biola and Vanguard. He has recruited and hired nearly 1000 people in the last 20 years\, and passionately believes in purpose\, culture and team as key ingredients to successful companies. He has frequently spoken at financial\, software and other conferences such as SaaStock\, Recurring Revenue\, Lendit\, AltFI\, Innovation Project\, Frost & Sullivan and IMA. Carey is an entrepreneur with a passion for sharing and discussing ideas while learning and teaching along the way. Carey is a husband and a father who loves to act like a kid because he’s truly a kid at heart. In his free time he enjoys spending time with his family and traveling. You’ll often find Carey on the sidelines of one of his children’s sporting games cheering them on. \n \n \n \n \n \n \n \n \n \n Austin Gispanski\n Managing Director & Partner\, BCGX\n Group Discussion Moderator\n View Bio \n \n \n \n \n \n \n \n \n \n \n Austin Gispanski\n Managing Director & Partner\, BCGX\n Group Discussion Moderator\n \n \n \n \n \n \n \n Austin is a Managing Director and Partner within BCG X\, BCG’s tech build and design unit focused in healthcare. Austin partners with healthcare companies to launch innovative new products and businesses ranging from digital front door solutions to digital care delivery products. Austin lead the GenAI efforts for the Healthcare Payer and Provider unit at BCG. Prior to BCG\, Austin has held roles across strategy\, engineering\, product\, design\, and operations in consulting\, technology companies\, and start-ups. Relevant BCG experience: Led shift for hospital from digital to product organization launching multiple products across maternity postpartum\, migraine treatment\, next-gen urgent care; Launched digital 2nd opinion platform for top specialty health system; Developed digital home health business and product strategy for regional health system; Built digital engagement platform aimed at preventing the progression of cardiac disease through sustained behavior change; Built AI-patient engagement app to improve adherence and experience; Launched healthcare business and hardware / software AI medical device for consumer goods company focused on driving health at home and preventative care; Conducted enterprise assessment and redesign for prior-authorization technology portfolio at a large national payer. Education: Stanford University\, M.S. in Mechanical Engineering & Product Design\, University of Florida\, B.S. in Mechanical Engineering & Business Administration. \n \n \n \n \n \n \n \n \n \n Debbie Lin\n VP of Strategic Partnerships\n Caris Life Sciences\n View Bio \n \n \n \n \n \n \n \n \n \n \n Debbie Lin\n VP of Strategic Partnerships\n Caris Life Sciences\n \n \n \n \n \n \n \n Dr. Debbie Lin has over 20+ years of business leadership experience in multinational environments\, having lived and worked in global executive positions in the US\, Europe and Asia. Debbie’s forte is new business model strategy\, business development\, venture capital in healthcare and medtech with a focus on scientific product development\, value proposition refinement\, and market access. As Executive Director for Boehringer Ingelheim Venture Fund\, Debbie was accountable for digital health investments\, board directorship and digital health strategy setting in North America. Previous to her role at the Venture Fund\, she was Global Director of Corporate Development where she crafted new business models for healthcare in major global markets. She has also held operational roles in field based Health Economics and Medical Affairs working with national payers\, regional providers and opinion leaders. She supported more than 5 drug launches and a variety of disease indications. Debbie is a Adjunct Faculty Advisor at UCLA Anderson School of Business and a mentor at Stanford MedicineX. She currently in VP of Strategic Partnerships at Caris Life Sciences\, a precision oncology diagnostics company and a Venture partner at T.Rx Capital. \n \n \n \n \n \n \n \n \n \n Phil Martie\n Founder and CEO\n Nicolette\, Inc.\n View Bio \n \n \n \n \n \n \n \n \n \n \n Phil Martie\n Founder and CEO\n Nicolette\, Inc.\n \n \n \n \n \n \n \n Phil Martie is the founder and CEO of Nicolette. Inspired by Phil’s NICU journey with extremely premature twins\, Nicolette was founded to put patients and their families at the center of care. Nicolette’s patient-facing apps transform raw patient data into easy-to-use yet powerful tools that empower patients to be competent and confident teammates with their care team. Prior to Nicolette\, Phil spent 15 years in the business process outsourcing (BPO) industry\, primarily with Canon. He served roles in analytics\, sales\, and operations\, last serving as VP Operations. \n \n \n \n \n \n \n \n \n \n TJ Malseed\n Chief Information Officer\n Keck Medicine of USC\n View Bio \n \n \n \n \n \n \n \n \n \n \n TJ Malseed\n Chief Information Officer\n Keck Medicine of USC\n \n \n \n \n \n \n \n TJ Malseed is the chief information officer for Keck Medicine of USC\, leading growth and overseeing operations for information systems at hospital sites\, ambulatory locations and office-based practices. He also supports information management and integration of care initiatives for Keck Medicine’s patients. \nMalseed also serves as associate dean for information services at the Keck School of Medicine of USC and chief information officer of the university’s Health Sciences Campus. \nPrior to joining Keck Medicine in 2016\, Malseed held the positions of vice president\, chief information officer and chief applications officer at Children’s Hospital Los Angeles (CHLA). With 20 years of experience in information technology\, Malseed oversaw the strategy and direction for CHLA’s technology efforts and led numerous clinical\, revenue cycles\, financial\, human resources and research technology efforts. \nMalseed holds a bachelor’s degree in international business and a minor in computer science from the University of California\, Davis. He is a member of the American College of Healthcare Executives and the Pediatric Leadership Council for Cerner Corporation. \n \n \n \n \n \n \n\n\n\n\n \n \n \n \n Health Systems Innovation Council Members\n \n \n \n Andrew Goldfrach\, CEO \nArrowhead Regional Medical Center  \nGeoffrey Hall\, CEO \nCalifornia Rehabilitation Institute  \nAlex Jawharjian\, COO \nCalifornia Rehabilitation Institute \nKelly Linden\, President and CEO \nCasa Colina Hospital and Centers for Healthcare \nBryan Croft\, EVP & COO \nCedars-Sinai \nNaser Mohammad\, CEO \nCentinela Hospital Medical Center \nOmkar Kulkarn\,VP\, Chief Transformation Officer | Chief Innovation Officer \nCHLA \nHarlan Levine\, President\, Health Innovation and Policy \nCity of Hope \nMick Zdeblick\, CEO \nCommunity Memorial Healthcare \nAnthony Russell\, CAO\, Ambulatory Medicine \nCommunity Memorial Healthcare \nJeremy Zoch\, President and CEO \nDignity Health\, Northridge Hospital Medical Center \nRon Werft\, President and CEO  \nCottage Health \nCarolyn Caldwell\, Hospital President and CEO \nDignity Health\, St. Mary Medical Center \nLori Morgan\, CEO \nHuntington Hospital \nTad Funahashi\, Chief Innovation Officer \nKaiser Permanente \nCamille Applin-Jones\, SVP & Area Manager \nKaiser Foundation Hospitals \nTJ Malseed\, CIO  \nKeck Medicine of USC \nAlen Oganesyan\, Assoc. Chief Information Officer \nKeck Medicine of USC \nManeesh Goyal\, COO \nMayo Clinic Platform \nMichael Torgan\, Chief Transformation Officer \nMission Community Hospital  \nKent Hoyos\, VP & Chief Information Officer \nPomona Valley Hospital Medical Center \nBernie Klein\, CEO \nProvidence Holy Cross \nMatt Bader\, Chief Strategy Officer  \nProvidence St. Joseph Health \nJohn Chapman\, President and CEO \nSan Antonio Regional Hospital \nNana Deeb\, CEO \nSouthwest Healthcare\, Palmdale Regional Medical Center \nKhurram Mir\, Director of Innovation \nUCI Health \nJennifer McCaney\, Chief of Innovation \nUCLA Health \nArmand Dorian\, CEO \nUSC Verdugo Hills Hospital \nSteven Shapiro\, SVP for Health Affairs \nUSC Health \nAndy Wilson\, Vice President\, Business Development Health Affairs \nUSC \nGus Valdespino\, President and CEO \nValley Presbyterian Hospital URL:https://alliancesocal.org/event/hsic-meeting-q1-2025/ CATEGORIES:Alliance Events ORGANIZER;CN="Alliance for SoCal Innovation":MAILTO:info@alliancesocal.org END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20250521T000000 DTEND;TZID=America/Los_Angeles:20250522T235959 DTSTAMP:20260406T100728 CREATED:20250517T033324Z LAST-MODIFIED:20250521T132113Z UID:6558-1747785600-1747958399@alliancesocal.org SUMMARY:First Look SoCal Life Science Innovation Showcase 2025 DESCRIPTION:  \n\n\n\n\n\n\n\nRegister now for the First Look SoCal Life Science Innovation Showcase on May 21 + 22 \n\n\n\nThe First Look SoCal Innovation Showcase is an annual event that celebrates the best early-stage startups commercializing deep tech and life science breakthroughs emerging from the top universities and research institutions in Southern California. This year we are dividing the annual event into two separate showcases to provide the best experience for Life Science and Deep Tech startups. \n\n\n\nEach startup will present a 3-minute quick pitch followed by 9 minutes of Q&A led by a panel of leading investors\, corporates\, and subject matter experts who will provide invaluable insights and access to capital. Celebrate and connect with industry leaders and investors at the post-event networking reception. \n\n\n\nTHE FIRST LOOK SOCAL LIFE SCIENCE INNOVATION SHOWCASE IS PARTNERING WITH UCLA \n\n\n\nFor the first time ever\, we are partnering with UCLA to host the First Look SoCal Life Science Showcases at UCLA’s LABEST Week which features two full days of world-class life science conferences at the Luskin Center on the UCLA campus. Selected startups (representing all of SoCal’s research and academic institutions) focused on MedTech will present on Wednesday\, May 21\, while Bioscience startups will present on Thursday\, May 22. Both of those events together attract over 1\,500 life science industry professionals from leading corporations\, VCs\, and research institutions around the world. Plus there are workshops and panels for early stage founders and much\, much more. \n\n\n\n\n\n\n\nCheck out the LABEST Week website for attendee info\, agenda and registration: \n\n\n\n\nAgenda + Registration\n\n\n\n\n\n\n\n\nMedTech Showcase on May 21\n\n\n\nShowcase runs from 1:30p – 4:10p in the Legacy room (2nd floor) \n\n\n\n\n\n\n\nMedTech Startups Presenting \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nBioscience Showcase May 22\n\n\n\nShowcase runs from 1:00p – 3:00p in the Illumination room (2nd floor) \n\n\n\n\n\n\n\n\n\nThe Bioscience Showcase is brought to you by: \n\n\n\n \n \n \n \n \n \n \n \n \n \n \n\n\n\n\nShowcase Moderated by: \n\n\n\nCharles Thomas\, Partner at KPPB \n\n\n\nCharles’s expertise in biotechnology\, medicine\, and biochemistry extends from his years of experience in both industry and academia. Learn more about Charles and KPPB\, leader in IP legal services \n\n\n\n \n\n\n\n\n\nBioscience Startups Presenting\n\n\n\n\n\n\n\n\n\n\n\n\n \n \n \n \n Life Science Showcase Judges\n \n \n \n \n \n \n \n \n \n \n\n \n \n \n \n \n \n\n \n \n\n \n Christopher Rowland\n\n \n Chief Executive Officer & Board Member\n KWGB Partners\n \n \n\n \n Bio \n \n \n \n \n \n\n \n \n\n \n Jessica Richter\n\n \n EVP\, CRO & Consulting Services\n Veranex\n \n \n\n \n Bio \n \n \n \n \n \n\n \n \n\n \n Debbie Lin\, Ph.D.\n\n \n VP Strategic Partnerships\, Venture Partner \n Caris Life Sciences\n \n \n\n \n Bio \n \n \n \n \n \n\n \n \n\n \n Ryan Krone\, Ph.D.\n\n \n Sr. Director\, Innovation Advanced Technologies\n Edwards Lifesciences\n \n \n\n \n Bio \n \n \n \n \n \n\n \n \n\n \n Ryan Potts\, Ph.D.\n\n \n Vice President and Head\, Induced Proximity Platform\n Amgen\n \n \n\n \n Bio \n \n \n \n \n \n\n \n \n\n \n Stephanie Chan\, Ph.D.\n\n \n Program Officer\n University Lab Partners\n \n \n\n \n Bio \n \n \n \n \n \n\n \n \n\n \n Suzy Engwall\n\n \n President and CEO\n Healthtech Strategies\n \n \n\n \n Bio \n \n \n \n \n \n\n \n \n\n \n Sonia Setayesh\, Ph.D.\n\n \n Investment Partner\n Civilization Ventures\n \n \n\n \n Bio \n \n \n \n\n \n \n \n \n \n \n\n \n\n \n \n \n \n \n \n \n \n \n \n \n\n \n \n \n \n \n \n\n \n \n Christopher Rowland\n\n \n Chief Executive Officer & Board Member\n KWGB Partners\n \n \n\n \n \n\n \n \n \n Christopher (Chris) Rowland has over 35 years of successful\, results-oriented experience in general\nmanagement\, sales\, and marketing within the medical device industry. He has more than 15 years of\nexperience as President and CEO in multicultural business environments. Currently\, he serves as Chairman\nof the Board for two MedTech companies and is an active board member or advisor for five additional\nMedTech companies.\n\nChris has a proven track record in revenue growth\, realignment\, and turnarounds in challenging\ncompetitive environments. He has experience in managing small\, mid-cap\, and large global multinational\ncompanies. His significant international experience includes managing organizations in the US and abroad\,\nwith several expatriate assignments and as a CEO of US\, Israeli\, and Chinese-held corporations.\nChris holds over 20 patents that have generated more than $1 billion in revenue. He has a strong history\nof identifying new opportunities\, launching new products\, and developing new markets. Previously\, he\nserved as CEO or President of companies acquired by Covidien/Medtronic\, Teleflex\, and a Chinese\nstrategic investor.\n\nChris earned a B.Sc. in Marketing from Southern Illinois University and completed the Executive\nLeadership Program at Harvard Business School and the Executive Management Program at Columbia\nBusiness School. \n \n \n \n\n \n \n \n \n \n \n\n \n \n Jessica Richter\n\n \n EVP\, CRO & Consulting Services\n Veranex\n \n \n\n \n \n \n \n \n \n\n \n \n \n Jessica Richter is the executive vice president of the regulatory\, clinical and quality services arm of Veranex. Jess joined Veranex in 2017 to expand our business development activities and to direct strategic growth initiatives. She has extensive experience in leadership\, sales and market development activities from her six years at Medtronic’s early technologies division and in the GI space. She has spearheaded successful\, high-impact projects in the areas of strategic sales planning\, physician education\, collaboration with patient advocacy groups and corporate project management. Jess has spent over ten years driving commercial sales activities within the medical device\, software and communications arena. At Veranex\, Jess interfaces with U.S. and international executives\, investors\, legal representation and clinical and policy advisors to expand industry networks and to deliver meaningful support to the firm’s clientele and partners. She holds a BA in Mass Communication/Media Studies from UC Berkeley. \n \n \n \n\n \n \n \n \n \n \n\n \n \n Debbie Lin\, Ph.D.\n\n \n VP Strategic Partnerships\, Venture Partner \n Caris Life Sciences\n \n \n\n \n \n \n \n \n \n\n \n \n \n Dr. Lin is Vice President – Strategic Partnerships at Caris Life Sciences. Prior to her role at Caris\, she was an Executive Director at Boehringer Ingelheim’s Venture Fund. Having spent over 14 years at Boehringer Ingelheim\, Dr. Lin held various roles in the US and internationally\, including leading US digital healthcare efforts and investments\, board directorship\, and in global strategy and corporate development\, and supporting drug launches in field-based roles in Health Economics and Medical Affairs.\n\nShe has earned a reputation as an executive deeply passionate and committed to steering her organization in new business strategy and development\, intrapreneurial and strategic thinking\, and executional excellence. She is an empathetic and dynamic leader who takes pride in helping to transform large organizations and pushing the envelope in new business strategies. A Life Science & Digital Health Investor and Pharmaceutical Executive\, Dr. Lin is also committed to supporting women and minorities in science and leadership.\n\nDr. Lin holds a Ph.D. in Pharmacogenomics and Bioinformatics from the University of California San Francisco\, a BS in Chemistry and Public Policy from Pomona College\, and an MSc. Eng. from Stanford University School of Engineering. \n \n \n \n\n \n \n \n \n \n \n\n \n \n Ryan Krone\, Ph.D.\n\n \n Sr. Director\, Innovation Advanced Technologies\n Edwards Lifesciences\n \n \n\n \n \n \n \n \n \n\n \n \n \n Ryan Krone is currently in his fourth year as Sr. Director of Innovation in the Advanced Technology incubator. Prior to Edwards\, Ryan has spent his career in early technology development and innovation roles for both large medical device companies as well as start-ups\, including his own. He was a Stanford Biodesign Innovation Fellow and has worked in structural heart\, women’s health\, neurology and cancer detection. His training is in Mechanical Engineering\, where he holds a PhD. \n \n \n \n\n \n \n \n \n \n \n\n \n \n Ryan Potts\, Ph.D.\n\n \n Vice President and Head\, Induced Proximity Platform\n Amgen\n \n \n\n \n \n \n \n \n \n\n \n \n \n Dr. Ryan Potts is VP of Research and Head of the Induced Proximity Platform at Amgen that works on ways to bring two or more molecules in close proximity to each other to tackle drug targets that are currently considered “undruggable.” He also leads Amgen’s Research & Development Postdoctoral Fellows Program. Ryan received his BS in biology from the University of North Carolina at Chapel Hill\, and he was awarded his PhD in cellular and molecular biology from UT Southwestern Medical Center. After completing his PhD\, Ryan served on the faculty at UT Southwestern Medical Center for eight years before accepting a position on the faculty at St. Jude Children’s Research Hospital. He joined the team at Amgen in 2020. In this interview\, he shares more about his life and science. \n \n \n \n\n \n \n \n \n \n \n\n \n \n Stephanie Chan\, Ph.D.\n\n \n Program Officer\n University Lab Partners\n \n \n\n \n \n \n \n \n \n\n \n \n \n \n \n \n \n\n \n \n \n \n \n \n\n \n \n Suzy Engwall\n\n \n President and CEO\n Healthtech Strategies\n \n \n\n \n \n \n \n \n \n\n \n \n \n Suzy Engwall is the CEO and Founder of HealthTech Strategies\, LLC\, a boutique consulting firm. She is a healthcare innovation leader\, speaker\, startup advisor and mentor that has been working to make change in healthcare for almost 2 decades.\n\nAt HealthTech Strategies\, Suzy works with teams from multiple areas within the healthcare innovation ecosystem including startups\, healthcare organizations and investors. She mentors and advises early-stage startups to help them navigate the challenging landscape of bringing a product to market in the highly regulated healthcare space. She also consults with healthcare organizations to set up their corporate innovation programs and assist them in the commercialization of new product. \n \n \n \n\n \n \n \n \n \n \n\n \n \n Sonia Setayesh\, Ph.D.\n\n \n Investment Partner\n Civilization Ventures\n \n \n\n \n \n \n \n \n \n\n \n \n \n Sonia is an Investment Partner at Civilization Ventures\, leading scientific diligence on early-stage biotech companies. She earned her PhD at USC\, where she developed liquid-biopsy assays—including an early breast-cancer test in collaboration with clinical sites—and previously helped advance two targeted immunotherapies into clinical trials. Sonia also brings hands-on oncology BD experience and has served as VP of Nucleate HQ and Biotech Connection Los Angeles. \n \n \n \n\n \n\n\n\n\n\n\nLook Forward To…\n\n\n\nConnect with investors\, peers\, and mentors\n\n\n\nUnparalleled opportunities to connect with investors\, mentors and other support resources crucial for early stage startups. \n\n\n\nStartup quick-pitch presentations\n\n\n\nTwo separate events for Life Science (MedTech and Biotech) and Deep Tech (Robotics\, Aerospace\, Advanced Manufacturing\, Energy\, Materials) where each event features startups doing 3-minute quick pitch presentations followed by 9 minutes of moderated Q&A led by a panel of investors\, corporate leaders\, and subject matter experts. \n\n\n\nOne of the largest showcases of university-based deep tech and life science startups\n\n\n\nThis is SoCal’s premiere gathering of the best startups emerging from the region’s top research institutions so it attracts the region’s community in a rare concentrated program that celebrates the entrepreneur’s journey from lab to market. \n\n\n\nNetworking Reception\n\n\n\nStay for drinks and small bites as we celebrate and connect with attendees and speakers (on 5/22). URL:https://alliancesocal.org/event/first-look-socal-ls-innovation-showcase-2025/ LOCATION:The Luskin Conference Center at UCLA in Los Angeles\, CA\, 425 Westwood Plaza\, Los Angeles\, California\, 90095\, United States CATEGORIES:Alliance Events END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20250605T093000 DTEND;TZID=America/Los_Angeles:20250605T143000 DTSTAMP:20260406T100728 CREATED:20250603T030302Z LAST-MODIFIED:20250605T055858Z UID:6610-1749115800-1749133800@alliancesocal.org SUMMARY:Health System Innovation Council Meeting - Q2 2025 DESCRIPTION:Topic: Remote Patient Management: influences\, obstacles and trends\n\n\n\nHosted by Kaiser Permanente @ The Tustin Ranch Medical Office \n\n\n\n\n\nEvent Sponsors\n\n\n\n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n\n\n\n\n\nStartup Showcase Sponsors\n\n\n\n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n\n\n\n\n\nEvent Hosts\n\n\n\n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n\n\n\n\n\n \n\n\n\nAGENDA \n\n\n\n9:00 AM Venture Fund Brainstorm Session \n\n\n\n9:45-10:30 AM –  Dell Digital Assistant demo \n\n\n\n10:00 AM – Check in\, meet and greet \n\n\n\n10:30 AM Welcome \n\n\n\nAlliance for SoCal Innovation\, HASC\, Kaiser Permanente \n\n\n\n10:40 AM Rapid Fire Introductions \n\n\n\n11:00 AM Short presentations from Kaiser practitioners \n\n\n\nIntroduction by Dr. Daniel Cantillon M.D.\, Chief Medical Officer at Massimo \n\n\n\nPresentations: Alyssa Millan\, Dr. Dan Huynh\, Dr. Columbus Batiste \n\n\n\n11:20 AM Panel Discussion \n\n\n\nRemote Patient Management: influences\, obstacles and trends \n\n\n\n\nDr. Tadashi Funahashi\, Chief Innovation and Transformation Officer\, Kaiser Permanente\n\n\n\nDr. Dan Huynh\, Physician Quality Lead for Advanced Medical Care at Home\, Kaiser Permanente SCAL\n\n\n\nDr. Columbus Batiste Regional Chief of Cardiology\, Kaiser Permanente\n\n\n\nAlyssa Millan\, Director of Care Transformation\, Kaiser Permanente\n\n\n\nBeth Andrews\, Chief Digital Health Officer and Biz Dev\, Healthcare; Dell Technologies\n\n\n\nModerated by Austin Gispanski\, Managing Partner\, BCGX\n\n\n\n\n12:10 PM Break + Grab Lunch \n\n\n\n12:20 PM Startup Presentations \n\n\n\nModerated by Jay Goss\, General Partner at Wavemaker Three-Sixty Health \n\n\n\nStartups Presenting \n\n\n\n\nCamino Mobility\, Duncan Orrell-Jones\, Co-Founder & CEO\n\n\n\nLaminar\, Jess Lee\, CEO\n\n\n\nSensorum\, Andrew Hotchkiss\, Co-Founder & CEO\n\n\n\n\n1:00 PM Group Discussion \n\n\n\nModerated by Austin Gispanski\, Managing Director and Partner at BCGX \n\n\n\n1:40 PM Wrap up and Conclusions \n\n\n\n1:45 PM Tour of Kaiser Permanente Innovation Studios (~30 mins) \n\n\n\nSpeakers\n\n\n\n\n \n \n \n \n \n Daniel Cantillon M.D.\n Chief Medical Officer\n Masimo\n View Bio \n \n \n \n \n \n \n \n \n \n \n Daniel Cantillon M.D.\n Chief Medical Officer\n Masimo\n \n \n \n \n \n \n \n \n \n \n Dr. Dan Cantillon is an adult EP cardiologist and Chief Medical Officer at Masimo Corporation\, a medical device company based in Irvine\, CA specializing in non-invasive patient monitoring. Previously\, Dr. Cantillon served at Cleveland Clinic for over 16 years with multiple leadership roles including departmental research as well as the enterprise-wide Medical Director of Cleveland Clinic’s remote patient monitoring command center for the main campus and regional hospitals serving over 2\,000 continuously monitored patients. His clinical achievements include the first-in-US implant of a dual chamber leadless cardiac pacemaker\, and the first-in-human implant of an entirely leadless pacemaker-defibrillator. His original research contributions include lead or senior authorship in the New England Journal of Medicine\, Journal of the American Medical Association\, other top-tier cardiology journals and clinical practice guidelines. He was the recipient of the Cleveland Clinic’s prestigious Sones-Favaloro Award for Innovation in Remote Patient Monitoring. \n \n \n \n \n \n \n \n \n \n Austin Gispanski\n Managing Director and Partner\, BCGX\n Group Discussion Moderator\n View Bio \n \n \n \n \n \n \n \n \n \n \n Austin Gispanski\n Managing Director and Partner\, BCGX\n Group Discussion Moderator\n \n \n \n \n \n \n \n \n \n \n Austin is a Managing Director and Partner within BCG X\, BCG’s tech build and design unit focused in healthcare. Austin partners with healthcare companies to launch innovative new products and businesses ranging from digital front door solutions to digital care delivery products. Austin lead the GenAI efforts for the Healthcare Payer and Provider unit at BCG. Prior to BCG\, Austin has held roles across strategy\, engineering\, product\, design\, and operations in consulting\, technology companies\, and start-ups. Relevant BCG experience: Led shift for hospital from digital to product organization launching multiple products across maternity postpartum\, migraine treatment\, next-gen urgent care; Launched digital 2nd opinion platform for top specialty health system; Developed digital home health business and product strategy for regional health system; Built digital engagement platform aimed at preventing the progression of cardiac disease through sustained behavior change; Built AI-patient engagement app to improve adherence and experience; Launched healthcare business and hardware / software AI medical device for consumer goods company focused on driving health at home and preventative care; Conducted enterprise assessment and redesign for prior-authorization technology portfolio at a large national payer. Education: Stanford University\, M.S. in Mechanical Engineering u0026amp; Product Design\, University of Florida\, B.S. in Mechanical Engineering u0026amp; Business Administration. \n \n \n \n \n \n \n \n \n \n Tad Funahashi\n Chief Innovation and Transformation Officer\n Kaiser Permanente\n View Bio \n \n \n \n \n \n \n \n \n \n \n Tad Funahashi\n Chief Innovation and Transformation Officer\n Kaiser Permanente\n \n \n \n \n \n \n \n \n \n \n Tad Funahashi\, MD\, is the Chief Innovation Officer for Kaiser Permanente Southern California. In this role\, he leads a team of physicians\, consultants\, designers\, data scientists\, and engineers​ who work together with teams and leaders across Kaiser Permanente ​to envision and build the healthcare delivery system of the future at the Kaiser Permanente Innovations Studio.  Dr. Funahashi and the Innovation Studio take a people-first approach to healthcare to enhance the member experience by improving care across the continuum\, leveraging big data to provide personalized and improved quality of care\, and exploring emerging opportunities that have transformative potential. He is also a practicing orthopedic physician with Southern California Permanente Medical Group. \n \n \n \n \n \n \n \n \n \n Dr. Dan Huynh\, M.D.\n Physician Quality Lead for Advanced Medical Care at Home\n Kaiser Permanente SCAL\n View Bio \n \n \n \n \n \n \n \n \n \n \n Dr. Dan Huynh\, M.D.\n Physician Quality Lead for Advanced Medical Care at Home\n Kaiser Permanente SCAL\n \n \n \n \n \n \n \n \n \n \n Dr. Dan Huynh\, MD FACP\, is a distinguished hospitalist practicing with the Southern California Permanente Medical Group (SCPMG). With over two decades of experience\, he has demonstrated exceptional leadership skills and a commitment to enhancing the quality of healthcare at Kaiser Permanente\, Southern California Region (KPSC). \nDuring his tenure as the regional hospitalist chief\, Dr. Huynh played a pivotal role in standardizing and enhancing the quality of care delivered by over 500 hospitalists across KPSC. His efforts contributed significantly to ensuring consistency and excellence in patient care throughout the region.\nIn his role as the regional medical director for home care services\, Dr. Huynh spearheaded the introduction of innovative care models\, such as the COVID Home Monitoring program. This initiative utilized technology to provide care for more than 22\,000 COVID patients in the comfort of their homes\, demonstrating Dr. Huynh’s commitment to leveraging advancements in healthcare to benefit patients. Currently\, Dr. Huynh leads the expansion of KPSC’s Advanced Medical Care at Home program\, the largest acute care at home program in the nation. This program ensures that patients receive high-quality\, personalized care outside of traditional hospital settings\, improving access and outcomes for individuals in need of acute medical services. \nDr. Huynh earned his medical degree from the University of California\, Irvine\, School of Medicine\, and completed his residency at UC Irvine Medical Center. \n \n \n \n \n \n \n \n \n \n Alyssa Millan\n Director of Care Transformation\n Kaiser Permanente\n View Bio \n \n \n \n \n \n \n \n \n \n \n Alyssa Millan\n Director of Care Transformation\n Kaiser Permanente\n \n \n \n \n \n \n \n \n \n \n Alyssa Millan is a healthcare leader based in Los Angeles\, California\, currently serving as Director of Care Transformation at Kaiser Permanente. In this role\, she spearheads initiatives that improve care delivery\, patient outcomes\, and operational efficiency across the organization. Alyssa played a key role in Kaiser’s COVID-19 Home Monitoring Program\, which enabled thousands of patients to recover safely at home. \nShe earned both her Bachelor of Science in Psychobiology and her Master of Public Health (MPH) from UCLA\, with her graduate studies completed at the UCLA Fielding School of Public Health. \n \n \n \n \n \n \n \n \n \n Dr. Columbus Batiste\n Regional Chief of Cardiology\n Kaiser Permanente\n View Bio \n \n \n \n \n \n \n \n \n \n \n Dr. Columbus Batiste\n Regional Chief of Cardiology\n Kaiser Permanente\n \n \n \n \n \n \n \n \n \n \n Dr. Columbus Batiste\, known as the “Healthy Heart Doc\,” is a captivating speaker and advocate of plant-based nutrition. His unique ability to turn disparity topics into relatable and engaging conversations makes him one of the leading lifestyle medical influencers. He educates his audience on simple healthy heart strategies for documentaries\, podcasts\, news outlets\, international conferences\, churches\, and nonprofit organizations. \nCARDIOLOGIST\nDr. Columbus Batiste is a double board-certified Cardiologist\, Interventional Cardiologist\, and passionate lifestyle advocate. Through the support of many giants in the field of lifestyle medicine\, he embarked on a crusade to educate and empower patients to enact change and defeat these preventable diseases thereby extending their health-span. \nAUTHOR\nIn SELFISH: A Cardiologist’s Guide to Healing a Broken Heart\, Dr. Columbus Batiste provides the ultimate blueprint for coping with the everyday stressors of life that lead to heart disease\, anxiety\, and depression. Built upon an evidence-based approach to optimal health\, SELFISH challenges readers to combine self-care techniques with the transformative power of plant-based nutrition to truly heal from the inside out\, and enjoy life on purpose. \nSPEAKER & CONTRIBUTOR\nDr. Batiste’s engaging viewpoint on heart health not only captures the attention of audiences but also imparts enlightening insights. Recognized for his expertise\, he has been featured in renowned documentaries like “Eating You Alive” and “The Game Changers.” Moreover\, he shares his wealth of knowledge on maintaining a healthy heart and adopting a plant-based diet through interviews on television\, radio\, and various podcast platforms. \n \n \n \n \n \n \n \n \n \n Beth Andrews\n Chief Digital Health Officer and Business Development\n Dell Technologies\n View Bio \n \n \n \n \n \n \n \n \n \n \n Beth Andrews\n Chief Digital Health Officer and Business Development\n Dell Technologies\n \n \n \n \n \n \n \n \n \n \n Beth Andrews is chief digital health officer and business development lead for life sciences and healthcare\, global alliances at Dell Technologies. Before joining Dell\, she spent more than 20 years as an entrepreneur and intrapreneur launching emerging tech in start-ups and F500 companies. She held product development\, business development and emerging technology leadership roles. Her leadership in these companies comprising the mHealth space helped to pioneer and establish the digital health segment. She helped develop one of the earliest commercialised wearable sensors and digital therapeutic patches in the early mHealth days. She led go-to-market adoption of remote patient monitoring solutions for medical surgery\, ICU and virtual ICU units as well as development of computer vision solutions. She is a MassChallenge HealthTech 2020 Cohort participation winner of the Accelerator’s Platinum Award. \n \n \n \n \n \n \n\n\n\n\n \n \n \n \n Health Systems Innovation Council Members\n \n \n \n Andrew Goldfrach\, CEO \nArrowhead Regional Medical Center  \nGeoffrey Hall\, CEO \nCalifornia Rehabilitation Institute  \nAlex Jawharjian\, COO \nCalifornia Rehabilitation Institute \nKelly Linden\, President and CEO \nCasa Colina Hospital and Centers for Healthcare \nBryan Croft\, EVP & COO \nCedars-Sinai \nNaser Mohammad\, CEO \nCentinela Hospital Medical Center \nOmkar Kulkarn\,VP\, Chief Transformation Officer | Chief Innovation Officer \nCHLA \nHarlan Levine\, President\, Health Innovation and Policy \nCity of Hope \nMick Zdeblick\, CEO \nCommunity Memorial Healthcare \nAnthony Russell\, CAO\, Ambulatory Medicine \nCommunity Memorial Healthcare \nJeremy Zoch\, President and CEO \nDignity Health\, Northridge Hospital Medical Center \nRon Werft\, President and CEO  \nCottage Health \nCarolyn Caldwell\, Hospital President and CEO \nDignity Health\, St. Mary Medical Center \nLori Morgan\, CEO \nHuntington Hospital \nTad Funahashi\, Chief Innovation Officer \nKaiser Permanente \nCamille Applin-Jones\, SVP & Area Manager \nKaiser Foundation Hospitals \nTJ Malseed\, CIO  \nKeck Medicine of USC \nAlen Oganesyan\, Assoc. Chief Information Officer \nKeck Medicine of USC \nManeesh Goyal\, COO \nMayo Clinic Platform \nMichael Torgan\, Chief Transformation Officer \nMission Community Hospital  \nKent Hoyos\, VP & Chief Information Officer \nPomona Valley Hospital Medical Center \nBernie Klein\, CEO \nProvidence Holy Cross \nMatt Bader\, Chief Strategy Officer  \nProvidence St. Joseph Health \nJohn Chapman\, President and CEO \nSan Antonio Regional Hospital \nNana Deeb\, CEO \nSouthwest Healthcare\, Palmdale Regional Medical Center \nKhurram Mir\, Director of Innovation \nUCI Health \nJennifer McCaney\, Chief of Innovation \nUCLA Health \nArmand Dorian\, CEO \nUSC Verdugo Hills Hospital \nSteven Shapiro\, SVP for Health Affairs \nUSC Health \nAndy Wilson\, Vice President\, Business Development Health Affairs \nUSC \nGus Valdespino\, President and CEO \nValley Presbyterian Hospital URL:https://alliancesocal.org/event/hsic-meeting-q2-2025/ CATEGORIES:Alliance Events ORGANIZER;CN="Alliance for SoCal Innovation":MAILTO:info@alliancesocal.org END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20250903T100000 DTEND;TZID=America/Los_Angeles:20250903T133000 DTSTAMP:20260406T100728 CREATED:20250902T205753Z LAST-MODIFIED:20250903T031328Z UID:6796-1756893600-1756906200@alliancesocal.org SUMMARY:Health Systems Innovation Council Meeting - Q3 2025 DESCRIPTION:Topic: Data Management & Privacy in the World of AI\n\n\n\nHosted by the Lundquist Institute\, Medical Research Labs \n\n\n\n\n\nEvent Sponsors\n\n\n\n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n\n\n\n\n\nStartup Showcase Sponsors\n\n\n\n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n\n\n\n\n\nEvent Hosts\n\n\n\n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n\n\n\n\n\n \n\n\n\nAGENDA \n\n\n\n10:00 am  Tour of the Lundquist Institute’s Medical Research Lab \n\n\n\nLed by Joe W. Ramos\, PhD\, President & CEO \n\n\n\n10:30 am  Welcome + Rapid Fire Introductions \n\n\n\n11:00 am  Update: Innovation Venture Fund \n\n\n\nAndy Wilson\, Vice President\, University of Southern California \n\n\n\n11:10 am  Panel: Data Management & Privacy in the World of AI \n\n\n\nSpeakers: Travis True (Oracle)\, David Morony (Casa Colina)\, Moderated by Sam Juraschka (BCGX) \n\n\n\n12:00 pm  Break + Grab Lunch \n\n\n\n12:15 pm  Startup Presentations \n\n\n\n Ready\, Set\, Food: Daniel Zakowski\, Co-Founder & CEO \n\n\n\n BDI: Jonathan Taub\, CEO \n\n\n\n12:45 pm  Group Discussion  \n\n\n\n1:30 pm  Adjourn \n\n\n\nSpeakers\n\n\n\n\n \n \n \n \n \n Joe W. Ramos\, PhD \n President and CEO at the Lundquist Institute\n View Bio \n \n \n \n \n \n \n \n \n \n \n Joe W. Ramos\, PhD \n President and CEO at the Lundquist Institute\n \n \n \n \n \n \n \n Dr. Joe W. Ramos\, PhD became the President and CEO of The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center in early 2025. TLI is a leading nonprofit biomedical research organization in Los Angeles dedicated to advancing medical research\, delivering on our mission to improve patient outcomes through cutting-edge research\, education\, and community engagement. \nPreviously\, Dr. Ramos was the Director and CEP of the Louisiana Cancer Research Center (LCRC) and Director of the Louisiana State University LCMC Health Cancer Center in New Orleans. Before his time in Louisiana\, he was the Interim Director at the University of Hawai’i Cancer Center (an NCI-designated Cancer Center)\, where he served more than 10 years in various leadership roles through two renewals of NCI designation. \nDr. Ramos grew up in a small town in Virginia and completed his undergraduate degree and his PhD at the University of Virginia Medical School. He went on to do postdoctoral studies at the Scripps Research Institute in La Jolla\, CA. Driven by a passion for research that makes a difference in people’s lives\, he works to assemble and lead formidable teams to conduct groundbreaking research\, deliver exceptional clinical care\, foster education\, and engage with communities\, all dedicated to addressing the unique needs of local populations. \nsource: https://lundquist.org/profile/joe-w-ramos-phd/ \n \n \n \n \n \n \n \n \n \n Dave Morony\n Chief Financial Officer at Casa Colina Hospital and Centers for Healthcare \n View Bio \n \n \n \n \n \n \n \n \n \n \n Dave Morony\n Chief Financial Officer at Casa Colina Hospital and Centers for Healthcare \n \n \n \n \n \n \n \n Dave Morony joined Casa Colina Hospital and Centers for Healthcare as the Chief Financial Officer in June 2012. He is responsible for overseeing the financial and business affairs of Casa Colina. He has more than 30 years of experience in healthcare accounting\, auditing\, reimbursement\, and consulting. Morony spent the first seven years of his career at KPMG Certified Public Accountants. Immediately prior to joining Casa Colina\, he spent 17 years at Ashtabula County Medical Center (an affiliate of the Cleveland Clinic)\, where he was both the Chief Financial Officer and a Vice President. Morony received his Bachelor of Science degree with a major in Accounting from West Virginia University in 1987 and is a Certified Public Accountant. \n \n \n \n \n \n \n \n \n \n Travis True\n Senior Director Health Network at Oracle Health\n View Bio \n \n \n \n \n \n \n \n \n \n \n Travis True\n Senior Director Health Network at Oracle Health\n \n \n \n \n \n \n \n Travis True is a senior leader responsible for Oracle Health clients across North America who have a vested interest in their Consumer\, Value-Based care strategy\, and AI. Travis has been a leader in Oracle for the past five years and has been in the healthcare industry for the previous twenty years. \nThroughout his career\, Travis has held leadership roles at industry-leading organizations\, including Oracle\, Vista Equity Partners\, and DaVita. His experience spans a wide range of healthcare domains\, including health networks\, information technology\, and consumer engagement. This breadth of knowledge enables him to develop innovative solutions that address the evolving needs of healthcare providers\, payers\, and patients. \nTravis graduated magna cum laude from the University of Arizona with a BS in Aerospace Engineering and a minor in MIS. He received his MBA from the University of California\, Irvine\, where he studied Healthcare Management and Policy. \nAs a dedicated advocate for the power of healthcare technology\, Travis is committed to fostering a healthier future for individuals and communities worldwide. His work embodies a steadfast belief in the potential of innovation to transform lives and create a more equitable healthcare system. \nTravis currently lives in Sedona\, Arizona\, with his wife and 2-year-old son. \n \n \n \n \n \n \n \n \n \n Sam Juraschka Allen \n Partner at BCG X\n View Bio \n \n \n \n \n \n \n \n \n \n \n Sam Juraschka Allen \n Partner at BCG X\n \n \n \n \n \n \n \n Sam Juraschka is a Partner at BCG X\, where she helps healthcare organizations — especially provider systems — build and scale innovation functions. She has led digital transformation and venture-building efforts across top U.S. hospitals\, with a focus on data strategy\, virtual care\, and digital infrastructure. Sam also advises on commercialization\, data governance\, and AI-driven care models\, drawing from experience across provider\, payer\, and life sciences ecosystems. \n \n \n \n \n \n \n \n \n \n Daniel Zakowski\n CEO at Ready\, Set\, Food\n View Bio \n \n \n \n \n \n \n \n \n \n \n Daniel Zakowski\n CEO at Ready\, Set\, Food\n \n \n \n \n \n \n \n I build and scale consumer health businesses by combining breakthrough products\, rigorous evidence\, and targeted distribution. At Ready\, Set\, Food!\, I pioneered the food allergy prevention category\, transforming a novel idea based on clinical studies into a national wellness brand that reached 200k+ families\, generated $20M+ in online/Amazon sales\, $7M+ in retail (Target\, Walmart\, Meijer\, Wegmans\, Sprouts)\, and secured multiple Medicaid contracts with >25% opt-in among eligible new parents. \nI raised $37M from leading strategics and investors\, including Johnson & Johnson\, Kenvue\, Danone\, Providence Health\, and Memorial Hermann; earned US/EU patents; appeared twice on Shark Tank; and helped lead a 1\,100-baby clinical trial proving the ROI of food allergy prevention. We launched partnerships with 15 large health systems to implement fully automated EMR integrations delivering food allergy education to parents (Providence\, Advocate Aurora\, Northwell\, Trinity\, Memorial Hermann\, and more) and helped pass legislation mandating insurance coverage for early allergen introduction in Delaware\, with similar bills advancing in other states. \nEarlier in my career\, I led corporate strategy at AECOM\, driving enterprise-wide planning and board reporting; built go-to-market and growth operations at OpenX; and led strategy and sales/product operations at The Wonderful Company/Teleflora. I also founded a B2B dental supply distribution company\, scaling to 45 employees and $10M in annual revenue. \nFocus areas: omnichannel consumer healthcare GTM (retail\, Amazon\, DTC\, provider engagement)\, payer reimbursement (Medicaid\, commercial\, employer)\, clinical partnerships\, value creation and turnarounds\, and P&L leadership. I advise founders and investors and seek Advisory\, Board\, or operational opportunities where my track record in scaling consumer and B2B health businesses can accelerate growth and impact. \n \n \n \n \n \n \n \n \n \n Jonathan Taub\n CEO at BDI\n View Bio \n \n \n \n \n \n \n \n \n \n \n Jonathan Taub\n CEO at BDI\n \n \n \n \n \n \n \n Before BDI\, Jonathan Taub was President of Sequoia/Tencent-backed medical image AI company VoxelCloud Inc.\, EVP of IP licensing company Acacia Research (helping grow Acacia’s market cap from $90 million to $2 billion in less than 5 years) and was the co-founder and CEO of ARCH-backed biopharma company Epirium Bio (previously Cardero Therapeutics). \nHe was previously director of strategic alliances at Microsoft and director of business development at Nortel Networks following Nortel’s $450M acquisition of cloud software pioneer Epicon\, where he headed business development. \nHe is a Wharton (University of Pennsylvania) and Harvard Law School graduate. \n \n \n \n \n \n \n\n\n\n\n \n \n \n \n Health Systems Innovation Council Members\n \n \n \n Andrew Goldfrach\, CEO \nArrowhead Regional Medical Center \nGeoffrey Hall\, CEO \nAlex Jawharjian\, COO \nCalifornia Rehabilitation Institute \nKelly Linden\, President and CEO \nCasa Colina Hospital and Centers for Healthcare \nBryan Croft\, EVP & COO \nCedars-Sinai \nNaser Mohammad\, CEO \nCentinela Hospital Medical Center \nOmkar Kulkarn\, VP\, Chief Transformation Officer | Chief Innovation Officer \nChildren’s Hospital LA (CHLA) \nHarlan Levine\, President\, Health Innovation and Policy \nCity of Hope \nMick Zdeblick\, CEO \nAnthony Russell\, CAO\, Ambulatory Medicine \nCommunity Memorial Healthcare \nRon Werft\, President and CEO \nCottage Health \nJeremy Zoch\, President and CEO \nDignity Health\, Northridge Hospital Medical Center \nCarolyn Caldwell\, Hospital President and CEO \nDignity Health\, St. Mary Medical Center \nLori Morgan\, CEO \nHuntington Hospital \nTad Funahashi\, Chief Innovation Officer \nKaiser Permanente \nCamille Applin-Jones\, SVP & Area Manager \nKaiser Foundation Hospitals \nTJ Malseed\, CIO \nAlen Oganesyan\, Assoc. Chief Information Officer \nKeck Medicine of USC \nManeesh Goyal\, COO \nMayo Clinic Platform \nMichael Torgan\, Chief Transformation Officer \nMission Community Hospital \nKent Hoyos\, VP & Chief Information Officer \nPomona Valley Hospital Medical Center \nBernie Klein\, CEO \nProvidence Holy Cross \nMatt Bader\, Chief Strategy Officer \nProvidence St. Joseph Health \nJohn Chapman\, President and CEO \nSan Antonio Regional Hospital \nNana Deeb\, CEO \nSouthwest Healthcare\, Palmdale Regional Medical Center \nKhurram Mir\, Director of Innovation \nUCI Health \nJennifer McCaney\, Chief of Innovation \nUCLA Health \nArmand Dorian\, CEO \nUSC Verdugo Hills Hospital \nSteven Shapiro\, SVP for Health Affairs \nUSC Health \nAndy Wilson\, Vice President\, Business Development Health Affairs \nUSC \nGus Valdespino\, President and CEO \nValley Presbyterian Hospital URL:https://alliancesocal.org/event/hsic-meeting-q3-2025/ CATEGORIES:Alliance Events ORGANIZER;CN="Alliance for SoCal Innovation":MAILTO:info@alliancesocal.org END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20250918T130000 DTEND;TZID=America/Los_Angeles:20250918T183000 DTSTAMP:20260406T100728 CREATED:20250310T230342Z LAST-MODIFIED:20260310T233059Z UID:6431-1758200400-1758220200@alliancesocal.org SUMMARY:The SoCal Deep Tech Symposium DESCRIPTION:Featuring the First Look SoCal Deep Tech Innovation Showcase\n\n\n\n\n\nConnect with Deep Tech innovators and investors at the 2nd Annual SoCal Deep Tech Symposium in El Segundo. Sponsored by Escalon Services\, Reitler\, Kenilworth Group at Morgan Stanley\, and TMX Group.\n\n\n\nWhat to know:  The Deep Tech Symposium gathers over 130 top corporate leaders\, government representatives\, startup founders\, and early-stage investors in fields such as Aerospace & Defense\, Advanced Manufacturing & Robotics\, Autonomous Mobility\, Renewable Energy\, AI and more. \n\n\n\nGet a glimpse of the future: This year’s symposium will also feature quick pitches from 5 selected startups commercializing breakthroughs created at top research universities in Southern California. The First Look SoCal Deep Tech Innovation Showcase is your opportunity to get a glimpse of tomorrow’s tech before it hits the market. \n\n\n\nSponsors & Partners\n\n\n\n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n\n\n\n\n\nTHE 2025 AGENDA: \n\n\n\n​PRE-EVENT WORKSHOP FOR FOUNDERS sponsored by Reitler and TMX (separate ticket required) \n\n\n\n​10AM – 12PM: Workshop with legal experts Gadi Navon and Daniel Erlikhman\, partners at Reitler law firm\, and fundraising expert Delilah Panio at TMX. This workshop will help startup founders navigate issues such as Protecting and Commercializing Deep Tech Intellectual Property; Fundraising\, and avoiding legal pitfalls. Lunch provided after the workshop. Combination ticket includes workshop\, lunch and General Admission to the symposium plus networking reception. \n\n\n\nWorkshop Leaders\n\n\n\n\n \n \n \n \n \n Daniel Erlikhman\n Partner at Reitler\n View Bio \n \n \n \n \n \n \n \n \n \n \n Daniel Erlikhman\n Partner at Reitler\n \n \n \n \n \n \n \n \n \n \n Daniel’s practice involves representing founders\, serial entrepreneurs\, emerging companies\, family offices and other sophisticated investors on a variety of corporate and financing matters\, including venture capital financings\, SAFE & convertible debt financings\, and other investment and corporate transactions. In his emerging company practice\, Daniel navigates clients through all growth milestones\, from basic formation to equity administration and founder arrangements\, to fundraisings and exits. Additionally\, Daniel acts as trusted legal advisor to middle-market clients and venture-backed and private equity fund portfolio companies in a mix of corporate matters\, ranging from leading traditional M&A transactions and later-stage financings\, strategic combinations and restructurings\, to advising on corporate governance\, intellectual property\, and commercial matters.\n \n \n \n \n \n \n \n \n \n \n Gadi Navon\n Partner at Reitler\n View Bio \n \n \n \n \n \n \n \n \n \n \n Gadi Navon\n Partner at Reitler\n \n \n \n \n \n \n \n \n \n \n Gadi Navon’s practice focuses on counseling clients with respect to the commercialization of their intellectual property\, technologies\, content\, brands\, and other assets. His expertise includes structuring and negotiating complex transactions involving the development\, licensing\, distribution or transfer of technologies and intellectual property assets; negotiating commercial agreements and service agreements; advising on e-commerce matters; counseling on IP protection strategies; and assisting in M&A transactions involving intellectual property assets.\nIn over thirty years of practice\, Gadi has represented clients in various industries\, including software\, semiconductor\, hardware\, medical device\, biotechnology\, mobile and e-commerce\, video game\, industrial goods and materials\, electric utility\, food and beverage\, supplements\, space ventures\, data collection\, tactical training products\, and clean energy. \n \n \n \n \n \n \n \n \n \n Delilah Panio\n Vice President\, US Capital Formation at TMX Group\n View Bio \n \n \n \n \n \n \n \n \n \n \n Delilah Panio\n Vice President\, US Capital Formation at TMX Group\n \n \n \n \n \n \n \n \n \n \n Delilah Panio is passionate about helping entrepreneurs access the aligned capital they need to create and grow great companies. As the VP of Capital Formation for Toronto Stock Exchange\, I work with US companies to consider listing and financing in the Canadian capital markets. As the founder of Fortuna Funding (a consulting firm)\, she works with early-stage companies on their business and funding strategy and on getting investor-ready. As a capital markets expert\, she has advised many companies on the going public process and can provide an understanding of private and public financing options in Canada and the United States. \n \n \n \n \n \n \n\n\n\nGeneral Admission Agenda:\n\n\n\n01:00 PM: Attendee Check-in \n\n\n\n​01:30 PM: Opening remarks: Dave de Csepel\, CEO at Alliance for SoCal Innovation; Mayor Chris Pimentel\, City of El Segundo; Drew “Murph” Busbee\, COO at DTI \n\n\n\n​01:45 PM: Keynote: Shahin Farshchi\, PhD\, Partner at Lux Capital in conversation with Ashutosh Shukla\, VP of Mechanical Engineering at Anduril \n\n\n\n​A candid conversation between one of deep tech’s most visionary investors and a leading executive at the frontier of autonomy\, defense\, and manufacturing. Together\, they’ll unpack the stories behind building category-defining companies. \n\n\n\n​02:15 PM Panels \n\n\n\nCommercializing and Scaling Deep TechThis panel will explore what it takes to bring cutting-edge technologies out of the lab and into the real world. Leaders from venture\, government\, and industry will share what works – and what doesn’t – when scaling deep tech companies in critical sectors like manufacturing\, energy\, and defense. \n\n\n\n\nModerator: Scott Stanford\, Founder & Partner @ ACME Capital\n\n\n\n​Panelists:\n\n​Shaun Stuger\, VP of Growth @ Space Kinetic Corp\n\n\n\n​Andrew Couillard\, Director & Investor @ Harpoon Ventures\n\n\n\n​Lt. Col Vinny Pande\, Materiel Leader & Deputy Director @ SpaceWERX\n\n\n\n​Rupika Brito\, Principal @ Alumni Ventures\n\n\n\n\n\n\nLessons from the Founder JourneyFounders behind some of SoCal’s most ambitious startups share the hard-won lessons from building and scaling in deep tech. From first checks to first shipments\, this session offers an unfiltered look at navigating the early stages of company-building. \n\n\n\n\nModerator: Krisztina (Z) Holly\, Operating Partner @ Good Growth Capital\n\n\n\n​Panelists:\n\n​Phillip Weicker\, Co-founder & CTO @ Harbinger Motors\n\n\n\n​Aleksey Matyushev\, Founder & CEO @ Natilus\n\n\n\n​Karl Pawlik\, Head of Technology & Life Science Verticals @ Escalon\n\n\n\n\n\n\n​04:00 PM Startup Pitch Showcase (aka the First Look SoCal Deep Tech Innovation Showcase) \n\n\n\n​Get an early glimpse into exciting new deep tech science-based startups emerging from SoCal’s top research universities. Each of the 5 selected startups will quick pitch for 3 minutes immediately followed by 6 minutes of Q&A with a panel of investors and subject matter experts. \n\n\n\n​Startups: \n\n\n\n\n​CISGAM\, Albert Cisquella\n\n\n\nNEXT Membranes\, Pat O’Brien\n\n\n\n​Neuramax Technologies\, Asish Satpathy\n\n\n\n​Super Foam Corporation\, Zef Neemuchwala\n\n\n\n\n(Additional info on each startup below) \n\n\n\n​Judges: \n\n\n\n\n​Krisztina (Z) Holly\, Operating Partner @ Good Growth Capital\n\n\n\n​Jennifer Byrne\, General Partner @ Grit VC\n\n\n\n​Abhi Mukherjee\, Operating Partner @ CerraCap Ventures\n\n\n\nJed Leidheiser\, Partner @ March Capital\n\n\n\nAaron Fyke\, Founder & General Partner @ Thin Line Capital\n\n\n\n\n​05:00 PM Networking Reception sponsored by the Kenilworth Group at Morgan Stanley \n\n\n\n​Continue the conversation and connect while enjoying refreshments and snacks \n\n\n\nSpeakers\n\n\n\n\n \n \n \n \n \n Dave de Csepel\n CEO & Executive Director at Alliance for SoCal Innovation\n View Bio \n \n \n \n \n \n \n \n \n \n \n Dave de Csepel\n CEO & Executive Director at Alliance for SoCal Innovation\n \n \n \n \n \n \n \n \n \n \n Dave brings a unique blend of entrepreneurial\, investment\, and leadership experience to the Alliance. He currently serves as Chairman of the TCA Venture Group and formerly held the same position at the Pasadena Angels. Both organizations are dedicated to mentoring and investing in early-stage companies\, with over 500 members offering deep\, cross-industry expertise throughout Southern California. \nDave is a serial entrepreneur and has spent the last decade as a lead investor and consultant at BioCorRx Inc.\, a publicly traded healthcare solutions company focused on treatments for alcohol and opioid addiction. Earlier in his career\, he was a founding member and owner of Veritas Realty Investments\, where he led design\, project management\, and sales for a portfolio of residential projects across Greater Los Angeles. \nDave also brings media and communications expertise from leadership roles at Discovery Networks\, Turner Entertainment\, and ESPN\, and is passionate about education—he currently serves as an Associate Professor of Entrepreneurship at the ArtCenter College of Design in Pasadena. \n \n \n \n \n \n \n \n \n \n Drew "Murph" Busbee\n Chief Operating Officer at DTI\n View Bio \n \n \n \n \n \n \n \n \n \n \n Drew "Murph" Busbee\n Chief Operating Officer at DTI\n \n \n \n \n \n \n \n \n \n \n As COO of DTI\, Drew leads initiatives at the intersection of government\, startups\, and venture capital architecting programs like I2A that help dual-use companies scale from concept to capability. In just over a year\, I2A-backed startups have secured $1.62B in government contracts\, $693M in venture capital\, and $125M in commercial deals\, making it one of the most impactful defense innovation efforts to date. \nOver the past decade\, Drew advised early-stage companies and venture firms on how to navigate the federal funding landscape\, resulting in $500M+ in non-dilutive capital raised across portfolios. He has helped build founding frameworks for government innovation orgs like SpaceWERX and SSC Front Door\, secured CRADAs to bridge venture and DoD priorities\, and served as a Defense Ventures Fellow. \n \n \n \n \n \n \n \n \n \n Chris Pimentel\n Mayor\, City of El Segundo\n View Bio \n \n \n \n \n \n \n \n \n \n \n Chris Pimentel\n Mayor\, City of El Segundo\n \n \n \n \n \n \n \n \n \n \n Mayor Chris Pimentel is a risk management executive and a former Marine Corps infantry officer. Chris was elected Mayor on December 17\, 2024 by his fellow Councilmembers and has served on El Segundo City Council since 2018. He has served on several committees focused on interaction with other cities and the state. Chris focuses much of his effort on preserving and sustaining the elements of El Segundo that make it the unique and thriving engine of the region.\nChris is active with little league\, softball\, soccer\, the Military Officers Association and joins his wife and children in their volunteer groups. \n \n \n \n \n \n \n \n \n \n Shahin Farshchi\, PhD\n Partner at Lux Capital\n View Bio \n \n \n \n \n \n \n \n \n \n \n Shahin Farshchi\, PhD\n Partner at Lux Capital\n \n \n \n \n \n \n \n \n \n \n Inspired by Knight Rider and Star Trek\, Shahin grew up passionate about using engineering to give humanity “superpowers\,” from coding on an IBM PC XT clone in grade school to taking apart engines at his uncle’s shop. After founding his own startup based on his PhD research in brain–computer interfaces\, he joined Lux Capital in 2006\, where he has since co-founded and led investments in companies that became public (AEVA\, PL) or were acquired by Amazon\, Intel\, and others. \n \n \n \n \n \n \n \n \n \n Ashutosh Shukla\n VP of Mechanical Engineering at Anduril\n View Bio \n \n \n \n \n \n \n \n \n \n \n Ashutosh Shukla\n VP of Mechanical Engineering at Anduril\n \n \n \n \n \n \n \n \n \n \n Ashutosh Shukla is an experienced engineer and leader in the world of developing mass scale hardware and currently serves as VP of Engineering at Anduril Industries in Costa Mesa. Prior to joining Anduril\, Ashutosh has been a part of product design teams at Apple\, Bose\, Rivian\, Snap\, and Meta leading teams and architecting category defining products spanning from EVs to smartphones to AR/VR devices\, and more. Ashutosh holds over 25 patents in electronics design and manufacturing technologies and earned his BS in Mechanical Engineering from Georgia Tech. Beyond hardware engineering\, he is a limited partner at Everywhere Ventures and advises emerging startups. \n \n \n \n \n \n \n \n \n \n Scott Stanford\n Co-Founder & Partner at ACME Capital\n View Bio \n \n \n \n \n \n \n \n \n \n \n Scott Stanford\n Co-Founder & Partner at ACME Capital\n \n \n \n \n \n \n \n \n \n \n Scott Stanford is a co-founder of ACME Capital and has spent over 25 years as an investor\, operator\, and advisor in technology. Previously\, he co-founded Sherpa Capital and co-headed Goldman Sachs’s Global Internet Investment Banking team\, advising and investing in companies such as Facebook\, Uber\, LinkedIn\, Palantir\, and Square. \n \n \n \n \n \n \n \n \n \n Shaun Stuger\n VP of Growth at Space Kinetic Corp\n View Bio \n \n \n \n \n \n \n \n \n \n \n Shaun Stuger\n VP of Growth at Space Kinetic Corp\n \n \n \n \n \n \n \n \n \n \n Shaun Stuger is Vice President of Growth at Space Kinetic Corporation\, a VC-backed startup advancing national security with next-generation capabilities for missile defense and space superiority. He previously held senior business development roles at Parsons\, Peraton\, GDMS\, Braxton Technologies\, and Raytheon\, following a 25-year career as a U.S. Air Force Colonel leading satellite operations\, engineering\, and acquisition. Shaun holds an Executive MBA from NYU Stern\, LSE\, and HEC Paris\, along with master’s degrees from Air War College and Pepperdine\, and a BA in Computer Science from Boston University. \n \n \n \n \n \n \n \n \n \n Andrew Couillard\n Director & Investor at Harpoon Ventures\n View Bio \n \n \n \n \n \n \n \n \n \n \n Andrew Couillard\n Director & Investor at Harpoon Ventures\n \n \n \n \n \n \n \n \n \n \n Andrew Couillard is an investor at Harpoon Ventures\, where he focuses on dual-use defense technology from pre-seed to growth stages and has helped incubate and scale a defense tech startup. A former U.S. Navy Explosive Ordinance Disposal Officer\, he led global teams\, managed a $50M unmanned undersea vehicle portfolio\, and drove AI/ML adoption in defense operations. He is currently pursuing his MBA at Stanford GSB\, holds a BS in Industrial & Systems Engineering from USC\, and previously worked as an engineer at Northrop Grumman. Outside of work\, Andrew is an avid endurance athlete\, snowboarder\, and skydiver with a passion for advancing innovation at the intersection of AI and defense. \n \n \n \n \n \n \n \n \n \n Rupika Brito\n Principal at Alumni Ventures\n View Bio \n \n \n \n \n \n \n \n \n \n \n Rupika Brito\n Principal at Alumni Ventures\n \n \n \n \n \n \n \n \n \n \n Rupika Brito is a Principal at Alumni Ventures’ Deep Tech Fund\, with experience spanning venture capital\, private equity\, and entrepreneurship. She previously led corporate ventures at Blockstream\, executed multi-billion-dollar transactions at Bank of America\, and co-founded a search fund\, bringing a uniquely versatile perspective to investing in transformative technologies. \n \n \n \n \n \n \n \n \n \n Lt. Col Vinny Pande\n Partner (Materiel Leader) at SpaceWERX\n View Bio \n \n \n \n \n \n \n \n \n \n \n Lt. Col Vinny Pande\n Partner (Materiel Leader) at SpaceWERX\n \n \n \n \n \n \n \n \n \n \n Lieutenant Colonel Vinny Pande is the Materiel Leader for SpaceWERX Ventures\, where he oversees the U.S. Space Force’s $450 million annual venture portfolio encompassing all stages of SBIR investments. Previously\, he has led strategic space and defense commercialization programs\, ranging from proliferated LEO satellite communications to high-value procurement initiatives and international tech diplomacy in the Indo-Pacific region. \n \n \n \n \n \n \n \n \n \n Krisztina "Z" Holly\n Operating Partner at Good Growth Capital\n View Bio \n \n \n \n \n \n \n \n \n \n \n Krisztina "Z" Holly\n Operating Partner at Good Growth Capital\n \n \n \n \n \n \n \n \n \n \n Z Holly is a seasoned innovation leader and venture capitalist with three decades of experience helping entrepreneurs and organizations turn cutting-edge ideas into global impact. Currently an Operating Partner at Good Growth Capital\, she has a track record of pioneering innovation programs (including the first TEDx event)\, founding multiple successful ventures\, advising the Obama Administration\, and investing in transformative science and technology companies across sectors like aerospace\, energy\, and life sciences. She combines deep technical expertise (from MIT) with extensive business acumen\, having helped founders raise over $1 billion in venture capital while maintaining her adventurous spirit through activities like skydiving\, flying planes\, and SCUBA instruction.\n \n \n \n \n \n \n \n \n \n \n Phillip Weicker\n Co-Founder & CTO at Harbinger Motors\n View Bio \n \n \n \n \n \n \n \n \n \n \n Phillip Weicker\n Co-Founder & CTO at Harbinger Motors\n \n \n \n \n \n \n \n \n \n \n Phillip Weicker is the Co-Founder and CTO of Harbinger\, leading innovation in electric vehicle powertrains and battery systems. With over 20 years of experience at Canoo\, Faraday Future\, QuantumScape\, and CODA\, he is a recognized expert in EV energy storage\, high-voltage systems\, and electrification technologies. \n \n \n \n \n \n \n \n \n \n Aleksey Matyushev\n Founder & CEO at Natilus\n View Bio \n \n \n \n \n \n \n \n \n \n \n Aleksey Matyushev\n Founder & CEO at Natilus\n \n \n \n \n \n \n \n \n \n \n Aleksey Matyushev is the CEO and co-founder of San Diego-based aircraft manufacturer Natilus\, the developer of a family of next-generation blended-wing-body aircraft delivering sustainable solutions to the commercial aviation industry. One of the foremost experts in commercializing aircraft\, Aleksey has nearly two decades of experience in the aerospace and aviation industries\, including at Piper Aircraft and Kratos Defense. Aleksey holds an Aerospace Engineering degree from Embry-Riddle Aeronautical University. \n \n \n \n \n \n \n \n \n \n Karl Pawlik\n Head of Technology & Life Science Verticals at Escalon Services\n View Bio \n \n \n \n \n \n \n \n \n \n \n Karl Pawlik\n Head of Technology & Life Science Verticals at Escalon Services\n \n \n \n \n \n \n \n \n \n \n Karl Pawlik leads our Technology and Life Sciences practice at Escalon Services.  Karl has over 20 years of experience working in various leadership roles in finance\, accounting\, and strategy\, with the last 10+ years being dedicated to the role of CFO of venture and pre-venture funded start-ups.  Earlier in his career\, Karl held global finance\, business development\, and strategy roles with Fortune 500 companies including Applied Materials\, and St. Jude Medical (now Abbott)\, where he was part of the team that acquired CardioMeMs and NanoStim. \nKarl has a passion for setting up organizations for success and gives back to the community by coaching competitive youth water polo. \nKarl received his B.S. degree in Finance and Accounting from the University of Arizona and an M.B.A. from California State University at Northridge. \n \n \n \n \n \n \n \n \n \n Jennifer Byrne\n General Partner at Grit Capital\n View Bio \n \n \n \n \n \n \n \n \n \n \n Jennifer Byrne\n General Partner at Grit Capital\n \n \n \n \n \n \n \n \n \n \n Jennifer Byrne is a General Partner at Grit Capital Partners investing in early-stage applied AI\, with over 20 years of experience across fintech\, insurtech\, and telecom. She’s an entrepreneur who founded global accelerators for women-led startups (Female Founders in FinTech\, InsurTech) and previously held executive roles at Fortune 100 companies including American Express and Verizon\, where she led strategy\, partnerships\, and innovation programs. \n \n \n \n \n \n \n \n \n \n Abhi Mukherjee\n Operating Partner at CerraCap Ventures\n View Bio \n \n \n \n \n \n \n \n \n \n \n Abhi Mukherjee\n Operating Partner at CerraCap Ventures\n \n \n \n \n \n \n \n \n \n \n Abhi Mukherjee is an Operating Partner at CerraCap Ventures with 25 years of experience spanning corporate leadership at major tech companies (Infosys\, Wipro\, UST)\, successful entrepreneurship (sold his AI startup Nirveda Cognition in 2021)\, and venture capital. He has managed over $1.2 billion in enterprise innovation engagements and now focuses on investing in and mentoring mission-driven entrepreneurs in AI\, quantum computing\, and frontier technologies. \n \n \n \n \n \n \n \n \n \n Aaron Fyke\n Founder and Managing Partner at Thin Line Capital\n View Bio \n \n \n \n \n \n \n \n \n \n \n Aaron Fyke\n Founder and Managing Partner at Thin Line Capital\n \n \n \n \n \n \n \n \n \n \n Aaron Fyke has spent thirty years as an investor\, engineer\, and entrepreneur\, having cofounded six companies\, including two unicorns\, in a number of technology areas including fuel cell\, ocean power\, concentrating solar\, and grid-scale energy storage. He is currently Founder and Managing Partner of Thin Line Capital. Thin Line Capital is deploying their second fund to bring investment capital to extraordinary clean energy/climate change companies\, participating in the biggest economic opportunity since the Industrial Revolution. Aaron earned his MBA and MSME as an LGO fellow at MIT\, and his BEng in Mechanical Engineering from the University of Victoria\, graduating at the top of his class. \n \n \n \n \n \n \n \n \n \n Jed Leidheiser\n Partner at March Capital\n View Bio \n \n \n \n \n \n \n \n \n \n \n Jed Leidheiser\n Partner at March Capital\n \n \n \n \n \n \n \n \n \n \n Jed Leidheiser is a Partner at March Capital with two decades of enterprise experience across investing and operating roles. He leads cybersecurity investing at March and is involved in the firm’s investment activities and industry networks. Jed has board responsibilities at Expel\, Immuta\, and SpyCloud. \nJed graduated from the University of California\, Los Angeles\, Anderson School of Management (MBA) and the University of Virginia (B.S.\, Computer Engineering; B.A.\, Economics). Having written his senior thesis at UVA on cybersecurity\, Jed’s role at March continues a lasting interest in the field. \nBefore joining March\, Jed invested throughout the startup lifecycle\, from an early stage at Work-Bench Ventures in New York City\, to public equities at Balyasny Asset Management in San Francisco. Earlier in his career\, Jed spent a decade at Accenture\, where he consulted Fortune 500 CxOs on strategy and technology. He credits this experience with teaching him how to sell 7-figure contracts\, develop go-to-market partnerships\, own a P&L\, and manage distributed teams. Jed first learned of March Capital while volunteering at The Montgomery Summit in 2015; after March closed its first fund in 2016\, Jed sought out the firm’s partners and became the first employee on the investment team. \nOutside of the office\, Jed is on the board of the UCLA Anderson Price Center for Entrepreneurship & Innovation and serves on the Advisory Council for the Alliance for Southern California Innovation. A lifelong outdoorsman\, Jed also enjoys skiing\, backcountry backpacking\, and rooting for UVA basketball to win another national championship. \n \n \n \n \n \n \n \n \n \n Eric Eide\n Managing Director at Alliance for SoCal Innovation \n View Bio \n \n \n \n \n \n \n \n \n \n \n Eric Eide\n Managing Director at Alliance for SoCal Innovation \n \n \n \n \n \n \n \n \n \n \n Eric is a seasoned economic development professional with experience spanning the private sector\, federal and municipal government\, and academia. He currently serves as the Managing Director at the Alliance for Southern California Innovation where he leads the Alliance’s Capital Access programs with VCs and founders as well as innovation community building efforts with startup communities\, local government\, and community partners. \nBefore joining the Alliance\, Eric grew the Government Relations team at startup electric scooter rental company Bird and expanded operations domestically and internationally. Previously\, Eric served as Director of International Trade for Los Angeles Mayor Eric Garcetti. In this role\, Eric worked to increase international business activity\, facilitate the import and export of goods\, and attract investment to Los Angeles. Eric also served in the U.S. federal government as an Advisor for Strategic Partnerships at the U.S. Department of State\, where he collaborated with U.S.-based entrepreneurs\, firms\, and universities with interests in South and Central Asia. In a prior role\, Eric represented the U.S. Small Business Administration with the startup community and improved the overall performance of a $2.6 billion federal program that funds early stage technology companies. \nEric holds a B.A. in Sociology from the University of California\, Santa Barbara and a Ph.D. in Sociology from the University of Michigan\, where his research focused on innovation ecosystems\, industrial policy\, and globalization. \n \n \n \n \n \n \n\n\n\nThe First Look SoCal Deep Tech Innovation Showcase\n\n\n\n\n\n\n\nEach startup will present a 3-minute quick pitch followed by 6 minutes of Q&A led by a panel of leading investors\, corporates\, and subject matter experts who will provide invaluable insights and access to capital. \n\n\n\nMeet the presenters\n\n\n\n\n \n \n \n \n \n Albert Cisquella Serra\n Co-Founder & CEO at CISGAM\n UC Irvine\n View Bio \n \n \n \n \n \n \n \n \n \n \n Albert Cisquella Serra\n Co-Founder & CEO at CISGAM\n UC Irvine\n \n \n \n \n \n \n \n \n \n \n Albert Cisquella Serra is a deep-tech entrepreneur and MEMS process engineer with a PhD and postdoctoral research in electrospray propulsion from the Electric Propulsion Laboratory at UC Irvine\, where CISGAM’s core technology was developed. At Iridia\, he co-developed a prototype DNA data writing chip for molecular storage. At Miltenyi Biotec\, he contributed to the development of the fastest MEMS-based cell sorting device on the market. Co-inventor of CISGAM’s propulsion system\, he brings extensive experience in microfabrication\, system integration\, and the transition of lab-scale technologies into scalable hardware platforms. \n \n \n \n \n \n \n \n \n \n Pat O'Brien\n Co-Founder & CEO at NEXT Membranes\n UCLA\n View Bio \n \n \n \n \n \n \n \n \n \n \n Pat O'Brien\n Co-Founder & CEO at NEXT Membranes\n UCLA\n \n \n \n \n \n \n \n \n \n \n Patrick O’Brien is a U.S. Army veteran and former DoD Counterintelligence Special Agent\, with a career dedicated to safeguarding national defense technologies. As a counterintelligence operative\, he led operations and investigations protecting sensitive defense innovations in AI\, machine learning\, and aerospace. \nBuilding on this deep-tech defense background\, Patrick is now the Co-Founder and Managing Partner of NEXT Membranes\, a cleantech venture pioneering advanced membrane technologies for water reuse and mineral recovery. He is currently pursuing his MBA at UCLA Anderson (Class of 2026)\, where he is focused on scaling breakthrough technologies that sit at the intersection of sustainability\, security\, and economic growth. \n \n \n \n \n \n \n \n \n \n Justin Wheeler\n Co-founder & CTO at Neuramax Technology\n UCLA and ASU – Skysong Innovations\n View Bio \n \n \n \n \n \n \n \n \n \n \n Justin Wheeler\n Co-founder & CTO at Neuramax Technology\n UCLA and ASU – Skysong Innovations\n \n \n \n \n \n \n \n \n \n \n Justin Wheeler is a former DoD civilian engineer with applied experience in machine learning and RF systems. He develops AI for embedded edge environments under operational constraints and is the architect of NeuraScan\, a real-time RF fingerprinting pipeline for drone detection and airspace security. \n \n \n \n \n \n \n \n \n \n Zef Neemuchwala\n Co-founder & CEO at Super Foam Corp\n San Diego State University\n View Bio \n \n \n \n \n \n \n \n \n \n \n Zef Neemuchwala\n Co-founder & CEO at Super Foam Corp\n San Diego State University\n \n \n \n \n \n \n \n \n \n \n Zef Neemuchwala is a serial entrepreneur\, business development expert\, and startup advisor with over a decade of experience helping early-stage and scaling ventures refine product-market fit\, secure strategic partnerships\, and accelerate go-to-market execution. As CEO of Super Foam Corp.\, he leads a team developing patented\, eco-friendly impact protection solutions\, and as host of the Be A Maker podcast\, he champions creative innovation through storytelling. Zef has successfully closed pre-seed funding rounds\, built business development funnels from scratch\, and guided startups through pitch competitions and grant evaluations. His collaborative leadership style\, deep expertise in product strategy\, and ability to forge partnerships with global brands like Google\, BCG\, and TechStars LA have helped over 100 startups reach critical growth milestones. A multilingual communicator\, published researcher\, and award-winning educator\, Zef is driven by a mission to help founders align business strategy with authentic market needs\, using humility\, empathy\, and a data-driven approach to achieve meaningful impact. \n \n \n \n \n \n \n\n\n\nCompany Information\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nLook Forward To…\n\n\n\nConnect with investors\, peers\, and mentors\n\n\n\nUnparalleled opportunities to connect with investors\, mentors and other support resources crucial for early stage startups. Past years attracted over 300 attendees including over 130 investors such as Lux Capital\, Kairos\, Wavemaker 360\, Upfront\, NEA\, Elevation Ventures\, FullCycle\, Aligned Climate Capital\, Mitsubishi Ventures and many more.  \n\n\n\nStartup quick-pitch presentations\n\n\n\nSee selected Deep Tech (Robotics\, Aerospace\, Advanced Manufacturing\, Energy\, Materials) startups doing 3-minute quick pitch presentations followed by 6 minutes of moderated Q&A led by a panel of investors\, corporate leaders\, and subject matter experts. \n\n\n\nTop university-based deep tech startups\n\n\n\nThis is SoCal’s premiere gathering of the best startups emerging from the region’s top research institutions so it attracts the region’s community in a rare concentrated program that celebrates the entrepreneur’s journey from lab to market. \n\n\n\nWorkshop for startup founders\n\n\n\nLearn from subject matter experts in IP law and licensing best practices for protecting and monetizing intellectual property as well as early stage startup commercialization of deep tech innovations. \n\n\n\nNetworking Reception\n\n\n\nStay for drinks and small bites as we celebrate and connect with attendees and speakers. URL:https://alliancesocal.org/event/deeptech-symposium-first-look-socal-dt-innovation-showcase-2025/ CATEGORIES:Alliance Events END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20251203T103000 DTEND;TZID=America/Los_Angeles:20251203T133000 DTSTAMP:20260406T100728 CREATED:20251203T045927Z LAST-MODIFIED:20251203T052304Z UID:7017-1764757800-1764768600@alliancesocal.org SUMMARY:Health Systems Innovation Council Meeting - Q4 2025 DESCRIPTION:Topic: Improving Provider and Patient Outcomes with Payors\n\n\n\nHosted by Huntington Hospital \n\n\n\n\n\nEvent Sponsors\n\n\n\n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n\n\n\n\n\nStartup Showcase Sponsors\n\n\n\n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n\n\n\n\n\nEvent Hosts\n\n\n\n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n\n\n\n\n\n \n\n\n\n\n \n \n \n \n Agenda\n \n \n \n 10:30 a.m.  Welcome \n\nMark Gamble\, Strategic Advisor\, Alliance for SoCal Innovation\nDr. John Corman\, Interim President and Chief Clinical Officer\, Huntington Health\nMike Strohl\, CEO\, e360\n\n10:50 a.m. Rapid-fire introductions \n11:10 a.m.  Featured Startup Presentation – Dr. David Kirk\, CMO\, Regard Health \n11:20 a.m. Panel Discussion: Improving Provider and Patient Outcomes with Payors \n\nDr. David Kirk\, CMO\, Regard Health\nRudy Braccili\, Jr.\, Senior Director Revenue Cycle Operations\, Keck Medicine of USC\nEunBi Lee\, Managing Director & Partner\, BCG\nMark Gamble\, Strategic Advisor\, Alliance for SoCal Innovation (moderator)\n\n12:05 p.m. Break + Grab lunch (boxed lunches provided) \n12:15 p.m.  Innovation Venture Fund Update by Andy Wilson \n12:25 p.m. Featured Speaker: Doug Mirsky\, PhD\, Vice President\, DiMe Seal\, Digital Medicine Society (DiMe) \n12:50 p.m. Interactive Council Discussion\, moderated by Mark Gamble & Andy Wilson \n1:30 p.m.  Tour of Huntington Hospital \n \n \n \n \n\n\n\n\n\n\n\n\nSpeakers\n\n\n\n\n \n \n \n \n \n John M. Corman\, MD\n Interim President and Chief Clinical Officer at Huntington Health\n View Bio \n \n \n \n \n \n \n \n \n \n \n John M. Corman\, MD\n Interim President and Chief Clinical Officer at Huntington Health\n \n \n \n \n \n \n \n Dr. Corman joins Huntington from Virginia Mason Franciscan Health\, where he served as vice president and chief clinical officer.  In this role\, he engaged with medical leadership to ensure continuity and stability at a time when the regional health care system was taking shape. He has a proven track record in quality oversight and outstanding collaboration with medical staff to support excellent care. Having built his career at Virgina Mason\, Dr. Corman has held such posts over the years as senior medical director of peri-operative and procedural services\, pathology\, radiology\, and anesthesiology. He was also medical director of the Virginia Mason Cancer Institute. Clinically\, Dr. Corman has completed over 2000 DaVinci surgeries and has been recognized as a Seattle Top Doctor for 16 consecutive years. \nDr. Corman received his undergraduate degree from Pomona College prior to graduating from Baylor College of Medicine in Houston\, Texas. He completed his postgraduate training at UCLA\, with an internship in general surgery and residency in urology.  In addition to his staff practice\, Dr. Corman has been a clinical professor in various capacities at medical centers and schools throughout the Pacific Northwest for more than two decades. Dr. Corman also has vast administrative experience throughout his various appointments on boards\, programs\, departments\, committees\, councils\, and educational courses. He has been widely published in such periodicals as the New England Journal of Medicine and the Journal of Urology. \n \n \n \n \n \n \n \n \n \n Mike Strohl\n CEO at e360\n View Bio \n \n \n \n \n \n \n \n \n \n \n Mike Strohl\n CEO at e360\n \n \n \n \n \n \n \n e360’s journey traces back to 1988\, born from the entrepreneurial spirit of Mike’s father. Initially a training company focused on application-based learning\, it laid the foundation for what e360 would become. \nIn 1994\, Mike and Matt took over the company when Mike’s father passed. They have expanded e360 to 250 employees and broadened its expertise in: \n\nDigital Workplace\nModern Infrastructure\nCybersecurity\nCloud Solutions\nEnterprise Managed Services\n\nAt e360\, we’re more than a company; we’re a community. This sense of family isn’t just because we started as one. It’s also because of our long-standing team members\, some with over two decades of dedication\, and our commitment to our clients. \n \n \n \n \n \n \n \n \n \n David Kirk\, MD\n Chief Medical Officer at Regard Health\n View Bio \n \n \n \n \n \n \n \n \n \n \n David Kirk\, MD\n Chief Medical Officer at Regard Health\n \n \n \n \n \n \n \n Dr. Kirk joins Regard following more than 20 years of leadership at WakeMed Health & Hospitals\, where he most recently served as Chief Clinical Integration Officer and Executive Medical Director of Critical Care Medicine and eICU. \nA nationally recognized clinician and innovation leader\, Dr. Kirk has led large-scale initiatives integrating artificial intelligence\, analytics and process improvement into clinical care. In his most recent executive roles at WakeMed\, he oversaw systemwide digital transformation and care delivery innovation\, aligning data science\, technology and operational strategy to improve quality\, efficiency and financial performance. His leadership drove more than $17 million in cost savings through data-driven process improvements\, including more than $9 million in recovered revenue from implementing Regard’s AI-powered Proactive Documentation platform. He also expanded clinical governance structures\, established incentive-based performance programs and spearheaded predictive analytics pilots in critical care – initiatives that earned him the North Carolina Healthcare Association’s 2025 Clinical Leadership Award for transforming care delivery through innovation and improvement. \n \n \n \n \n \n \n \n \n \n Rudy Braccili\, Jr.\, MBA\, CHFP\n Senior Director Revenue Cycle Operations at Keck Medicine of USC\n View Bio \n \n \n \n \n \n \n \n \n \n \n Rudy Braccili\, Jr.\, MBA\, CHFP\n Senior Director Revenue Cycle Operations at Keck Medicine of USC\n \n \n \n \n \n \n \n Rudolph Braccili Jr. is a seasoned and highly regarded leader in healthcare revenue cycle operations\, currently serving as Senior Director of Revenue Cycle Operations at Keck Medicine of USC in Los Angeles. \nOver a long and distinguished career\, Rudy has held senior leadership roles across multiple organizations. His prior positions include President & CEO of IMPACT A/R; Senior Director of AR Operations at Conifer Health Solutions; Vice President of Revenue Cycle at KPC Healthcare\, Inc.; and Executive Director of Revenue Cycle Services at Boca Raton Community Hospital (among others). \nRudy has led both single-facility and multi-facility revenue cycle operations. His expertise spans business-operation consolidations\, system-implementation project teams\, complex reorganizations\, and ongoing revenue cycle transformations — delivering sustained improvements in key performance metrics year after year. \n \n \n \n \n \n \n \n \n \n Eun Bi Lee\n Managing Director and Partner at BCG\n View Bio \n \n \n \n \n \n \n \n \n \n \n Eun Bi Lee\n Managing Director and Partner at BCG\n \n \n \n \n \n \n \n Eun Bi is a Managing Director & Partner in the Los Angeles office. She has worked extensively with regional and national payers across the country on distribution strategy\, marketing strategy\, and growth strategy. Eun Bi first joined BCG at the Mexico City office in 2013 as an Associate\, and transferred to the Los Angeles office in 2015.  \nEun Bi graduated from Yale University and holds a Bachelor of Arts degree in History. Her previous work experience includes interning at Hanwha General Insurance Co. in Asset Management division\, and at various non-profit organizations such as Women 4 Women. Eun Bi holds an MBA from the Kellogg School of Management. She is fluent in English\, Spanish\, and Korean\, and speaks basic Japanese. \n \n \n \n \n \n \n \n \n \n Doug Mirsky\, PhD\n Vice President\, DiMe Seal\, Digital Medicine Society (DiMe)\n View Bio \n \n \n \n \n \n \n \n \n \n \n Doug Mirsky\, PhD\n Vice President\, DiMe Seal\, Digital Medicine Society (DiMe)\n \n \n \n \n \n \n \n Dr. Doug Mirsky is a distinguished leader in digital innovation and healthcare transformation\, currently spearheading the DiMe Seal\, a new unifying evaluation framework to establish quality and trust across the digital health software ecosystem. Previously\, Doug led the Digital Medicine Society’s (DiMe’s) groundbreaking public-private partnership announced by The White House as a national digital health accelerator within the revitalized Cancer Moonshot initiative. Joined by Moffitt Cancer Center\, the Office of the National Coordinator for Health IT (ONC)\, and the Office of the Assistant Secretary for Health (OASH)\, Dr. Mirsky led work to harness cutting-edge technology and collaboration among health systems to drive forward the fight against cancer. With a robust academic background and a passion for advancing digital health\, Dr. Mirsky is committed to creating innovative solutions that enhance patient outcomes and revolutionize care. He has previously held roles as Co-Founder of a venture-backed digital health startup\, led consulting engagements for Fortune 500 enterprises and was a multi-role executive at GLG\, the leading technology-enabled knowledge marketplace\, during its early hyper-growth. He holds a PhD from the University of Chicago in human evolutionary anatomy and lives in Portland\, OR with his wife and two children. \n \n \n \n \n \n \n\n\n\n\n \n \n \n \n Health Systems Innovation Council Members\n \n \n \n Andrew Goldfrach\, CEO \nArrowhead Regional Medical Center \nGeoffrey Hall\, CEO \nAlex Jawharjian\, COO \nCalifornia Rehabilitation Institute \nKelly Linden\, President and CEO \nCasa Colina Hospital and Centers for Healthcare \nBryan Croft\, EVP & COO \nCedars-Sinai \nNaser Mohammad\, CEO \nCentinela Hospital Medical Center \nOmkar Kulkarn\, VP\, Chief Transformation Officer | Chief Innovation Officer \nChildren’s Hospital LA (CHLA) \nHarlan Levine\, President\, Health Innovation and Policy \nCity of Hope \nMick Zdeblick\, CEO \nAnthony Russell\, CAO\, Ambulatory Medicine \nCommunity Memorial Healthcare \nRon Werft\, President and CEO \nCottage Health \nJeremy Zoch\, President and CEO \nDignity Health\, Northridge Hospital Medical Center \nCarolyn Caldwell\, Hospital President and CEO \nDignity Health\, St. Mary Medical Center \nLori Morgan\, CEO \nHuntington Hospital \nTad Funahashi\, Chief Innovation Officer \nKaiser Permanente \nCamille Applin-Jones\, SVP & Area Manager \nKaiser Foundation Hospitals \nTJ Malseed\, CIO \nAlen Oganesyan\, Assoc. Chief Information Officer \nKeck Medicine of USC \nManeesh Goyal\, COO \nMayo Clinic Platform \nMichael Torgan\, Chief Transformation Officer \nMission Community Hospital \nKent Hoyos\, VP & Chief Information Officer \nPomona Valley Hospital Medical Center \nBernie Klein\, CEO \nProvidence Holy Cross \nMatt Bader\, Chief Strategy Officer \nProvidence St. Joseph Health \nJohn Chapman\, President and CEO \nSan Antonio Regional Hospital \nNana Deeb\, CEO \nSouthwest Healthcare\, Palmdale Regional Medical Center \nKhurram Mir\, Director of Innovation \nUCI Health \nJennifer McCaney\, Chief of Innovation \nUCLA Health \nArmand Dorian\, CEO \nUSC Verdugo Hills Hospital \nSteven Shapiro\, SVP for Health Affairs \nUSC Health \nAndy Wilson\, Vice President\, Business Development Health Affairs \nUSC \nGus Valdespino\, President and CEO \nValley Presbyterian Hospital URL:https://alliancesocal.org/event/hsic-meeting-q4-2025/ CATEGORIES:Alliance Events ORGANIZER;CN="Alliance for SoCal Innovation":MAILTO:info@alliancesocal.org END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20260311T180000 DTEND;TZID=America/Los_Angeles:20260311T200000 DTSTAMP:20260406T100728 CREATED:20260213T215024Z LAST-MODIFIED:20260303T020558Z UID:7100-1773252000-1773259200@alliancesocal.org SUMMARY:Fundraising in Today's Market DESCRIPTION:🌟 Founders Spotlight: Journey to Success in SoCal 🌟 \n\n\n\n​​Location: Glendale (register to get venue details) \n\n\n\nJoin us for an inspiring evening in Glendale as the Alliance for SoCal Innovation highlights the founder journey through real stories of perseverance\, innovation\, and success. This evening is brought to you by Citizens Bank and the LA Tech Corridor (LATC). \n\n\n\n​​🎙️ Featured Speakers: \n\n\n\n\n​​Pablo Fernandez\, CEO & Founder of Glendale-based Big Rentals\, recently raised $2.8M in funding (LinkedIn)\n\n\n\n​Marcos Gonzalez\, Managing Partner\, VamosVentures (LinkedIn)\n\n\n\n\n​​🗣️ Moderator: \n\n\n\n\nJasmine Jiang\, SVP\, Sunstone Management (LinkedIn)\n\n\n\n\n​​This event is a must-attend for founders who plan to raise venture\, innovators\, and anyone passionate about the startup ecosystem. Gain invaluable insights from leaders who have navigated the challenges and triumphs of fundraising in today’s market. \n\n\n\n​​The event will also provide time to network over tasty food and beverages provided by our sponsors. \n\n\n\n​Agenda: \n\n\n\n​6:00p: Arrive and Check-in \n\n\n\n​6:20p: Welcome and Panel Discussion \n\n\n\n​7:00p: Networking Reception \n\n\n\n​8:00p: Program Concludes \n\n\n\n​​This event is part of the activities organized by the Glendale Growth Alliance\, a partnership between the Alliance for SoCal Innovation\, FoundersBoost and HackerFund\, and is funded by a State Grant awarded through the City of Glendale Economic Development Division. \n\n\n\n\n\n\n\n​​ 🔗 RSVP now to secure your spot and be part of the SoCal startup conversation! \n\n\n\n​This evening is sponsored by: \n\n\n\n\n\n\n\n\n\n\n\n​This event is in support of the SoCal Venture Pipeline program from the Alliance for SoCal Innovation which connects investor-ready startups seeking Seed and Series A funding with the right VCs that match their criteria. Learn more at our website. \n\n\n\n​The SoCal Venture Pipeline program is made possible by the generous underwriting of the following sponsors: URL:https://alliancesocal.org/event/fundraising-in-todays-market/ CATEGORIES:Alliance Events ORGANIZER;CN="Alliance for SoCal Innovation":MAILTO:info@alliancesocal.org END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20260325T141500 DTEND;TZID=America/Los_Angeles:20260325T183000 DTSTAMP:20260406T100728 CREATED:20260324T213332Z LAST-MODIFIED:20260324T225026Z UID:7220-1774448100-1774463400@alliancesocal.org SUMMARY:Health Systems Innovation Council Meeting - Q1 2026 DESCRIPTION:Topic: Innovation Strategies featuring Hoag\, Rady Children’s Hospital\, and ARPA-H\n\n\n\nHosted by Hoag Hospital in Newport Beach \n\n\n\n\n\n \n \n \n \n Sponsors\n \n \n \n \n \n \n \n \n \n \n Lead Sponsor\n \n\n \n \n \n \n From Strategy to Scale: IT Solutions Built for What's Next. Your vision\, powered by our top-tier talent.\n\n \n \n \n \n \n \n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n\n\n\n\nEvent Hosts\n\n\n\n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n\n\n\n\n\n \n\n\n\n\n \n \n \n \n Agenda\n \n \n \n 2:30 p.m.  Welcome by Haleh Armian\, Director of Biomedical Innovation Ventures at Hoag Hospital \n2:35 p.m.  Welcome by Mark Gamble\, Strategic Director\, Health Systems Innovation at the Alliance for SoCal Innovation: \n2:40 p.m.  Rapid-Fire Introductions \n3:10 p.m.  Presentations from Hoag and Featured Startups: \n    • Dr. Michael Brant-Zawadzki\, VP\, Clinical Research Administration\, CATALiST \n    • Ken Tang\, CEO\, Precidx \n    • Chris Freudiger\, CTO\, Invenio \n3:45 p.m.  Update on Innovation Venture Fund: Andy Wilson\, VP BD\, Keck Medicine of USC \n3:55 p.m.  Break \n4:05 p.m.  Sharief Taraman\, Attending Physician Rady Children’s Hospital and CEO of Cognoa \n4:20 p.m.  Dr. Bon Ku\, and Paul Sheehan\, Program Managers at ARPA-H \n4:50 p.m.  Interactive Council Discussion (Moderated by Andy Wilson & Mark Gamble) \n5:30 p.m.  Wine Reception \n \n \n \n \n\n\n\n\n\n\n\n\nSpeakers\n\n\n\n\n \n \n \n \n \n Michael Brant-Zawadzki\, MD\n VP\, Clinical Research Administration\, CATALiST at Hoag Health System\n View Bio \n \n \n \n \n \n \n \n \n \n \n Michael Brant-Zawadzki\, MD\n VP\, Clinical Research Administration\, CATALiST at Hoag Health System\n \n \n \n \n \n \n \n Dr. Brant-Zawadzki is currently the Vice President of Clinical Research Administration\, Center for Accelerating Technology and Life Sciences Translation (CATALiST)\, and Addiction Services at Hoag Hospital.  Formerly\, he was Hoag’s Senior Physician Executive\, facilitating business and strategic relationships with specialist clinicians\, overseeing a platform for programmatic care that integrates specialized services with population health. He also served as the Executive Medical Director of the Pickup Family Neurosciences Institute\, where he held the Sandi and Ron Simon Endowed Chair\, helping Hoag transform health care strategy\, focusing it on specific health conditions using a program driven\, physician led\, multi-disciplinary team approach\, measured by patient focused outcomes. \nDr. Brant-Zawadzki has a BA from Stanford\, and earned his MD from the University of Cincinnati\, graduating first in his class. He trained in diagnostic radiology and in interventional neuroradiology at Stanford. He spent six years in the Department of Radiology at UCSF\, he also held an Adjunct Professorship at Stanford until 2023. Dr. Brant-Zawadzki has authored over 250 papers\, numerous textbooks\, serves on a variety of editorial boards for professional journals and sat on numerous professional organization boards and committees. He lectures internationally. He is a Fellow of the American College of Radiology\, and is a Gold Medal recipient from the Society of Magnetic Resonance in Medicine\, and from the American Society of Neuroradiology. \nHe earned the Certificate in Leadership for Health Care Transformation from UC Irvine’s Paul Merage School of Business. He is a founder of\, and consultant to\, a number of companies in the biotech and radiology fields. \n \n \n \n \n \n \n \n \n \n Ken Tang\n CEO at Precidx\n View Bio \n \n \n \n \n \n \n \n \n \n \n Ken Tang\n CEO at Precidx\n \n \n \n \n \n \n \n Kenneth Tang is the CEO and Co-Founder of Precidx\, a healthcare data optimization company building the performance and data access layer for digital pathology and medical imaging. Through its Precidx Optimization Platform (POP)\, the company enables faster access\, reduced storage costs\, and scalable infrastructure for large-scale imaging datasets while preserving native files. \nPrecidx is working with leading health systems and industry partners to enable scalable digital pathology infrastructure. \nKenneth holds an M.S. in Biotechnology\, Enterprise from The Johns Hopkins University and a B.A. from the University of California\, Irvine\, and has conducted research in quantitative imaging at UCSF and UCI. \n \n \n \n \n \n \n \n \n \n Chris Freudiger\, Ph.D.\n CTO at Invenio\n View Bio \n \n \n \n \n \n \n \n \n \n \n Chris Freudiger\, Ph.D.\n CTO at Invenio\n \n \n \n \n \n \n \n \n18+ years of experience in biomedical imaging and medical device innovation\nCo-inventor of stimulated Raman histology (SRH) at Harvard and technology leader behind the NIO Laser Imaging System\nLed development of Invenio’s imaging platform and AI capabilities from early innovation through clinical implementation\nExperienced in translating advanced imaging and artificial intelligence into practical tools for hospital workflows\nWorked closely with leading physicians and health system partners to support early adoption and commercialization\n\n \n \n \n \n \n \n \n \n \n Sharief Taraman\, M.D.\n Attending Physician at Rady Children's Hospital and CEO at Cognoa\n View Bio \n \n \n \n \n \n \n \n \n \n \n Sharief Taraman\, M.D.\n Attending Physician at Rady Children's Hospital and CEO at Cognoa\n \n \n \n \n \n \n \n Dr. Sharief Taraman\, is dual board-certified in Neurology with special qualifications in Child Neurology from the American Board of Psychiatry and Neurology and Clinical Informatics from the American Board of Preventive Medicine. \nDr. Taraman was the former Division Chief of Pediatric Neurology at Rady Children’s Health Orange County and University of California-Irvine. He remains an active member of the medical staff and the Sharon Disney Lund Medical Intelligence\, Information\, Investigation\, & Innovation Institute at CHOC. \nHe is a Health Sciences Associate Clinical Professor at UC Irvine School of Medicine in the Department of Pediatrics and UC Riverside School of Medicine in the Department of Psychiatry & Neurosciences as well as an Affiliate Professor at Chapman University\, Dale E. and Sarah Ann Fowler School of Engineering. \nRecognized globally as an innovator and specifically an advocate in the field of pediatrics\, Dr. Taraman has been involved with the development of multiple FDA designated breakthrough devices\, awardee of the prestigious National Capital Consortium for Pediatric Device Innovation grant and is an advisor to Board of Directors for the International Society for Pediatric Innovation. \nCurrently\, he is the Chief Executive Officer at Cognoa and formerly served as the Chief Medical Officer leading the clinical trials that led to the FDA authorization of Cognoa’s lead product\, Canvas Dx\, the first and only FDA authorized AI based diagnostic device for autism for children 18-72 months old with concern for developmental delay. \nDr. Taraman is active in the community having previously served as a past president of the American Academy of Pediatrics (AAP) Orange County Chapter\, board member of AAP-California\, and committee member for the development of the AAP National CHILD health registry. He continues to volunteer on the Irvine Unified School District Medical Advisory Board\, with the Capistrano Unified School District and Girl Scouts of Orange County. \nDr. Taraman graduated Magna Cum Laude from the University of Michigan having majored in Biochemistry. He completed his medical education at Wayne State University School of Medicine and went on to complete residency training in Pediatrics and Pediatric Neurology at the Detroit Medical Center and Children’s Hospital of Michigan. \n  \n \n \n \n \n \n \n \n \n \n Bon Ku\, M.D.\, MPP\n Program Manager\, Resilient Systems at ARPA-H\n View Bio \n \n \n \n \n \n \n \n \n \n \n Bon Ku\, M.D.\, MPP\n Program Manager\, Resilient Systems at ARPA-H\n \n \n \n \n \n \n \n \n\nDr. Bon Ku joined ARPA-H in August 2023 from Sidney Kimmel Medical College at Thomas Jefferson University\, where he served as an associate dean and the Marta and Robert Adelson Professor of Medicine and Design. Ku also worked as the director of the Health Design Lab\, where his research focused on the medical applications of 3D printing and different ways in which to help design healthier communities. He also currently serves as a practicing emergency physician. \nKu holds a doctorate in medicine from Pennsylvania State University and a master’s in public policy from Princeton University. He is an internationally renowned speaker and has been featured at high-profile events such as SXSW and TEDx. Ku’s work toward redesigning health care has been featured in popular venues including CNBC and The New York Times. Ku is also the co-author of Health Design Thinking and the host of Design Lab Podcast. \n\n\n\n\n\n\n\n\n\n \n \n \n \n \n \n \n \n \n Paul E. Sheehan\, Ph.D.\n Program Manager\, Resilient Systems at ARPA-H\n View Bio \n \n \n \n \n \n \n \n \n \n \n Paul E. Sheehan\, Ph.D.\n Program Manager\, Resilient Systems at ARPA-H\n \n \n \n \n \n \n \n Dr. Paul Sheehan joined ARPA-H in February 2023 from the Defense Advanced Research Projects Agency (DARPA)\, where he was a Program Manager in the Biological Technologies Office. His research at that time focused on leveraging developments in synthetic biology to detect and address threats to human health\, including novel pathogens in the environment and microbial imbalances in the gut. \nBefore joining DARPA\, Sheehan spent 16 years at the U.S. Naval Research Laboratory where he worked first as a research scientist and then as the head of surface nanoscience and sensor technology. He holds a doctorate in chemical physics from Harvard University and completed a postdoctoral fellowship at the National Research Council. His papers have received over 18\,500 citations and have been spotlighted in outlets such as the Economist and the New York Times. \n \n \n \n \n \n \n\n\n\n\n \n \n \n \n Health Systems Innovation Council Members\n \n \n \n Andrew Goldfrach\, CEO\n\nArrowhead Regional Medical Center \nGeoffrey Hall\, CEO \nAlex Jawharjian\, COO \nCalifornia Rehabilitation Institute \nKelly Linden\, President and CEO \nCasa Colina Hospital and Centers for Healthcare \nBryan Croft\, EVP & COO \nCedars-Sinai \nNaser Mohammad\, CEO \nCentinela Hospital Medical Center \nOmkar Kulkarni\, VP\, Chief Transformation Officer | Chief Innovation Officer \nChildren’s Hospital LA (CHLA) \nHarlan Levine\, President\, Health Innovation and Policy \nCity of Hope \nMick Zdeblick\, CEO \nAnthony Russell\, CAO\, Ambulatory Medicine \nCommunity Memorial Healthcare \nKaty Bazylewicz\, Chief Marketing Officer and VP Population Health \nCottage Health \nJeremy Zoch\, President and CEO \nDignity Health\, Northridge Hospital Medical Center \nCarolyn Caldwell\, Hospital President and CEO \nDignity Health\, St. Mary Medical Center \nJohn Corman\, President \nHuntington Hospital \nTad Funahashi\, Chief Innovation Officer \nKaiser Permanente \nCamille Applin-Jones\, SVP & Area Manager \nKaiser Foundation Hospitals \nTJ Malseed\, CIO \nAlen Oganesyan\, Assoc. Chief Information Officer \nKeck Medicine of USC \nManeesh Goyal\, COO \nMayo Clinic Platform \nMichael Torgan\, Chief Transformation Officer \nMission Community Hospital \nKent Hoyos\, VP & Chief Information Officer \nPomona Valley Hospital Medical Center \nBernie Klein\, CEO \nProvidence Holy Cross \nMatt Bader\, Chief Strategy Officer \nProvidence St. Joseph Health \nJohn Chapman\, President and CEO \nSan Antonio Regional Hospital \nNana Deeb\, CEO \nSouthwest Healthcare\, Palmdale Regional Medical Center \nKhurram Mir\, Director of Innovation \nUCI Health \nJennifer McCaney\, Chief of Innovation \nUCLA Health \nArmand Dorian\, CEO \nUSC Verdugo Hills Hospital \nSteven Shapiro\, SVP for Health Affairs \nUSC Health \nAndy Wilson\, Vice President\, Business Development Health Affairs \nUSC \nGus Valdespino\, President and CEO \nValley Presbyterian Hospital URL:https://alliancesocal.org/event/hsic-meeting-q1-2026/ CATEGORIES:Alliance Events ORGANIZER;CN="Alliance for SoCal Innovation":MAILTO:info@alliancesocal.org END:VEVENT END:VCALENDAR